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Abstract
At present, 170 million people are infected with Hepatitis C Virus, which is about
3 % of the world population. Currently available treatment is successful in only 50
% of treated patients. Further development of the treatment strategies requires a
profound quantitative understanding of the viral lifecycle. This remains a major
challenge, however, by combining the experimental and modeling approaches it has
become possible to understand it quantitatively.
In this thesis, we develop a mathematical model to investigate the intracellular dy-
namics of HCV replication. In this model, two processes, the translation of viral
proteins and the replication of viral genomes are considered. This model is es-
tablished by using ordinary diﬀerential equations. The established model is then
calibrated by using the time course data representing the viral plus-, minus-strand
RNA and the polyprotein dynamics and the steady state data reﬂecting the ratios
among the plus-, minus-strand RNA and the non-structural proteins. Subsequently,
the model is validated using the independent measurements highlighting the replica-
tion deﬁcient and synthesis inhibited HCV RNA dynamics. Furthermore, the model
is used to analyze the observed diﬀerence in HCV RNA replication in the clonal
Huh-7 cell lines. We demonstrate that this diﬀerence can be explained by the dif-
ferential expression of the cellular host factor which involves in the replication of
viral genomes. Using the model, a role of replication vesicles with respect to viral
dynamics is analyzed. A sensitivity analysis is performed on the model parameters
to reveal the crucial steps in the viral replication. This analysis shows that the pro-
cesses in the replication vesicles are the most crucial for HCV replication. Finally,
an identiﬁability analysis is performed to check whether the model parameters are
suﬃciently estimated from the measured data.
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Zusammenfassung
Heutzutage sind etwa 170 Millionen Menschen, d.h. 3% der Weltbevölkerung,
mit Hepatitis C Virus inﬁziert. Die derzeit verfügbare Behandlung ist nur bei
50 % der behandelten Patienten erfolgreich. Die Weiterentwicklung von Behand-
lungsstrategien erfordert ein fundiertes quantitatives Verständnis des viralen Leben-
szyklus. Dies ist eine große Herausforderung, aber durch die Kombination von ex-
perimentellen und Modellierungsansätzen ist es möglich geworden, den Lebenszyklus
quantitativ zu verstehen.
In dieser Arbeit entwickeln wir ein mathematisches Modell, um die intrazelluläre
Dynamik der HCV-Replikation zu untersuchen. In diesem Modell werden zwei
Prozesse, die Translation der viralen Proteine und die Replikation des viralen Genoms,
betrachtet. Das Modell wird durch die Verwendung gewöhnlicher Diﬀerentialgle-
ichungen etabliert. Das Modell wird dann unter Verwendung experimenteller Zeitrei-
hendaten der Dynamik von Plus-, Minusstrang-RNA und Polyprotein, sowie Mes-
sungen der Verhältnisse zwischen Plus- und Minus-Strang-RNA sowie der nicht-
strukturellen Proteine im stationären Zustand, kalibriert. Anschließend wird das
Modell mithilfe von unabhängigen Messungen der Dynamik von replikationsdeﬁzien-
ter bzw. Synthese-inhibierter HCV-RNA validiert. Darüber hinaus wird das Modell
verwendet, um unterschiedliche Replikationsdynamik von HCV-RNA in verschiede-
nen Huh-7-Zelllinien zu analysieren. Wir zeigen, dass dieser Unterschied durch
die diﬀerentielle Expression eines zellulären Wirtsfaktors, welcher an der Replika-
tion des viralen Genoms beteiligt ist, erklärt werden kann. Mithilfe des Modells
wird die Rolle der Replikationsvesikel in der viralen Dynamik analysiert. Um die
entscheidenden Schritte in der viralen Replikation aufzudecken, eine Sensitivitäts-
analyse bezüglich der Modellparameter wird durchgeführt. Diese Analyse zeigt, dass
die Prozesse innerhalb der Replikationsvesikel den größten Einﬂuss auf die HCV-
Replikation haben. Abschließend wird eine Identiﬁzierbarkeitsanalyse durchgeführt,
um zu überprüfen, ob die Modellparameter ausreichend genau auf Grundlage der
gemessenen Daten geschätzt werden können.
vi
Acknowledgements
I would like to thank those people who helped me to realize and bring this work
to the end. First of all, I am deeply grateful to my group leader Professor Dr.
Lars Kaderali for oﬀering this highly interesting research project, for his continuous
support, guidance, encouragement and for the excellent work environment during
my doctoral studies. I am grateful to my supervisor, Professor Dr. Angela Stevens
for her continuous support, critique, helpful comments and discussions. I would
like to thank our experimental collaborators Dr. Marco Binder and Professor Dr.
Bartenschlager for the excellent and fruitful collaboration with support of exper-
imental data, numerous help with biological questions, for always ﬁnding time to
discuss the results. I would like to express my gratitudes to Dr. Johannes Schlöder
for carefully reading the manuscript and his helpful comments on the optimization
part of the thesis. I would like to thank Simon Lenz and Dr. Johannes Schlöder
for their support with Parﬁt software and performing Multiple Shooting Algorithm
and for their numerous discussions. Further, I am very thankful to my collegues
Dr. Narsis Kiani and Dr. Diana Clausnitzer for their critical reading of the thesis
and useful comments. Also, I am very thankful to all my collegues in Viroquant Re-
search Group Modeling for their helpful discussions and support. I am very grateful
for spending nice time with you while working on my project. I would also like
to thank all my friends for their continuous support and encouragement. Finally,
I want to thank my family for their love, support, encouragement and understanding.
Heidelberg, June 2012 Nurgazy Sulaimanov
viii
Contents
Abstract iii
Zusammenfassung v
Acknowledgements vii
Contents ix
List of Figures xiii
List of Tables xv
Foreword 1
1 Introduction 5
1.1 Hepatitis C Virus infection . . . . . . . . . . . . . . . . . . . . . . . . 5
1.1.1 Acute infection . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.1.2 Chronic infection . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.2 Hepatitis C Virus lifecycle . . . . . . . . . . . . . . . . . . . . . . . . 7
1.2.1 Model systems to study HCV lifecycle . . . . . . . . . . . . . 7
1.2.2 Genome organization . . . . . . . . . . . . . . . . . . . . . . . 8
1.2.3 HCV entry . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
1.2.4 HCV RNA replication . . . . . . . . . . . . . . . . . . . . . . 9
1.2.5 HCV assembly . . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.3 Diﬀerential equations . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.3.1 Nonlinear systems . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.3.2 Dynamical systems . . . . . . . . . . . . . . . . . . . . . . . . 15
1.4 First replication model . . . . . . . . . . . . . . . . . . . . . . . . . . 16
1.4.1 Model predictions . . . . . . . . . . . . . . . . . . . . . . . . . 18
1.4.2 Limitations of the model . . . . . . . . . . . . . . . . . . . . . 19
x2 Modeling HCV Replication 25
2.1 Translation Process . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.1.1 Processing of a transfected plus-strand RNA . . . . . . . . . . 26
2.1.2 Translation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.2 Replication in replication vesicles (RV) . . . . . . . . . . . . . . . . . 29
2.3 Host factor assumption . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.4 Complex model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.5 Experimentally determined parameter values . . . . . . . . . . . . . . 35
3 Model Calibration 39
3.1 Inverse problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.2 Parameter estimation . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
3.2.1 Multiple shooting parametrization . . . . . . . . . . . . . . . . 44
3.2.2 Generalized Gauss-Newton method . . . . . . . . . . . . . . . 46
3.2.3 Statistical analysis . . . . . . . . . . . . . . . . . . . . . . . . 47
3.2.4 Software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.2.5 Genetic algorithm . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.2.6 Genetic algorithm operators . . . . . . . . . . . . . . . . . . . 49
3.2.7 A simple genetic algorithm . . . . . . . . . . . . . . . . . . . . 51
3.2.8 Optimization using genetic algorithm . . . . . . . . . . . . . . 52
3.3 HCV replication dynamics . . . . . . . . . . . . . . . . . . . . . . . . 55
3.3.1 Plus-strand RNA kinetics . . . . . . . . . . . . . . . . . . . . 56
3.3.2 Minus-strand RNA kinetics . . . . . . . . . . . . . . . . . . . 56
3.3.3 Polyprotein kinetics . . . . . . . . . . . . . . . . . . . . . . . . 57
3.3.4 Steady state observations . . . . . . . . . . . . . . . . . . . . . 58
4 Model Validation and Predictions 61
4.1 Model validation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4.1.1 Replication deﬁcient virus dynamics . . . . . . . . . . . . . . . 61
4.1.2 Initiation hampered HCV RNA dynamics . . . . . . . . . . . 64
4.2 Model predictions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
4.2.1 Permissiveness of HCV RNA replication in diﬀerent cells . . . 67
4.2.2 Degradation inside the replication vesicles . . . . . . . . . . . 73
4.2.3 Steady state predictions . . . . . . . . . . . . . . . . . . . . . 76
4.2.4 Transfected plus-strand RNA degradation . . . . . . . . . . . 77
4.3 Sequential binding of ribosomes to HCV RNA . . . . . . . . . . . . . 79
xi
5 Sensitivity Analysis 81
5.1 Local Sensitivity Analysis . . . . . . . . . . . . . . . . . . . . . . . . 81
5.1.1 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
5.2 Global Sensitivity Analysis . . . . . . . . . . . . . . . . . . . . . . . . 86
5.2.1 Extended Fourier Amplitude Test (eFAST) . . . . . . . . . . . 86
5.2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
5.2.3 Local sensitivity versus global sensitivity . . . . . . . . . . . . 94
6 Identiﬁability Analysis 97
6.1 Prior Identiﬁability . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
6.2 Practical Identiﬁability . . . . . . . . . . . . . . . . . . . . . . . . . . 99
6.3 Local Identiﬁability Analysis . . . . . . . . . . . . . . . . . . . . . . . 101
6.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
7 Discussion 107
7.1 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
7.2 Comparison with other models . . . . . . . . . . . . . . . . . . . . . . 113
7.3 Perspectives for future work . . . . . . . . . . . . . . . . . . . . . . . 114
7.3.1 Infection model . . . . . . . . . . . . . . . . . . . . . . . . . . 114
7.3.2 Future application of the model . . . . . . . . . . . . . . . . . 115
Appendix A 117
Appendix B 121
Appendix C 129
References 131
xii
List of Figures
1.1 Genetic organization and polyprotein processing of HCV . . . . . . . 8
1.2 Hepatitis C Virus replication cycle . . . . . . . . . . . . . . . . . . . 12
1.3 First replication model . . . . . . . . . . . . . . . . . . . . . . . . . . 22
1.4 Model ﬁtting using the existing model with original parameter ranges 23
1.5 Model ﬁtting using the existing model with the extended parameter
ranges . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.1 Mathematical model of Hepatitis C Virus replication cycle . . . . . . 32
3.1 Multiple shooting approach . . . . . . . . . . . . . . . . . . . . . . . 45
3.2 Mutation in genetic algorithm . . . . . . . . . . . . . . . . . . . . . . 50
3.3 Crossover in genetic algorithm . . . . . . . . . . . . . . . . . . . . . . 51
3.4 Model calibration against experimental data . . . . . . . . . . . . . . 59
4.1 Validation of the model dynamics using a replication deﬁcient virus . 63
4.2 Model validation by the synthesis inhibited virus dynamics . . . . . . 66
4.3 Host factor diﬀerence explains the cell permissiveness for HCV repli-
cation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
4.4 Eﬀect of diﬀerent factors on the HCV replication dynamics . . . . . . 71
4.5 Correlation between virus components and cellular host factor amounts 72
4.6 Eﬀect of protective property of the replication vesicles on the repli-
cation dynamics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
4.7 Steady state predictions . . . . . . . . . . . . . . . . . . . . . . . . . 77
4.8 Initial plus-strand RNA dynamics . . . . . . . . . . . . . . . . . . . . 79
4.9 Replication dynamics in the case of sequential binding . . . . . . . . 80
5.1 Local sensitivity analysis on the model parameters . . . . . . . . . . . 85
5.2 Parameter sensitivity at t = 4 hours . . . . . . . . . . . . . . . . . . 92
5.3 Parameter sensitivity at t = 72 hours . . . . . . . . . . . . . . . . . . 93
xiv
6.1 Correlation matrix representing the correlation between the individ-
ual parameters. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
List of Tables
1.1 Parameter estimates of the ﬁrst replication model. . . . . . . . . . . . 21
2.1 Deﬁnitions of the model parameters . . . . . . . . . . . . . . . . . . . 37
3.1 Estimated kinetic parameters and initial values using Multiple Shoot-
ing Algorithm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.2 Estimated kinetic parameters and initial values using Genetic Algo-
rithm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
3.3 Values of genetic algorithm operators used in parameter estimation . 54
4.1 Parameter values in the case of inhibited HCV replication . . . . . . 66
5.1 Parameter ranges for global sensitivity analysis . . . . . . . . . . . . 95
6.1 Practical identiﬁability analysis on the model parameters. . . . . . . . 105
xvi
Foreword
Mathematical modeling plays a key role in providing a solid framework which enables
us to build experiments and to generate hypotheses. The use of mathematics to
model biological systems has a long history. As variuos models are used in an
attempt to improve our understanding of a complicated phenomena, it is becoming
clear that the more complex models are required to capture the rich variety of
dynamics observed in natural systems. By complex models, one can imagine a large
systems of diﬀerential equations which can be quite good at approximating observed
behavior, unfortunately, they contain a large number of parameters which need to be
estimated from the experimental data. At the same time, diﬀerent models are able to
produce qualitatively similar dynamics. The question is how to distinguish between
them and how to determine which may be the relevant mechanism. Moreover, the
model predictions depend on the estimated parameters and the model may lead to
wrong predictions if the model parameters are not properly estimated. Therefore,
it is becoming obvious that the close interplay between mathematical modeling and
experiments is required to precisely analyze the biological processes.
Mathematical modeling to study the intracellular plus-strand RNA virus lifecycle
was ﬁrst applied to RNA bacteriophages, Qβ [37]. This provided and important
point for developing intracellular HCV replication models. Recently, Dahari et al.
developed the ﬁrst mathematical model to study HCV replication in Huh-7 cells
[48]. This model was applied to study the mechanisms which explain the steady
state dynamics based on the experimental data measured at steady state. Recent
advances in HCV research and generation of new time course data for HCV lifecycle
require a development of more complex and realistic models that enables us to study
the host and virus interactions and to make proper predictions.
The thesis is focused on the diﬀerential equation model which based on mass ac-
tion kinetics to describe the intracellular Hepatitis C Virus replication kinetics. In
this work, we try to answer the question what are the underlying mechanisms which
shape the HCV replication dynamics. How do the complex interactions between the
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virus and the host determine the fate of viral replication?
The structure of this thesis is as follows:
Chapter 1 introduces the biological background of Hepatitis C Virus. We give
some latest facts about HCV disease and HCV lifecycle. We motivate the impor-
tance to understand HCV lifecycle in order to increase the drug eﬃciency againts
the disease. In the same chapter, we discuss the existing model for HCV replication
and its advantages and disadvantages. We discuss why this model fails to explain
the experimental data quantitatively and why it is important to develop a more
comprehensive model.
Chapter 2 focuses on the development of the new mathematical model for HCV
replication. The model is deﬁned in the form of ordinary diﬀerential equations and
based on mass action kinetics. All individual steps of the model are discussed in de-
tails. We further discuss the model parameters which are experimentally determined.
Chapter 3 discusses the model calibration process where the model is ﬁtted to the
experimental data. We discuss the formulation of the objective function and the
optimization methods used in the model calibration. We also discuss the kinetic
and steady state data which are used to verify the model eﬃciency. We show the
importance of the cellular host factor’s eﬀect in explaining the highly dynamic repli-
cation process.
Chapter 4 focuses on the validation of the established model and the predictions
drawn from the model analysis. For the validation process, we use independent
measurements which are not used in the model calibration and show that the model
simulations are consistent with these data. Using the model, we examine the dif-
ferent HCV replication dynamics in the Huh7 cells and identify the factors which
explain this observation. We further analyze the role of replication vesicles in shap-
ing the viral replication dynamics.
In Chapter 5, we use the sensitivity analysis to determine the crucial steps in viral
replication. A local sensitivity analysis is employed to check the sensitivity at the
vicinity of the best ﬁt values. For a more detailed analysis, a global sensitivity anal-
ysis is performed where the output eﬀect is calculated by changing all parameters
simultaneously.
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Chapter 6 discusses the identiﬁability of the model parameters. We discuss two
types of identiﬁability analysis which are a practical identiﬁability analysis and a
local version of the structural identiﬁability analysis. Using the practical identiﬁ-
ability analysis, we identify those parameters which cannot be properly estimated
from the experimental data. The local identiﬁability analysis is performed at the
best ﬁt values which are obtained from the model calibration.
In Chapter 7, we conclude the thesis by giving a short overview of the results and
further discuss the challenges and the future applications of the model.
In Appendix A, we present some mathematical formulations to improve the read-
ability of the text. Appendix B provides some biological terminology which sim-
plify the readability of the thesis. Finally, Appendix C provides the list of publi-
cations arising from this thesis.
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Chapter 1
Introduction
1.1 Hepatitis C Virus infection
HCV is a small, single-stranded RNA virus which belongs to the Flaviviridae family
of viruses, that cause other serious human infections, such as dengue and yellow
fever [21]. Nowadays, HCV is a global health problem, causing 40% of chronic
liver disease [40],[6]. Currently, approximately 170 million people are aﬀected with
HCV worldwide, comprising 3% of the global population [104], but depending on
the country, the prevalence ranges from 0.1 to 12% (reviewed in [6]). According
to the latest statistics, HCV infection is a leading cause of chronic hepatitis, liver
cirrhosis and hepatocellular carcinoma worldwide [97], [144], [138] and estimated to
be the most common indication for a liver transplantation in most Europe countries,
USA and Australia [5], [96], [80]. It is estimated that nearly 75% − 85% of HCV
infected people are progressing to the chronic HCV infection [138], and at least 30%
of carriers develop a progressive liver disease, including cirrhosis and hepatocellular
carcinoma (HCC)1 [145, 152]. HCV can be divided into 6 major genotypes (1 to
6) and 11 common subtypes (1a-c, 2a-c, 3a, 3b, 4a, 5a, and 6a) (reviewed in [6]).
Geographically, HCV genotypes 1, 2, and 3 occur worldwide, whereas infection with
HCV genotypes 4 and 5 occurs mainly in Africa, and HCV genotype 6 appears
mainly in Asia [11].
1.1.1 Acute infection
Acute infection occurs less frequently because the most of acutely infected people are
asymptomatic [138]. According to one study, about 70 % to 80 % of acute infections
1 The most common type of liver cancer.
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were asymptomatic [88].
The best diagnosis for the acute infection are HCV RNA tests [6] and the viral
RNA that can be detected in human blood within 1 to 3 weeks of explosure [10].
However, a beginning of the infection is frequently undetected since an icteric phase
(actual phase) of typical hepatitis occurs in only 25% of acute infections [6]. Several
studies suggested that the acute infection is very sensitive to a therapy than the
established disease [151]. An interferon therapy performed by the German Acute
Hepatitis C Therapy Group during the acute phase of infection, resulted in a re-
markable SVR1 of 98% [35], (reviewed in [151]). This study indicated that an early
treatment of the patients with the acute hepatitis C can prevent a chronic infec-
tion. Nevertheless, it has been reported that in 50% of patients, the acute infection
evolves into a chronic disease [81].
1.1.2 Chronic infection
The majority of HCV-infected individuals are unable to clear the virus during the
acute phase and become chronically infected. Chronic hepatitis is determined as
the persistence of HCV RNA in the blood for at least 6 months after the onset
of infection [138]. During the ﬁrst decade of infection, hepatitis C can progress
very slowly without liver-speciﬁc symptoms or physiological signs [6]. Most patients
experience liver related symptoms with the development of advanced liver disease
10 to 30 years after infection [152], [145], [6]. It was reported that the rate of
chronic HCV infection is aﬀected by many factors which include the age at time of
infection, the gender, and the ethnicity (reviewed in [138]). The data of one study
suggested that the people with HCV infection at younger age have chronic hepatitis
C less frequently than those infected at older age [18]. The current results indicated
that the diﬀerent racial and ethnic groups have diﬀerences in the rate of disease
progression and the response to treatment [138].
Cirrhosis occurs in about 10% to 15% of individuals with chronic HCV infec-
tion [104], [138] and higher levels of the alcohol consumption contributes to the
development of this liver disease [138], [112], [111].
It was observed that the rate of chronic HCV infection in the patients with human
immunodeﬁciency virus (HIV) infection, was higher than in the patients without
HIV infection which shows a signiﬁcance of immune response in the development of
1Sustained virological response is a best indicator of eﬀective treatment and deﬁned by the
absence of detectable HCV RNA or lower limit of detection in the serum after the end of the
treatment [1].
1.2 Hepatitis C Virus lifecycle 7
chronic hepatitis C [149], [138].
The best available treatment for HCV infection for many years was the monother-
apy with interferon which produces a sustained response in < 20% of patients [151].
The combination therapy with interferon-α and ribavirin made a signiﬁcant improve-
ment in the treatment [133], [151] and this treatment produced a sustained virus
response (SVR) in about 40% of patients with chronic HCV infection. Later, a com-
bination therapy using peginterferon instead standard interferon has been found to
be superior [83, 42]. In spite of these developments, only about 50% of individuals
with genotype 1 disease respond after the combination therapy for 48 weeks [151]
which indicates that there is still a urgent need for more eﬀective therapies.
1.2 Hepatitis C Virus lifecycle
Profound advances in understanding the important steps of the HCV lifecycle have
been made in recent years, however, many steps remained poorly understood. Figure
1.2 depicts the HCV lifecycle which comprise a viral entry, a genome replication
and a particle formation. Here, we will review the recent developments in the
ﬁeld of HCV lifecycle from Moradpour et al. [32], Bartenschlager et al., [17] and
Tellinghuisen et al. [148].
1.2.1 Model systems to study HCV lifecycle
HCV lifecycle has been studied using diﬀerent model systems (reviewed in [32]).
In 1999, Lohmann et al. [154] engineered a bicistronic subgenomic replicon system
for HCV in Huh7 cells and later it has become the standard cell-based assay to
study HCV replication. In this study, the authors reported an establishment of
persistent HCV RNA replication in a human hepatoma cell line (Huh-7)1 using a
subgenomic genotype 1b (Con1) replicon. Later, the adaptive mutations in non-
structural proteins were identiﬁed which enhance the eﬃciency of HCV replication
[148], [16]. However, a full-length HCV genome with these adaptive mutations
failed to produce an infectious virus [32]. Later, Date et al. [34] and Kato et al. [62]
revealed an HCV genotype 2a strain (JFH-1)2 capable of replication without any
adaptation (reviewed in [148]). This genotype is capable of producing an infectious
1Huh-7 is a well diﬀerentiated hepatocyte derived cellular carcinoma cell line and an immortal
cell line of epithelial-like tumorigenic cells that was originally taken from a liver tumor in a 57-
year-old Japanese male in 1982 [2]
2A japanese patient with rare case of acute fulminant hepatitis
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virus when transfected into the Huh-7 cells [157] and this achievement led to study
HCV lifecycle in vitro for the ﬁrst time.
1.2.2 Genome organization
The HCV genome consists of a positive-sense, single-stranded RNA approximately
9600 nucleotides in length. It encodes a single ORF (open reading frame)1, that is
ﬂanked by 5′- and 3′ - NCRs (non-coding regions) and the 5′-NCR contains an in-
ternal ribosome entry site (IRES) which is essential for cap-independent translation
of the viral RNA and is composed of four domains numbered I to IV (Figure 1.1)
[32]. It was reported that the domain I is not required for IRES activity, but the
domains I and II are both essential for HCV RNA replication [32],[41]. The 3′-NCR
is composed of three regions that essential for HCV replication. Translation of the
HCV open reading frame yields a polyprotein precursor that is processed into the
three structural (core, E1, E2) and six non-structural proteins (NS2, NS3A, NS4A,
NS4B, NS5A, NS5B) (Figure 1.1) [32](For more information refer to Appendix B).
9.6 kb
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Figure 1.1: Genetic organization and polyprotein processing of hepatitis C virus (HCV)
(Adapted from [98]). At the top, the HCV genome is depicted. HCV genome encodes for
the polyprotein which is depicted at the middle. The polyprotein is cleaved into the core,
structural and non-structural proteins which are depicted at the bottom.
1a portion of a gene which contains a sequence of bases that could potentially encode a protein
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1.2.3 HCV entry
The ﬁrst step in the virus life-cycle is the attachment of the virus particle to the
host cell. This is done by a speciﬁc interaction between several receptors on the
cell surface and a viral attachment protein on the surface of the particle. CD81
is a putative HCV receptor which interacts with the viral protein, E2 [115], and
it should present in a suﬃcient amount in the cell surface level for HCV entry to
be eﬃcient [67]. Low density lipoprotein receptor [7] is found to associate with
viral particle via serving as a primary collector for further targeting to CD81 and
additional receptor components (Figure 1.1) [32]. Another receptor, which binds
to a viral protein is a scavenger receptor, SR-BI [134], which mediates a selective
uptake of cholesteryl esters1 from the high density lipoprotein (HDL) into the cellular
membrane [148]. Recently, some studies [39] identiﬁed a claudin-1 (CLND1), a
component of cellular tight junctions expressed at high levels in the liver cells, as
an additional factor required for HCV entry, which functions at a late stage of cell
entry [148]. HCV binding and internalization is initiated by the interaction between
the HCV-associated lipoproteins and the lipoprotein receptors SR-BI and the virus
enters the cell by endocytosis and fusion of the viral envelope which leads to the
release of the viral nucleocapsid into the cytoplasm [27].
1.2.4 HCV RNA replication
Once the virus enters the cell, a translation of HCV RNA by the cellular ribosomes
starts. Translation is the whole process by which the nucleotide sequence of an
mRNA is used to order and to join the amino acids in a polypeptide chain [76]. HCV
RNA acts as an mRNA to synthesize the polyprotein. The ribosomes physically
move along an viral RNA, thereby catalyzing the assembly of amino acids into
polypeptide chains [76]. The translation of the HCV open reading frame (ORF)
generates a large polyprotein that undergoes co- and post-translationally cleavage
events processed by both cellular and viral proteases into the structural and non-
structural proteins (Figure 1.1) [148], [32]. The structural proteins are processed by
the endoplasmic reticulum (ER) signal peptidase and the non-structural proteins
are processed by the two viral proteases, NS2 − 3 protease and the NS3 − 4 serine
protease [32]. Like other plus-strand RNA viruses, HCV replication starts with the
synthesis of a complementary minus-strand RNA using the genome as a template
1Cholesterol esters form from the chemical reaction between an alcohol and an
acid. They often used for transport and storage than free cholesterol. Read more:
http://www.livestrong.com/article/136499-deﬁnition-cholesterol-esters
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and after the minus-strand is synthesized, a genomic plus-strand RNA is produced
from a minus-strand RNA template, where the both steps are catalyzed by the
NS5B RdRp polymerase [32]. Co-precipitation and immunostaining studies have
demonstrated that the newly synthesized HCV genome exists in association with
a membraneous web [142], [137]. Expression of all structural and non-structural
protein in the context of the entire HCV polyprotein has been observed to induce
membrane changes [36]. This study revealed that HCV NS4B protein can induce
the formation of the membraneous web alone.
Morphologically similar structures have been identiﬁed by the electron microscopy
within the hepatocytes of HCV-infected chimpanzees [113]. All HCV non-structural
proteins are found to be associated with the membraneous web in Huh-7 cells har-
boring subgenomic HCV replicons [121]. Experimental studies have shown that
the viral RNA and proteins exist within detergent resistant, lipid-raft membranes
[153, 128]. Furthermore, a membrane separation analysis has revealed that the HCV
NS proteins exist in both in ER and Golgi apparatus, however, the viral RNA was
found to primarily occur in the Golgi fraction [8].
What kind of role these membranes play in the HCV replication is not well
understood. There are some speculations about the possible functions of them in
the HCV RNA synthesis (reviewed in [32]). It has been hypothesized that they may
physically support and organize RNA replication complex [79], compartmentalize
the viral products [136], tether the viral RNA during unwinding, provide the lipid
constituents important for replication and protect the viral RNA from double-strand
RNA-mediated host defences.
Hepatitis C virus (HCV) encodes a large polyprotein and all viral proteins are
produced in equimolar amounts regardless of their function [120]. Analysis on the
Huh-7 cells harboring full-length HCV genomes or subgemonic replicons revealed
about 1000-fold excess of HCV proteins over plus and minus-strand RNA [120]. To
examine whether all nonstructural protein copies are involved in RNA synthesis,
the authors isolated the active HCV replication complexes from the replicon cells
and examined them for their content of viral RNA and proteins before and after
a treatment with the protease and the nuclease. As the result, they demonstrated
that almost the entire minus- and plus-strand RNA were resistant to the nuclease
treatment, whereas < 5% of the nonstructural proteins were protected from the
protease digest but accounted for the full in vitro1 replicase activity. In consequence,
only a minor fraction of the non-structural proteins was actively involved in RNA
1In lab conditions, the components of organism have been isolated to allow more profound
analysis than in whole organism. It is also known as “test tube experiments“.
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synthesis. Comparing the nuclease-resistant viral RNA to the protease-resistant
viral proteins, they estimated that the active HCV replicase complex consists of one
minus-strand RNA, two to ten plus-strand RNA, and several hundred nonstructural
protein copies. Since only the minor fraction of viral proteins participate in RNA
synthesis, the role of other proteins is not well understood. It is believed that
several factors may account for the production of the large amount of NS proteins
that are not part of replication complexes [146]. They could be the by-products
of polyprotein synthesis that produces large amounts of structural proteins; they
might play active roles in counteracting innate immunity or cell cycle regulation;
they may participate in the formation of infectious virions.
In the following, we will review some cellular factors which have been found
to associate with HCV replication. As reviewed in [146], several studies identiﬁed
that many cellular cofactors regulate HCV replication in vitro, including an miRNA
[59, 109], the distinct host proteins that interact with nonstructural proteins, and the
components of the RNA interference pathway [122]. Recent studies demonstrated
that a cyclosporin A (CsA) inhibits HCV replication in vitro and a cyclophilin1 B
is a target of CsA action [60]. Recently, it has been reported that the cyclophilin
A not the cyclophilin B is the key mediator of inhibition of HCV replication by the
cyclosporin A [63], [162].
Some studies suggested that the hyperphosphorylation2 of NS5A reduces an in-
teraction with the human vesicle associated membrane protein A (hVAP-A) [38],
[32]. hVAP-A has been reported to direct nonstructural proteins to lipid rafts that
may be involved in viral replication [43]. In cell culture, HCV RNA replication is
stimulated by saturated and mono-unsaturated fatty acids, and inhibited by polyun-
saturated fatty acids or inhibition of fatty acid synthesis [32]. These results indicate
that a membrane ﬂuidity is important for the function of the replication complex.
Recent studies [124] on human kinome using a siRNA screen revealed that a kinase,
phosphatidylinositol-4 kinase III alpha (PI4KIIIα) are required for HCV replication.
The authors reported that an enzymatic activity is critical for HCV replication and
the viral non-structural protein NS5A was found to interact with PI4KIIIα and
stimulate its kinase activity and the absence of PI4KIIIα activity induced a dra-
matic change in the structural morphology of the membraneous HCV replication
complex. The data of another study also supported the importance of this host
1Cyclophilins (CyPs) are a family of cellular enzymes possessing the peptidyl-prolyl isomerase
activity [162]
2Hyperphosphorylation means when a biochemical with multiple phosphorylation sites is fully
saturated
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factor in regulating HCV replication [72].
Figure 1.2: Hepatitis C Virus replication cycle (Adapted from [15]). The process starts
by an attachment of the HCV particle to the cell surface receptors. The virus enters
the cell by a fusion where the viral genome is released into the cell. The viral genome
is then translated by the host ribosomes into a viral polyprotein which is cleaved into a
core, structural and nonstructural proteins. The viral genome then replicates within the
membraneous web by synthesizing a complementary minus-strand RNA using its genome
as a template. The newly produced minus-strand RNA is served as a template for the
synthesis of a new plus-strand RNA. Eventually, the viral genome participates in assembly
and particle formation.
1.2.5 HCV assembly
The last step of HCV lifecycle consists of packaging, assembly and particle release.
Currently, a little information is available about the late steps of the viral lifecy-
cle, which indicates that this area is still in its infancy. It has been shown that
the mutations in NS5A, NS2 and NS3 block the production of infectious viruses
which suggested a role of these non-structural proteins in the virus assemlby and
the particle release (reviewed in [146]). Cellular host factors like lipoproteins were
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detected to participate in HCV assemly [54], [90] and HCV assembly was shown to
occur on lipid droplets [94]. Virions is believed to form by budding into ER derived
compartment and leave the cell through the secretory pathway [32].
1.3 Diﬀerential equations
A diﬀerential equation is an equation which involves an unknown function and one
or more of its derivatives. Many of the fundamental laws of science are formulated in
terms of diﬀerential equations. When modeling a complex process, one usually ends
up with a complex model consisting of several equations which include non-linearity
terms. In the following, we will start discussing diﬀerential equations by giving some
facts about non-linear ordinary diﬀerential equations of the ﬁrst order from [110].
1.3.1 Nonlinear systems
Let us consider an initial value problem given by the linear systems of ordinary
diﬀerential equations
x˙ = Ax, x(0) = x0 (1.1)
where x ∈ Rn, A ∈ Rn×n has a solution through each point x0 ∈ Rn, which is
x(t) = eAtx0. This solution is unique and deﬁned for all t ∈ R.
In the case of the non-linear equations, a unique solution exists only under certain
conditions.
Lets consider a non-linear systems of ordinary diﬀerential equations given by
x˙ = f(x) (1.2)
and for simplicity assume that they are autonomous. In general, this equation has
a solution if the function f is continuous for all x ∈ Rn. However, in contrast to the
linear problem, a continuity of f is not suﬃcient to quarantee the uniqueness of the
solution of (1.2).
Deﬁnition 1.3.1. Assume that f ∈ C(E) where E is an open subset of Rn. Then
x(t) is a solution of the diﬀerential equation (1.2) on an interval I if x(t) is diﬀer-
entiable on I and for all t ∈ I, x(t) ∈ E and
x′(t) = f(x(t))
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and given x0 ∈ E, x(t) is a solution of the initial value problem
x˙ = f(x), x(t0) = x0
on an interval I if t0 ∈ I, x(t0) = x0 and x(t) is a solution of (1.2) on the interval I.
For the existence and uniqueness of the solution, one needs to show that C1
functions are locally Lipschitz.
Deﬁnition 1.3.2. Let E be an open subset of Rn. A function f : E → Rn is said
to satisfy a Lipschitz condition on E if there is a positive constant K such that for
all x, y ∈ E
|f(x)− f(y)| ≤ K|x− y|
The function f is said to be locally Lipschitz on E if for each point x0 ∈ E there
is an − neighborhood of x0, N(x0) ⊂ E and a constant K0 > 0 such that for all
x, y ∈ N(x0)
|f(x)− f(y)| ≤ K0|x− y|
− neighborhood of x0 means an open ball of radius  given by
N(x0) = {x ∈ Rn, |x− x0| < }.
The following lemma indicates the conditions under which the function f is lo-
cally Lipschitz.
Lemma 1.3.3. Let E be an open subset of Rn and let f : E → Rn. Then if
f ∈ C1(E), f is locally Lipschitz on E.
The following theorem shows the existence and uniqueness of the solution of
nonlinear ordinary diﬀerential equation.
Theorem (The Fundamental Existence-Uniqueness Theorem) 1.3.4. Let E
be an open subset of Rn containing x0 and assume that f ∈ C1(E). Then there
exists a positive a > 0 such that the initial value problem
x˙(t) = f(x(t)) x(0) = x0 (1.3)
has a unique solution x(t) on the time interval [−a, a].
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This theorem shows that the initial value problem (1.3) has a unique solution
deﬁned on some interval. The following theorem shows that (1.3) has a unique so-
lution on a maximal interval of existence (α, β).
Theorem 1.3.5. Let E be an open subset ofRn and suppose that f ∈ C1(E). Then
for each point x0 ∈ E, there is a maximal open interval (α, β) on which the initial
value problem (1.3) has a unique solution, x(t); i.e., if the initial value problem has
a solution y(t) on an interval I then I ⊂ (α, β) and y(t)− x(t) for all t ∈ I.
1.3.2 Dynamical systems
We ﬁrst start with deﬁning dynamical systems. We assume that the temporal be-
havior of a system is given as a function Φ(x(0), t) of the initial state x(0) and the
time t. Moreover, we assume that x(t) satisﬁes an initial value problem of the form
x˙(t) = f(x(t)), x ∈ E, x(0) = x0 (1.4)
where, E is an open subset of Rn and the function f ∈ C1(E → Rn) is a
continuously diﬀerentiable function. That is, all partial derivatives of f with respect
to xj, ∂fi/∂xj, with i, j = 1, ..., n, exist and are continuous. This guarantees the
existence of a unique solution x(t) in a time interval [−a, a] (see theorem 1.3.4).
The solution of system (1.4) is related to a dynamical system, which provides
a functional description of the solution of the system. Here, we will give a formal
deﬁnition of a dynamical system and detailed information can be found in [110].
Deﬁnition (Dynamical system) 1.3.6. A dynamical system on E is a C1- map
Φ : R× E → E (1.5)
where E is an open subset of Rn, and if Φt(x) := Φ(t, x) then Φt satisﬁes
• Φ0 = x for all x ∈ E and
• Φt ◦ Φs(x) = Φt+s(x) for all s, t ∈ R and x ∈ E.
Φ(t, x0), for ﬁxed x0 ∈ E corresponds to the solution of the initial value problem
in Theorem 1.3.4. The ﬁrst property in Deﬁnition 1.3.6 assures that the initial
condition x(0) = x0 is fulﬁlled. The second property states that the evolution of
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the system is uniquely determined for every t′ ∈ R if the state x of the system
at any t is known. This means that the solution curves in the state space cannot
intersect, since otherwise the time evolution of the system would not be unique at
the intersection point. More clearly, we state the following relation between the
dynamical system and the initial value problem: If Φ(t, x) is a dynamical system
deﬁned on E ⊆ Rn, then
f(x) = d
dt
Φ(t, x)|t=0 (1.6)
Deﬁnes a C1 - vector ﬁeld on E, and for each x0 ∈ E,Φ(t, x0) solves the initial
value problem (1.4). Furthermore, a solution of the initial value problem (1.4) exists
for every t ∈ R, meaning that for each x0 ∈ E, the maximal interval of existence
of Φ(t, x0) is the time interval I(x0) = (−∞,∞). Thus, each dynamical system is
related to a C1- vector ﬁeld f , and the dynamical system describes the solution set of
the diﬀerential equation deﬁned by this vector ﬁeld. Conversely, given a diﬀerential
equation x˙ = f(x), x ∈ E with f ∈ C1(E) and E an open subset of Rn, the solution
Φ(t, x0) of the initial value problem (1.4) with x0 ∈ E will be a dynamical system
on E if and only if for all x0 ∈ E, the maximal interval of existence I(x0) of Φ(t, x0)
is (−∞,∞). In this case, we say that Φ(t, x0) is the dynamical system on E deﬁned
by the diﬀerential equation x˙ = f(x).
1.4 First replication model
First replication model for HCV was developed by Dahari et al. [48]. Their model is
based on the assumptions that the translation of HCV polyprotein occurs in the cy-
toplasm, HCV RNA synthesis occurs in the vesicular membrane structures (VMS)1
and the strategy of replication involves a double-stranded RNA intermediate. Using
the model, the authors tried to address the question if what kind of mechanisms or
factors can explain the steady-state observations published in [120]. Here, we will
discuss their results more in details. The model is based on the HCV replication
scheme depicted in Figure 1.3. They used the biological facts that the translation of
the HCV polyprotein takes place in the cytoplasm by involving host ribosomes and
the replication of HCV RNA occurs in the vesicular membrane structures (VMS).
The model equations describing the translation process in cytoplasm are described
1 in our case, we use the deﬁnition of replication vesicles (RV).
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as follows:
dRcytP
dt
= k2Tc + kPoutRP − k1RiboRcytP − kPinRcytP − µcytP RcytP
dTc
dt
= k1RiboRcytP − k2Tc − µTcTc
dP
dt
= k2Tc − kcP
dEcyt
dt
= kcP − kEinEcyt − µcytE Ecyt
(1.7)
where RcytP represents the numbers of plus-strand RNA, Tc represents the numbers of
translation complexes formed by an interaction of plus-strand RNA with the host ri-
bosomes, P represents the numbers of viral polyprotein, Ecyt represents the numbers
of viral polymerase, NS5B, formed as the result of polyprotein cleavage. Parame-
ter k1 is the interaction rate of plus-strand RNA, RcytP , with the host ribosomes,
Ribo, to form a translation complex, Tc, which degrades at rate µTc . The constant
µcytP is the degradation rate of free plus-strand RNA. Ribo represents a complex of
several ribosomes that interacts with RcytP to initiate the translation. To keep the
model simple, they assumed that 10 ribosomes simultaneously translate the same
HCV mRNA. The viral polyprotein, P , is translated by the eﬀective rate k2 and
the ribosomes involved in translation dissociate when the synthesis of polyprotein is
complete. Newly formed polyprotein is cleaved at rate kc into several structural and
non-structural proteins. One of the non-structural proteins NS5B, Ecyt, is impor-
tant for HCV replication and degrade at rate µcytE . Furthermore, NS5B molecules
are transported into the replication vesicles (RV) at rate kEin. Rtotibo is a fraction
of the total pool of cellular ribosomes and the number of free ribosome complexes
in translation is given by: Ribo = Rtotibo − Tc. Once the translation is complete, the
plus-strand RNA, RcytP , reappear at rate k2. Some fraction of free plus-strand RNA
is lost due to a transport from cytoplasm into VMS by rate kPin and is gained by
a transport out at rate kPout. The equations that describe the replication kinetics
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are:
dRP
dt
= −k3RPE + k4pRIds + kPinRcytP − (kPout + µcytP )RP
dRds
dt
= k4mRIp + k4pRIds − k5RdsE − µdsRds
dE
dt
= kEinEcyt + k4mRIp + k4pRIds − k3RPE − k5RdsE − µEE
dRIp
dt
= k3RPE − k4mRIp − µIpRIp
dRIds
dt
= k5RdsE − k4pRIds − µIdsRIds
(1.8)
RP , Rds and E represent the numbers of plus-strand RNA, double-stranded
RNA (dsRNA), and HCV polymerase complexes, respectively. The numbers of
plus-strand RNA and dsRNA replicative intermediate complexes given by RIp and
RIds, respectively. The intermediate complex, RIp, which is formed at rate k3 and
degrades at rate µIp, comprises a plus-strand RNA that serves as a template for
the newly synthesized minus-strand RNA, the polymerase which plays a machinery
role in replication, and the nascent complementary minus-strand RNA. The RIds,
that is formed at rate k5 and degrades at rate µIds, is composed of dsRNA which
contains the minus-strand RNA that serves as a template for the newly synthesized
plus-strand RNA, the polymerase E, and the nascent complementary plus-strand
RNA, RP . It was assumed that once the synthesis of minus-strand RNA has ended,
the replication complex, RIp, immediately dissociates into the dsRNA, Rds, and the
replication machinery E at rate k4m. The same strategy is also applied for minus-
strand replication complex RIds. So, when the synthesis of the newly produced
RNA, RP , has ended, the replication complex, RIds, immediately dissociates into
the new plus-strand RNA, the polymerase E, and the dsRNA at rate k4p. Both the
free plus-strand RNA and the dsRNA degrade with rate µp and µds, respectively.
Additionaly, the polymerase complex, E, degrades at rate µE.
Importantly, any activity of the cellular factors that could limit the replication
process was neglected by assuming that they are abundant.
1.4.1 Model predictions
In the following, we will summarize the results obtained by the replication model
from [48]. The experimental data which will be discussed in this Subsection are
from [120] and a short overview about the details is given in Section 3.3.
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A model analysis showed that the main factor which signiﬁcantly aﬀects the
number of NS5B polymerase molecules is the number of ribosomes. The results
demonstrated that about 500 to 1000 ribosomes complexes are needed for the syn-
thesis of a million NS5B molecules at steady-state.
Further, the model is able to predict 1 : 1 ratio of the total plus-strand RNA in
cytoplasm to the total plus-strand RNA in RVs (VMS), by assuming kPin/kPout =
1 which means an equal transport of plus-strand RNA into and out of the RVs.
However, for the rest of analysis, they set kPin/kPout = 0.2 and µIds/kEin = 104,
because it didn’t aﬀect 1 : 1 ratio and it was needed to explain further observations.
Further analysis was done on the asymmetry levels of plus-strand and minus-
strand RNA. In [120], it was reported that the asymmetry level reﬂects that the
ratio of plus-strand to minus-strand RNA is about 10 : 1. To obtain an approximate
ratio, they needed to assume that the formation rate of RIds is about 200-fold faster
than the formation rate of RIp. Here RIds and RIp are the minus and plus-strand
replicative intermediate complexes, respectively. In terms of kinetic rates, it gives
k5/k3 ≈ 200. The rate constant k3 varies between 0.004 and 0.02 h−1 molecules−1.
This large ratio also explains the observed 6 : 1 ratio of plus-strand to minus-strand
RNA within the RVs [120]. This analysis explains how this asymmetry between the
plus-strand and the minus-strand arises.
Further analysis was performed on the level of plus-strand RNA at steady-state.
They reported that kEin and µcytP are the parameters that mostly aﬀect the steady-
state level of total plus-strand RNA. The model analysis showed that the ranges of
µcytP (0.06 to 15 h−1) and kEin (3.8 × 10−6 to 6.0 × 10−5 h−1) allow a steady state
with the observed plus-strand RNA level.
Moreover, they used the model to analyze the time to reach the steady state. Af-
ter the ratios were ensured, the remaining parameters [kc, k1, k3, µE, µTc and R
cyt
P (0)]
were adjusted to allow the system to reach the steady-state at about 48 hours. The
analysis revealed that by keeping a large ratio of k5/k3, both the plus- and minus-
strand RNA attain the steady state at 48 hours, when RcytP (0) ≈ 500 copies/cell,
µTc < 0.02 h−1 and k1 ≈ 80 h−1. Moreover, the model analysis showed that there is
an inverse correlation between RcytP (0) and time to reach the steady state.
1.4.2 Limitations of the model
Due to a lack of experimental data on the numbers of plus-strands at the time
of transfection and the lack of detailed kinetic information about the growth rate
of plus-strand RNA, minus-strand RNA and proteins from transfection to steady
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state, they could not estimate the parameter values precisely. As we discussed in
Subsection 1.4.1, the model parameters were adjusted by using the steady-state
data, whereas for a proper estimation the kinetic data is required. At a ﬁrst glance,
we examined whether the model calibrated with the steady state data can explain
the kinetic measurements (for kinetic data see Section 3.3). We ﬁtted the total
plus-strand RNA, the minus-strand RNA and the polyprotein (luciferase) to the
corresponding kinetic data, which highlight the replication dynamics from trans-
fection to 72 hours. Initially, we restricted the model calibration to the original
parameter ranges (Table 1.1). As a result, we have seen that the model is not
able to capture the replication dynamics in the plus-, minus-strand RNA and the
polyprotein (Figure 1.4). As we have seen from the parameter estimation by keeping
them in the original ranges, it was actually impossible to ﬁt the model to the data.
Next, we tried to relax the parameter ranges to check if the model is able to
ﬁt. The results show that there is a signiﬁcant improvement, but still the model
fails to explain the dynamics quantitatively (Figure 1.5). Figure 1.5 depicts several
ﬁts performed with the diﬀerent scale factors. For more information about the
scale factor, we refer to Section 3.3. This plot reﬂects how the diﬀerent scale factor
values change the way of the ﬁtting, which mostly aﬀects the dynamics of plus-
and minus-strand RNAs, however, it does not aﬀect the ﬁt at the polyprotein curve
initially. Additionally, the initial phase of polyprotein is overestimated in all cases.
Theoretically, this issue could be resolved by either decreasing k1 or increasing µcytP ,
however within the given ranges, tuning these parameters is unsuﬃcient to decrease
the level of polyprotein initially and it leads to underestimation of a later phase of
polyprotein. For small values of the scale factor, the prediction for the minus-strand
RNA and as well as plus-strand RNA after 8 hours is underestimated (Figure 1.5 A).
Obviously, the polyprotein prediction is overestimated comparing to the observation.
When the scale factor gradually increases, the quality of the prediction for the
minus-strand RNA and the later phase of plus-strand RNA is slightly improved,
whereas the initial phase of the latter one is getting worse (Figure 1.5 B, C, D).
Thereby, withing the parameter ranges given in [48], it was not possible to ﬁnd any
proper ﬁt. These results demonstrated that the model lacks some vitally important
reactions and indicates a need for a more comprehensive model to make quantitative
predictions.
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Table 1.1: Parameter estimates of the ﬁrst replication model [48].
Parameter name Parameter deﬁnition Parameter values
k1 Tc formation 1-100 (h−1 molecule−1)
k2 polyprotein translation 100∗ (h−1)
kc polyprotein cleavage 0.2-1 (h−1)
kPin R
cyt
P transport into RV 0.2 (h−1)
kPout RP transport into cytoplasm 0.2 (h−1)
kEin E
cyt transport into RV 4e-6 to 4e-5 (h−1)
k4m Rds synthesis 1.7∗ (h−1)
k4p RP synthesis 1.7∗ (h−1)
k5 RIds formation k5/k3 = 200 (h−1 molecule−1)
k3 RIp formation 0.001-0.02 (h−1 molecule−1)
µcytP R
cyt
P degradation 0.06-15∗ (h−1)
µTc Tc degradation 0.001-0.02 (h−1)
µcytE E
cyt degradation 0.06∗ (h−1)
µIp RIp degradation 0.01-0.06∗ (h−1)
µds Rds degradation 0.06∗ (h−1)
µE E degradation 0.001-0.06 (h−1)
µIds RIds degradation µIds/kEin = 104 (h−1)
µP RP degradation 0.07∗ (h−1)
Rtotibo ribosome complexes 500-1000 molecules
RcytP (0) transfected plus-strand RNA 10-1000 molecules
*, from literature
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Figure 1.3: Model for Hepatitis C Virus replication cycle (Adapted from [48]). See text
for details.
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Figure 1.4: The ﬁtting with the original model within the parameter ranges given in
Table 1.1 with respect to the diﬀerent scale factors. Experimental data for numbers of the
total plus-, minus-strand RNAs and the polyprotein are denoted by blue, red and black
circles, respectively (obtained from high permissive Huh7 Lunet cells). The data points
indicate mean values. The corresponding model simulations are denoted by red, blue and
black curves, respectively. (A) scale factor = 0.001, (B) scale factor = 0.004, (C) scale
factor = 0.01, (D) scale factor = 0.1
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Figure 1.5: The ﬁtting with the original model using the extended ranges with respect
to the diﬀerent scale factors. Experimental data for numbers of the total plus-, minus-
strand RNAs and the polyprotein are denoted by blue, red and black circles, respectively
(obtained from high permissive Huh7 Lunet cells). The data points indicate mean values.
The corresponding model simulations are denoted by red, blue and black curves, respec-
tively. (A) scale factor = 0.001, (B) scale factor = 0.004, (C) scale factor = 0.01, (D)
scale factor = 0.1
Chapter 2
Modeling HCV Replication
As we already discussed in Subsection 1.4.2, the model developed by Dahari et al.
[48] can reproduce the steady state data, but failed to explain the kinetic data. The
measurements on HCV kinetics demonstrated that the initial stage of replication
is highly dynamic. Additionally, these measurements revealed signiﬁcantly diﬀerent
replication courses in the Huh7 cell clones. We found out that this model failed to
even explain the individual measurements performed in these cell lines. All these
indicate a strong need for a new model which can elucidate the highly dynamic
replication kinetics and predict a source of the diﬀerent replication dynamics in
Huh7 cell lines. In this Chapter, we will discuss the development of a new replication
model using mass action kinetics1.
2.1 Translation Process
Translation is a process by which the nucleotide sequence of an mRNA is used to
order and to join the amino acids in a polypeptide chain. In this process, HCV RNA
acts as an mRNA to synthesize the polyprotein [76]. Ribosomes physically move
along a viral RNA, thereby catalyzing the assembly of amino acids into polypeptide
chains. Polypeptide also known as polyprotein is cleaved into a core and several
structural and non-structural proteins. In a modeling process, we ignore the role of
core and structural proteins, because in the experimental studies the regions that
encode for these proteins were removed so that the process can be explained only
with non-structural proteins and a viral RNA. Importantly, the whole process takes
place in the cellular cytoplasm.
1for more information see Appendix A
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2.1.1 Processing of a transfected plus-strand RNA
In the transfection experiments, a large amount of viral genome is transfected into
the cell. How eﬀectively these tranfected genomes can replicate is not known. It was
observed that a high variation in HCV replication may indicate that a signiﬁcant
fraction of viral genomes appear to be defective [85], [17]. It also may be explained
from the fact that in vitro conditions, the viral genome lacking a coat protein is
used. It is believed that viral genome without the coat protein is more likely to
degrade faster than the viral genome which enters the cell in a natural way. Simply,
viral genomes which include defects do not contribute to the replication, and those
which are not defected contribute. Further, it might be that an adaptation to the
cell environment aﬀect the replication process causing defects in the viral genome.
Here, we include an initial step which accounts for this kind of eﬀects.
RunpP
k0−→ RcytP (2.1)
where, the newly transfected plus-strand RNA, RunpP , is assumed to be unprocessed,
meaning that it comprises all plus-strands which are capable of translating and
those which are not. This unprocessed free plus-strand RNA process at rate k0 to
the processed free plus-strand RNA, RcytP and degrades at an eﬀective rate, µ
unp
P .
Using mass action kinetics, we can convert this reaction to the following equation:
dRunpP
dt
= −k0RunpP − µunpP RunpP (2.2)
the solution of which nothing else but a typical exponential function:
RunpP (t) = R
unp
P (0)e−(k0+µ
unp
P )t (2.3)
where, RunpP (0) is an initial number of transfected plus-strand RNA molecules. As
we see, the processing step is independent of other processes and can be computed
directly. The role of this additional step will be discussed in Chapter 4.
2.1.2 Translation
Once processed, the plus-strand RNA can directly interact with the cellular ribo-
somes, a complex molecule machine composed of both RNA and protein, to form a
translation complex:
RcytP +Ribo
k1−→ Tc (2.4)
2.1 Translation Process 27
This reaction happens at rate k1 and the viral plus-strand RNA degrades at rate
µcytP . Tc is a translation complex that comprises plus-strand RNAs and ribosome
complexes, Ribo, and degrades at rate µTc . A protein bound RNAs were found to
be more stable against the host nuclease, therefore, we assume µTc < µ
cyt
P . This
condition indicates that free the plus-strand RNA, RcytP degrade faster than the
plus-strand RNA within the translation complex, Tc. During the translation, the
ribosome assembles and links together amino acids in the precise order dictated by
the viral plus-strand RNA (serves as a messenger RNA), which leads to the ﬁnal
product, a polyprotein. This process can be simply modelled as:
Tc
k2−→ P +RcytP +Ribo (2.5)
The synthesis of the polyprotein, P is done at rate k2. Once the polyprotein pro-
duction is complete, the translation complex dissociates into the plus-strand, RcytP
and the ribosome complex, Ribo at the same rate k2.
The viral polyprotein, P , is then cleaved by host protease into several non-
structural (NS) proteins. The NS proteins were found to play a major role in the
replication and the role of them are being extensively studied. The key protein
which plays a major role in RNA synthesis is an NS5B protein having a polymerase
activity. This polymerase can directly copy a complementary RNA from a plus-
strand RNA template. Therefore, to keep the model simple, we address the role of
this protein in our model. In reaction terms,
P
kc−→ Ecyt (2.6)
The cleavage of polyprotein, P , is done at rate kc or simply, we can say, Ecyt is
produced from P at rate kc. In turn, the polymerase, Ecyt degrades at rate µcytE .
Once the polymerase is cleaved from the polyprotein, it can be used in the
formation of so called replication complexes inside the replication vesicles (RV)
(vesicular membrane structures, (VMS)), within which the replication undergoes.
Recent experimental studies have revealed that the viral replication happens inside
these structures. The formation of these structures (RV) can be induced by viral
proteins. Viral plus-strand RNA can only enter the RV together with the viral
protein NS5B, translated from itself. This property is called a cis-process where the
viral plus-strand RNA is ﬁrst translated to produce the polyprotein, and after can
be used for a complementary RNA synthesis.
First, we assume that NS4B induces the formation of the replication vesicles. As
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a ﬁrst step after RV has been formed, we assume the formation of the intermediate
replicative complex, which we deﬁne as RIp, which contains a plus-strand RNA and
a polymerase. This complex is called a plus-strand intermediate replicative complex.
Here, we consider that the formations of the replication vesicles and the replication
complexes are independent processes, therefore, we assume only the eﬀect of NS5B
in the process. The formation of RV happens with physical conformation of cellular
components which might participate in this process. Experimental studies have
revealed several factors that interact with viral components at the replication stage
of viral RNA. Here, we assume that a putative cellular factor participates at the
formation of RV. Adding this term to the model, we obtain:
Tc + Ecyt +HF
kPin−−→ RIp +Ribo (2.7)
This represents the formation of the replication complex from the plus-strand RNA,
the polymerase and the cellular host factor. Here, assume that the ribosomes within
the translation complexes dissociate at the same rate kPin.
Additionally, in order to describe the dynamics of polyprotein marker (luciferase),
we include an additional reaction:
Tc
k2−→ L (2.8)
This polyprotein marker is used to quantify the polyprotein dynamics and we assume
that it degrades at rate µL.
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Combining all processes that have been described above, we can write the equa-
tions for the translation process:
dRunpP
dt
= −k0RunpP − µunpP RunpP
dRcytP
dt
= k0RunpP + k2Tc − k1RiboRcytP − µcytP RcytP
dTc
dt
= k1RiboRcytP − k2Tc − kPinTcHFEcyt − µTcTc
dP
dt
= k2Tc − kcP
dEcyt
dt
= kcP − kPinTcHFEcyt − µcytE Ecyt
dHF
dt
= −kPinTcHFEcyt + k4mRIp
dRibo
dt
= −k1RiboRcytP + k2Tc + µTcTc + kPinTcHFEcyt
dL
dt
= k2Tc − µLL
(2.9)
2.2 Replication in replication vesicles (RV)
Recent studies revealed that HCV ampliﬁes its RNA inside a membraneous web.
This web harbors the viral RNA and the polymerase from being degraded by host
nuclease and protease. We assume that, the already available plus-strand RNA
serves as a template for a synthesis of new minus-strand RNA, which in turn, serves
as a template for the formation of new plus-strand RNA.
The family of viruses to which HCV belongs, has a feature of forming the inter-
mediate replication complexes which initiate the production of new viral RNA.
The mechanism of HCV RNA replication inside the RV is not clearly understood.
Most well known fact is that the viral RNA and the polymerase participate in this
process. Once RV is formed, the ﬁrst component which serves as a starting point
is the plus-strand intermediate replicative complex. The polymerase within this
complex can copy a complementary-strand, which is the minus-strand RNA, from
the plus-strand template. This process can simply be written as:
RIp
k4m−−→ Rds + E +HF (2.10)
Here, the minus-strand RNA, Rds is synthesized at rate k4m from the intermediate
complex, RIp. Once the production of Rds is complete, RIp dissociates into the plus-
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strand RNA, Rds, the polymerase, E and the cellular factor, HF . Here, we assume
that the new minus-strand RNA exists in a double-stranded form. Therefore, Rds
consists of both plus-strand and minus-strand RNA. During the computation this
term will account for both variables.
After the minus-strand synthesis is complete, the minus-strand RNA, Rds inter-
acts with the polymerase, E to form a minus-strand intermediate replicative complex
at rate k5:
Rds + E k5−→ RIds (2.11)
This intermediate complex comprises double-strand RNA and polymerase. Within
this complex, minus-strand RNA serves as a template for the production of new
complementary plus-strand RNA. Then this intermediate complex leads to the for-
mation of a new plus-strand RNA at an eﬀective rate k4p:
RIds
k4p−−→ RP +Rds + E (2.12)
After the production of new plus-strand RNA, RP is done, the intermediate complex
dissociates into the double-stranded RNA and the polymerase.
The newly produced plus-strand RNA then interacts with the polymerase, E
to participate in the minus-strand synthesis or is exported at rate kPout into the
cytoplasm, where it will be translated by the host ribosomes, Ribo thereby leading
to a replication cycle, which lasts till a signiﬁcant number of viral RNA accumulates
in the cell:
RP
kPout−−−→ RcytP (2.13)
This reaction gives a positive feedback to the viral RNA in the cytoplasm.
All reactions developed in this section can be converted to the following system
of ordinary diﬀerential equations:
dRIp
dt
= kPinTcHFEcyt − k4mRIp + k3RPE − µIpRIp
dRds
dt
= k4mRIp + k4pRIds − k5RdsE − µdsRds
dE
dt
= k4mRIp + k4pRIds − k5RdsE − k3RPE − µEE
dRIds
dt
= k5RdsE − k4pRIds − µIdsRIds
dRP
dt
= k4pRIds − k3RPE − kPoutRP − µPRP
(2.14)
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Eventually, all processes in the cytoplasm and the RV can be integrated into a
whole model which is given in Figure 2.1. Similarly, all equations can be combined
into a complete system of ordinary diﬀerential equations:
dRunpP
dt
= −k0RunpP − µunpP RunpP
dRcytP
dt
= k0RunpP + k2Tc + kPoutRP − k1RiboRcytP − µcytP RcytP
dTc
dt
= k1RiboRcytP − k2Tc − kPinTcHFEcyt − µTcTc
dP
dt
= k2Tc − kcP
dEcyt
dt
= kcP − kPinTcHFEcyt − µcytE Ecyt
dHF
dt
= −kPinTcHFEcyt + k4mRIp
dRibo
dt
= −k1RiboRcytP + k2Tc + µTcTc + kPinTcHFEcyt
dL
dt
= k2Tc − µLL
dRIp
dt
= kPinTcHFEcyt − k4mRIp + k3RPE − µIpRIp
dRds
dt
= k4mRIp + k4pRIds − k5RdsE − µdsRds
dE
dt
= k4mRIp + k4pRIds − k5RdsE − k3RPE − µEE
dRIds
dt
= k5RdsE − k4pRIds − µIdsRIds
dRP
dt
= k4pRIds − k3RPE − kPoutRP − µPRP
(2.15)
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Figure 2.1: Mathematical model of Hepatitis C Virus replication cycle. HCV replication
starts once the plus-strand RNA enters the cell during the transfection. We assume that
they should to be processed ﬁrst by rate k0 and during processing degrade with rate µunpP .
Once processed, the viral plus-strand RNA interacts with the host ribosome complexes to
form the translation complex with the rate k1. Once the translation complex is formed,
a viral polyprotein is produced at rate k2 and subsequently cleaved into nonstructural
proteins with rate kc. Viral proteins induce the formation of replication vesicles, and the
translated plus-strand RNA, the viral polymerase and the cellular factors enter the vesicle
with rate kPin, by forming intermediate plus-strand replication complexes inside. The
complementary minus-strand is then formed with rate k4m, and the intermediate complex
is dissociated into dsRNA and NS5B polymerase. Here, we assume that free minus-strand
RNA exists in the form of double-stranded RNA (dsRNA). Finally, when the minus-strand
RNA is present, the formation of the dsRNA replicative intermediate occurs at rate k5 and
it leads to the synthesis of new plus-strand RNA with rate k4p. Once the full plus-strand
RNA is synthesized, the intermediate complex dissociates into dsRNA and polymerase.
The newly synthesized plus-strand RNA then participates in the intermediate complex
formation at rate k3 or leaves the vesicle to participate in the translation process at rate
kPout. In addition, the corresponding degradation rates of the variables are shown.
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2.3 Host factor assumption
In this section, we will discuss about a particular case of the model. Generally, the
property of the host factor which may limit the replication is not known. There are
two possible assumptions that we can make about the host factor. First, it may
have an enzymatic activity and second, it may be consumed during the replication.
In both cases, the host factor will limit the replication. In the model, which has
been described above, we assumed that the host factor plays an enzymatic role in
the replication process:
Tc + Ecyt +HF
kPin−−→ RIp k4m−−→ Rds + E +HF (2.16)
In this reaction, the host factor, HF participates in the process by playing a ma-
chinery role without being consumed. In the case of consumed host factor, we can
describe the process as follows:
Tc + Ecyt +HF
kPin−−→ RIp k4m−−→ Rds + E (2.17)
In this case, there will be no feedback from the replication complex, RIp to HF
and the host factor, HF is getting consumed in the formation of replication complex,
RIp. Then the corresponding diﬀerential equation for the host factor HF looks as
follows,
dHF
dt
= −kPinTcEcytHF (2.18)
2.4 Complex model
In our model, we used a simpliﬁed approach which considers a simultaneous binding
of 10 ribosome molecules to an HCV RNA. More realistic picture of RNA binding to
ribosomes can be obtained by considering a sequential binding. A sequential binding
model has been developed and discussed in [48]. The elongation rate in eukaryotes
has been estimated at three to eight amino acids per second per ribosome [77], [107].
At these rates, the subgemonic HCV polyprotein, which is 2000 amino acids long,
is translated at rate range 5.4 to 14.4 polyproteins per hour per ribosome, which
gives a mean rate of 10. Wang et al. [158] have shown that at least eight ribosomes
were present on an eﬃcient replication of HCV RNA during the translation. If we
consider approximately that 10 ribosomes are required for an eﬃcient replication,
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then the complex model can be rewritten as:
RcytP +Ribo
k1−→ R1
Ri +Ribo
k∗1−→ Ri+1(i = 1, .., 8)
R9 +Ribo
k∗1−→ Tc k2−→ R9 +Ribo + P
(2.19)
Here, Ri represents the number of polysomes consisting of i ribosomes attached to
an HCV RNA. The free plus-strand RNA molecules, RcytP , are converted at rate
k1 into R1 because of ribosome attachment. A gradual attachment of ribosomes
leads to Ri + Ribo
k∗1−→ Ri+1 where (i = 1, .., 8). Ri and Ri+1 diﬀer by the ribosome
molecules attached to the HCV RNA. Once the last ribosome molecule attached to
the R9, the translation complex, Tc is formed:
R9 +Ribo k1−→ Tc (2.20)
Then the translation complex leads to the production of a polyprotein
Tc
k2−→ P +Ribo +R9 (2.21)
After the synthesis of polyprotein is complete, Tc dissociates into R9 and Ribo. We
further assume that once the plus-strand RNA attaches to a ribosome and become
a polysome, it will remain in this state until its degradation with an average rate
of µTc . Under these assumptions, the model can be converted into the following
diﬀerential equations:
dR1
dt
= k1RiboRcytP − k∗1RiboR1 − µTcR1
dRn+1
dt
= k∗1RiboRn − k∗1RiboRn+1 − µTcRn+1
dR9
dt
= k∗1RiboR8 + k2Tc − k∗1RiboR9 − kPinTcEcytHF − µTcR9
(2.22)
Adding and modifying these equations to the system of equations from the simpliﬁed
model, we get a complex system of ordinary diﬀerential equations for HCV RNA
replication described by the model of sequential binding. Throughout the thesis, we
will concentrate on the simpliﬁed model and the complex model will be considered
only as a special case.
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2.5 Experimentally determined parameter values
Totally, the simpliﬁed model contains 20 kinetic parameters and 3 initial values. Out
of all parameters, 5 are experimentally determined. From the available kinetic data,
we have determined one initial value which is the number of transfected plus-strand
RNA. Here, we will give a short overview from the literature about some parameters
which have been experimentally determined.
HCV polyprotein elongation rate
We have already discussed in Section 2.4 that in eukaryotes the elongation rate has
been estimated as at three to eight amino acids per second per ribosome [77], [107].
This gives 5.4 to 14.4 polyproteins per hour per ribosome. A mean rate, in this case,
is 10 polyproteins per hour per ribosome. It has been reported that at least 8 ribo-
somes were present on an eﬃcient replicon HCV RNA during translation [158]. In
our simple model, as it was applied in [48], we assumed that 10 ribosome molecules
simultaneously translate one molecule of HCV RNA. Thus, we have the polysome
size of 10 ribosomes per HCV RNA yielding a subgenomic HCV polyprotein trans-
lation rate, k2 = 100 polyproteins per hour per ribosome.
HCV plus- and minus-strand RNA synthesis rate
Experimentally, HCV RNA has been estimated to be synthesized at about 150 nu-
cleotides (nt) per minute by the HCV recombinant NS5B puriﬁed from Escherichia
Coli [106]. In Huh-7 cells, it has been estimated about 180 nt/min [82]. HCV RNA
consists of about 6300 nt, and a respective synthesis rate gives k4p = 1.7 RNA
molecules per hour per replicative intermediate complex [154]. Since in our model,
minus-strand RNA exists with dsRNA, we assume that there is no diﬀerence in the
synthesis rate when the minus-strand or the plus-strand serves as a template for
replication, k4m = k4p.
NS5B polymerase degradation rate in cytoplasm
A protease treatment in vitro revealed that about 95% of NS5B were sensitive and
found not to be involved in a replicase activity [120], [95]. This suggests that a vast
majority of polymerase molecules reside in the cytoplasm, whereas only a minor
fraction reside in the RV. We assumed that reported half life of 12 hours of NS5B
[114], which was measured in Huh-7 cells in vitro corresponds to the half life of poly-
merase in the cytoplasm. From this, we can calculate the corresponding degradation
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rate, which is µcytE = 0.06 h−1.
HCV plus- and minus-strand RNA degradation rates
A nuclease1 treatment of replicon cells revealed that some fraction of plus-strand
RNAs as well as minus-strand RNAs were resistant against this treatment. The cor-
responding half-life of both variables were detected to be about 10 and 11.5 hours,
respectively. This gives the corresponding degradation rates 0.07 h−1 and 0.06 h−1,
respectively. We set this rate as a lower boundary for the cytoplasmic HCV RNA
degradation. From the kinetic data, we calculated that the transfected plus-strands
degrade with the half life about 1 hour which corresponds to the degradation rate,
0.7 h−1. We used this information when estimating the degradation rate of trans-
fected plus-strand RNA.
Degradation rate of polyprotein marker
The polyprotein kinetics have been measured using a luciferase reporter. It has
been reported that the half life of this polyprotein marker is about 2−4 hours [150],
[69]. In our case, we assume that the half life is equal to 2 hours, which gives the
corresponding degradation rate of µL = 0.35 h−1.
1Nuclease is an enzyme that cleaves the bonds between nucleotide subunits of nucleic acids.
They degrade RNA and DNA into their mononucleotide building blocks [76].
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Table 2.1: Deﬁnitions of the model parameters.
Parameters Deﬁnitions
k0 processing rate of transfected plus-strand RNA
k1 formation rate of translation complex
k2 polyprotein translation rate
kc polyprotein cleavage rate
kPin formation rate of the plus-strand replicative intermediate complex
kPout transport rate of new plus-strand RNA into cytoplasm
k4m minus-strand RNA synthesis rate
k4p plus-strand RNA synthesis rate
k5 formation rate of the minus-strand replicative intermediate complex
k3 formation rate of the minus-strand replicative intermediate complex
µunpP degradation rate of transfected plus-strand RNA
µcytP degradation rate of processed plus-strand RNA
µTc degradation rate of translation complex
µcytE degradation rate of NS5B protein
µIp degradation rate plus-strand replicative intermediate complex
µds degradation rate of minus-strand RNA
µE degradation rate of active polymerase in replication vesicles
µIds degradation rate of minus-strand replicative intermediate complex
µP degradation rate of nascent plus-strand RNA
µL degradation rate of polyprotein (luciferase)
RunpP (0) initial number of transfected plus-strand RNA
Ribo(0) initial number of ribosome complexes
HF (0) initial number of cellular host factor
pscale scaling factor for polyprotein levels (luciferase)
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Chapter 3
Model Calibration
Calibration is a process by which parameters in a model are adjusted to match
a model performance to experimental data [9]. Model calibration has a potential
to yield correct and weakly determined values. When learning the speciﬁc process
kinetically, the rate of the certain process is of great importance. Calibrating the
models againts the kinetic data gives an excellent method to estimate the kinetic
rates of interest. In this Chapter, we will discuss about the model calibration process
by explaining individual steps in details.
3.1 Inverse problem
After we obtained the ordinary diﬀerential equation model for HCV replication, the
next task for us is to learn essential parameters in the model which are unknown. In
the present case, except the parameters which have been experimentally observed,
the remaining parameters should be estimated from the experimental data, which
leads to an inverse problem. Given a complete description of a physical system,
we can predict the outcome of some measurements. This problem of predicting the
result of measurements is called the modelization problem, the simulation problem,
or the forward problem [147].
The inverse problem consists of using the actual result of some measurements
to infer the values of the parameters that characterize the system. The forward
problem has a unique solution, while the inverse problem does not.
Lets assume an equation of the form,
K(x) = y (3.1)
Where K is an operator describing the explicit relation between the observation y
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and the parameter x. One can formulate the direct problem as the evaluation of the
operatorK, given the parameter x. Similarly, the inverse problem can be formulated
as to solve (3.1) for the parameter x.
The inverse problem is ill-posed, while the direct problem is well-posed in the
sense of Hadamard [50]. According to [65], a deﬁnition of a well-posed problem can
be given as follows:
Deﬁnition (well-posedness) 3.1.1. Let X and Y be normed spaces, K : X → Y
a linear or nonlinear mapping. The equation Kx = y is called well-posed if the
following conditions hold:
• Existence: For every y ∈ Y there is at least one x ∈ X such that Kx = y.
• Uniqueness: For every y ∈ Y there is at most one x ∈ X with Kx = y.
• Stability: The solution x depends continuously on y, i.e., for every sequence
(xn) ⊂ X with Kxn → Kx(n→∞), it follows that xn → x(n→∞).
If one of these properties does not hold then the problem is called ill-posed.
Inverse problems are usually ill-posed, whereas the direct problems are well-
posed. The following theorem implies that the linear equations of the form Kx = y
with the compact operators K are always ill-posed.
Theorem 3.1.2. Let X and Y be normed spaces and K : X → Y be a linear
compact operator with nulspace N(K) := x ∈ X : Kx = 0. Let the dimension of
the factor space X/N(K) be inﬁnite. Then there exists a sequence (xn) ⊂ X such
that Kxn → 0 but (xn) n does not converge. In particular, if K is one-to-one, the
inverse K−1 : Y ⊃ K(X)→ X is unbounded.
One method to solve an equation Kx = y is a least squares method. In the
following, we will shortly overview this method. For more information see [65].
Lets a ﬁnite dimensional subspace Xn ⊂ X is given. Determine the solution
xn ∈ Xn such that
||Kxn − y|| ≤ ||Kzn − y|| for all zn ∈ Xn. (3.2)
Existence and uniqueness of xn ∈ Xn follow from the fact that Xn is ﬁnite dimen-
sional and K is one-to-one. The solution xn of this least squares problem is deﬁned
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as
(Kxn, Kzn) = (y,Kzn) for all zn ∈ Xn. (3.3)
If one chooses a basis xˆj, j = 1, ..., n of Xn, then (3.2) reduces to a ﬁnite dimensional
system.
n∑
j=1
αj(Kxˆj, Kxˆi) = βi = (y,Kxˆi), i = 1, ..., n. (3.4)
If we denote Aij = (Kxˆj, Kxˆi), then we have Aα = β, where A ∈ Kn×n and positive
deﬁnite, because K is one-to-one. If K = R then A is symmetric. Now we assume
that the right hand side of equation (3.3) is perturbed. Let xδn be the solution of
the following equation for continuous perturbations,
(Kxδn, Kzn) = (yδ, Kzn), ∀zn ∈ Xn (3.5)
where yδ ∈ Y is the perturbed right hand side with ||yδ − y|| ≤ δ. The same can
be applied to the ﬁnite system (3.4). In this case, we consider that β ∈ Kn is
substituted by βδ ∈ Kn with |βδ − β| ≤ δ, where |.| is an Euclidean norm in Kn.
By doing this, one obtains the following ﬁnite system of equations:
n∑
j=1
αδj(Kxˆj, Kxˆi) = βδj , i = 1, ..., n. (3.6)
Because A is positive-deﬁnite, this system of equations has a unique solution.
Since the least squares method is convergent, any optimization algorithm can be
applied to minimize ||Kx − y||. In the following Section 3.2, we will use the opti-
mization algorithms based on Multiple-Shooting and Genetic Algorithm to ﬁnd an
optimal x which minimizes the value of objective function.
3.2 Parameter estimation
Prior to estimation, we speciﬁed some parameter values based on the literature
data, which we discussed in Section 2.5. Except those parameters which values
were available from the literature, the remaining parameters are estimated from the
experimental data by minimizing an objective function. The parameter estimation
has been performed using the multiple shooting and genetic algorithms. A complete
list of parameter values is given in Table 3.1. The detailed description of the opti-
mization algorithms, we will give below. We will start with the formulation of the
parameter estimation problem.
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Lets assume that the replication system (2.15) is given in a general form
y˙(t) = f(t, y(t), p), t ∈ [t0, tf ] (3.7)
where y(t) denotes the vector given by the concentrations of the 13 species,
y(t) = (RunpP , R
cyt
P , Tc, P, E
cyt, HF , RIp, Rds, E,RIds, RP , Ribo, L)
p is a unknown parameter and has to be determined by parameter estimation. t ∈
[t0, tf ] is the time.
Lets assume that the experiments have been carried out at the given times tj, j =
1, ...,m yielding the measurements ηij, i = 1, ...,mj, j = 1, ...,m of the observation
function hij which depends on the variables y(t) and the parameter p,
ηij = hij(tj, y(tj), p) + εij, (3.8)
which are subject to the measurement errors εij. This formulation also includes the
case when several species are measured at a time tj.
The parameters are estimated by minimizing the diﬀerence between the model
and the data,
||F1(y(t1), ..., y(tm)), p)|| = ||(ηij − hij(tj, y(tj), p))wij|| (3.9)
In our case, the objective function is chosen as a least squares sum of the diﬀerences
between the measurement ηij and the model predictions hij weighted with the factor
wij,
min
y(t),p
∑
ij
((ηij − hij(tj, y(tj), p))wij)2 (3.10)
In the case of independent and normally distributed measurement errors with
zero mean,
εij = ηij − hij(tj, y(tj), p) ∈ N(0, σ2ij) (3.11)
and choosing wij =
1
σij
, (3.10) yields a maximum likelihood estimate.
Moreover, the additional knowledge about the state variables and the parameters
in the model can be considered as the equality and inequality constraints at time tj,
F2(y(tj), p) = 0, F3(y(tj), p) ≥ 0, (3.12)
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summing up, the parameter estimation problem can be formulated as
min
y(t),p
∑
ij
((ηij − hij(tj, y(tj), p))wij)2
s.t. (y(t), p) solves y˙(t) = f(t, y(t), p), t ∈ [t0, tf ]
F2(y(tj), p) = 0, F3(y(tj), p) ≥ 0
(3.13)
The unknown parameters in our case are,
p =(k0, k1, kc, kPin, kPout, k5, k3, µunpP , µ
cyt
P , µTc,
Ribo(0), µVMS, µL, HF,high(0), HF,low(0), pscale)
(3.14)
The experimental measurements have been performed within the time interval 0
and 72 hours. Hence, the time interval is chosen as t ∈ [t0, tf ] = [0, 72].
In our case, the measurement function hij is deﬁned as follows:
For the plus-strand RNA measurements, the measurement function is given by
RtotP = R
unp
P +R
cyt
P + Tc +RP +RIp +Rds +RIds (3.15)
For the minus-strand RNA measurements
Rtotm = Rds +RIds (3.16)
and for the polyprotein measurements, it is given by
Lpol = pscaleL (3.17)
Additionally, we have the information about the state variables at steady state
and the measurement functions for them are deﬁned as:
The ratio of plus-strand RNA to minus-strand RNA,
RtotP /R
tot
m = (R
unp
P +R
cyt
P + Tc +RP +RIp +Rds +RIds)/(Rds +RIds) (3.18)
The ratio of plus-strand RNA to minus-strand RNA in the replication vesicles,
RRVP /R
tot
m = (RP +RIp +Rds +RIds)/(Rds +RIds) (3.19)
The ratio of plus-strand RNA in the cytoplasm to plus-strand RNA in the repli-
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cation vesicles,
RCY TP /R
RV
P = (R
unp
P +R
cyt
P + Tc)/(RP +RIp +Rds +RIds) (3.20)
3.2.1 Multiple shooting parametrization
The problem (3.13) is an inﬁnite-dimensional optimization problem, since the func-
tions y have been deﬁned as the optimization variables, which have to fulﬁll an
inﬁnite dimensional equality constraint. To reduce the optimization problem to a ﬁ-
nite dimension, we used a multiple shooting method [22], [23], [24]. This method has
many applications in diﬀerent areas such as chemical engineering (the denitrogeniza-
tion of pyridine, [22]), biophysics (the photosynthesis process, [14]) and civil space
ﬂight (satellite orbit determination, [71]). Bock at el. [24] reported that this method
is numerically stable and usage of this method enables to decrease the nonlinearity
of the problem. Dividing the integration interval limits an error propagation and
allows to solve optimization problems for unstable or chaotic systems [24], [13], [61].
We can now brieﬂy describe the procedure of this method. For detailed overview,
we refer to [24] and [71].
One discretizes the time interval where the measurements are given by choosing
a suitable grid of multiple shooting nodes τk,
t0 = τ0 < τ1 < ... < τM = tf , (3.21)
The value of the state variables, sk are chosen as additional unknowns andM relaxed
initial value problems at each grid point (see Figure 3.1).
Initial value problem,
y˙(t) = f(t, y(t), p), y(τk) = sk (3.22)
are solved on each interval [τk, τk+1] giving a solution y(tk, sk, p). To ensure that y(t)
is continuous in the solution of the optimization problem, the matching conditions
are imposed,
sk+1 − y(τk+1; sk, p) = 0, k = 0, ...,M − 1 (3.23)
Inserting the computed values y(tk, sk, p) into (3.13), one obtains a constrained
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Figure 3.1: Multiple shooting approach. Adapted from [24]. The constrained problem
(3.24) is solved as a boundary value problem within the interval of [τk, τk+1].
problem in the variables (s, p) = (s0, ..., sM , p),
min
s,p
∑
i,j
((ηij − hij(tj, y(tj), p))wij)2
s.t. F2(s, p) = 0, F3(s, p) ≥ 0
sk+1 − y(τk+1; sk, p) = 0, k = 0, ...,M − 1
(3.24)
Setting M = 0 and omitting the matching conditions will give a single shooting
method.
New constrained problem (3.24) is solved using the Gauss-Newton method which
is described in Subsection 3.2.2.
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3.2.2 Generalized Gauss-Newton method
A nonlinear constrained problem simply can be written as
min
x
||F1(x) = 0||22 s.t. F2(x) = 0, F3(x) ≥ 0 (3.25)
For solving this least squares problem, a generalized Gauss-Newton method is
used (refer to [71], [24]).
The generalized Gauss-Newton method is an iterative method. Given an itera-
tion,
xk → xk+1 = xk + tk∆xk, 0 < tk ≤ 1 (3.26)
which starts from an initial guess x0 for the optimization variables. Here, ∆xk is
determined as the solution of a linearized constrained least-squares problem which
is derived from (3.25):
min
∆xk
||F1(xk) + J1(xk)∆xk||22
s.t. F2(xk) + J2(xk)∆xk = 0,
F3(xk) + J3(xk)∆xk ≥ 0
(3.27)
where Ji(xk) =
∂Fi(x)
∂x
∣∣∣
x=xk
is the Jacobian matrix of the function Fi(x) with i =
1, 2, 3. The tk ∈ [0, 1) in (3.26) is a stepsize.
Using the following notations,
F (xk) =

F1(xk)
F2(xk)
F3(xk)
 and J(xk) =

J1(xk)
J2(xk)
J3(xk)
 (3.28)
the solution of the linearized problem can be written as
∆xk = −J+(xk)

F1(xk)
F2(xk)
F3(xk)
 (3.29)
where J+(xk) is a generalized inverse of J(xk).
In order to improve the convergence behavior of Gauss-Newton method, the
damped iterations xk → xk+1 = xk + λk∆xk, with the damping factor λk ∈ (0, 1]
was used [25].
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3.2.3 Statistical analysis
For the solution of the optimization problem, a statistical analysis was performed
which is very important for parameter estimation problems. This statistical analysis
is based on the covariance matrix C [24], which is computed from the generalized
inverse by
C = β2cJ+(xk)
I 0
0 0
 (J+(xk))T (3.30)
where I denotes the identity matrix and β2c is a common factor, which is computed
by β2c =
||F1(xk)||22
l2
, where l2 denotes the number of degrees of freedoms, i.e. the
number of optimization variables minus the number of equality constraints. Esti-
mated standard errors for all optimization variables are calculated by the square
roots of the diagonal elements of the covariance matrix.
A conﬁdence interval for the probability α for the optimization variable xi can
be obtained by
xi = [xi − δxi, xi + δxi] (3.31)
where δxi =
√
Cii
√
l1F1−α(l1, l2), where l1 is the number of least squares conditions
minus l2. F1−α(l1, l2) is a quantile of the F distribution for error probability 1− α.
In our case, we observed that during the parameter estimation, the optimization
violated the biologically plausible bounds for the parameters k5 and kc. To avoid
this issue, we ﬁxed the parameters to their upper bounds and did the covariance
analysis for remaining parameters.
3.2.4 Software
The numerical methods for the solution of nonlinear constrained least squares prob-
lems and the statistical analysis are implemented in the software PARFIT [22],[23],
which was used for the parameter estimation of our model. The initial value prob-
lem solutions and their derivatives are computed using the solver METANB, which
is incorporated in PARFIT.
3.2.5 Genetic algorithm
Genetic algorithms are search algorithms based on the mechanics of natural selection
and natural genetics [46]. We summarize this algorithm from [86] as following:
The genetic algorithm solves optimization problems by mimicking the principles of
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biological evolution, repeatedly modifying a population of individual points using
rules modeled on gene combinations in biological reproduction.
We will begin by discussing the genetic algorithm and its properties. A detailed
description about the genetic algorithm can be found in [46], [159].
These algorithms are a subclass of evolutionary algorithms where the elements
of the search space are binary strings or arrays of other elementary types. Genetic
algorithms have been developed by John Holland and his colleagues at the University
of Michigan [53].
In the genetic algorithm, an objective function is referred to ﬁtness functions.
The search space of genetic algorithms is referred to genome and its elements are
called genotypes. Genotypes encompass the whole hereditary information of an
organism encoded in the DNA. The DNA is a string of base pairs that encodes
the phenotypical characteristics of the creature it belongs to. In genetic algorithm,
the genomes are strings, like natural prototypes. Due to a linear structure, these
phenotypes are also called chromosomes [159]. The position where a speciﬁc gene
is located in a chromosome is called a locus.
Deﬁnition (String Chromosome) [159] 3.2.1. A string chromosome can either
be a ﬁxed-length tuple or variable-length list.
In the case of ﬁxed-length tuple, the loci i of the genes gi are constant and,
hence, the tuples may contain elements of diﬀerent types Gi,
G = {∀(g[1], g[2], ..., g[n]) : g[i] ∈ Gi, ∀i ∈ 1, ..., n} (3.32)
This is not a case in variable-length string genomes. Here, the positions of the genes
may shift when the reproduction operations are applied. Thus, all elements of such
genotypes must have the same type GT ,
G = {∀lists, g : g[i] ∈ GT ,∀0 ≤ i < len(g)} (3.33)
String chromosomes are normally bit strings, vectors of integer numbers or vectors
of real numbers.
Deﬁnition (Intron) [159] 3.2.2. Parts of a genotype g ∈ G that does not con-
tribute to the phenotype x = gpm(g) are called introns.
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3.2.6 Genetic algorithm operators
Here, we will discuss the genetic algorithm operators and for detailed information
refer to [159] and [46].
Creation: Creation of ﬁxed-length string individuals means to create a new tuple
of the structure deﬁned by the genome and initialize it with random values. It can
be roughly described as:
createfl() ≡ (g[1], g[2], ..., g[n]) : g[i] = Gi[ randomu ∗ len(Gi)], ∀i ∈ 1, ..., n
Variable-length strings can be created by ﬁrst randomly drawing a length l > 0 and
then creating a list of that length ﬁlled with random elements. In this process, the
individual strings are copied according to their ﬁtness function values. This means
that the strings with higher value contribute more oﬀspring in the next generation
with higher probability.
Mutation: Mutation is an important method for keeping the diversity of the so-
lution candidates by introducing small, random changes into them. In ﬁxed length
string chromosomes, this is done by randomly modifying the value (allele) of a gene
(Figure 3.2 (a) and (b)). More general version of this form of mutation where
0 < n < len(g) locations in the genotype g are changed simultaneously. In binary
coded chromosomes, for instance, these genes are bits which can simply be toggled.
For real-encoded genomes, modifying an element gi can be realized by replacing
it with a number drawn from a normal distribution with an expected value g1,
gnewi ∼ N(g1, σ2). In the case of the string chromosomes with variable length, the
set of mutation operations can be extended by two additional methods. First, a cou-
ple of genes with randomly chosen alleles at any given position can be inserted into
a chromosome (Figure 3.2 (d)). Second, in constrast, the elements can be deleted
from the string (Figure 3.2 (e)).
Permutation: The permutation is one of mutation methods where the alleles of
two genes are exchanged (Figure 3.2 (c)). This makes sense only if all genes have
similar data types.
Crossover: Crossover is a recombination of two string chromosomes which is per-
formed by swapping parts of two genotypes. In a case of single-point crossover,
both parental chromosomes are split at randomly determined crossover points. As a
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result, a new child genotype is created by appending the second part of the second
parent to the ﬁrst part of the ﬁrst parent (Figure 3.3 (a)). In two-point crossover,
both parental genotypes are split at two points and a new oﬀspring is created by us-
ing parts number one and three from the ﬁrst, and the middle part from the second
parent chromosome (Figure 3.3 (b)). For ﬁxed-length strings, the crossover points
for both parents are always identical. In the variable-length string chromosomes,
the same crossover operations are available as for ﬁxed-length strings except the
strings that are no longer necessarily split at the same points. The length of the
new strings resulting from such deletion and insertion operation may diﬀer from the
lengths of the parents.
(a) (b) (c)
(d) (e)
Figure 3.2: Mutation and permutation in genetic algorithm (a) Single gene mutation (b)
Multi gene mutation (c) Permutation of genes. Adapted from [159].
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(a) (b)
Figure 3.3: Crossover in genetic algorithm (a) Single gene mutation (b) Multi gene mu-
tation (c) Permutation of genes. Adapted from [159].
3.2.7 A simple genetic algorithm
Now, we will brieﬂy show how a simple genetic algorithm works. In his work,
Mitchell [93] summarized the simple genetic algorithm as follows:
1. Generate a random population of n l-bit chromosomes i.e. candidate solutions.
2. Calculate the ﬁtness f(x) of each chromosome x in the population.
3. The following steps should be repeated until n oﬀspring have been created:
(a) Select a pair of parent chromosomes from the current population. Proba-
bility of selection depends on the ﬁtness function. The same chromosome can
be selected to become a parent more than once.
(b) Cross over the pair with probability pc at a randomly chosen point to form
two oﬀsprings. If there is no crossover, then two oﬀsprings which are exact
copies of ther parents are formed.
(c) Mutate the two oﬀsprings at each locus with the probability pm. If there
is a mutation takes place, then there will be now a change in the chromo-
some. In opposite, if there is 100% mutation, then the whole chromosome is
changed. After the mutation integrate the resulting chromosomes into the new
population. Mutation often prevents from stacking into a local minima.
4. Replace the current population with the new population.
5. Go to step 2 (these procedure should be repeated with the new population).
Each iteration in GA is referred to a generation.
Another important parameter which can improve the optimization is a popula-
tion size. Population size gives information about the number of chromosomes in
population [103]. If the population size is too small, only a small part of search space
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is explored. In this case, the probability of performing crossover will be dropped.
A high population size leads to the generation of many chromosomes which slows
down the optimization process.
3.2.8 Optimization using genetic algorithm
We performed optimization using Global Optimization Toolbox in Matlab. We used
Genetic Algorithm (GA) to solve the least squares problem (3.13) deﬁned in Section
3.2. Since there is no structured guidence for using GA operators which maximizes
the search for an optimum solution, we set up these operators as following:
Out of total population, we set 10% to be elite children which means that 10%
of all individuals with the best ﬁtness value proceed to the next generation.
In Matlab, the parameter which controls the crossover is given in a range of
[0, 1]. 0 means no crossover and 1 means full crossover. We set up this parameter as
0.7, which means that 70% of population which remain after excluding elite children
participate in the crossover. The remaining individuals participate in the mutation.
The population size has been chosen between 300-2000 individuals. We found out
that the optimization with the high population size gives better results. However,
it took longer to converge to the optimum solution. Optimization with the low
population size has higher probability to stack into a local minima and usually
requires more generations to converge to a global minima.
The number of generations have been chosen between 1000 and 2000. The op-
timization with the high population size required less generations, whereas the op-
timization with the low population size needed more generations. If the population
size is X, then the distribution of the population will look as,
0.1 ∗X = elite children
0.7 ∗ (X − 0.1 ∗X) = crossover children
remaining population = mutation children
(3.34)
Table 3.3 demonstrates the GA operators used in our case. The best parameter
values obtained by GA are given in Table 3.2.
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Table 3.1: Estimated kinetic parameters and initial values using Multiple Shooting Algo-
rithm.
Parameter name Parameter values 90% conﬁdence intervals
k0 0.00587 h−1 (−1.49× 10−3, 0.0132)
k1 1 h−1molec−1 ﬁxed
k2 100 h−1 experimentally observed
kc 1 h−1 ﬁxed
kPin 2.07 × 10−6 h−1molec−2 (−3.23× 10−6, 7.36× 10−6)
kPout 0.333 h−1 (0.165, 0.502)
k4m 1.7 h−1 experimentally observed
k4p 1.7 h−1 experimentally observed
k5 10 h−1molec−1 ﬁxed
k3 10−4 h−1molec−1 ﬁxed
µunpP 0.758 h−1 (0.464, 1.05)
µcytP 0.487 h−1 (0.212, 0.762)
µTc 0.243 h−1 (0.106, 0.381)
µcytE 0.06 h−1 experimentally observed
µIp 0.0703 h−1 (0.0329, 0.108)
µds 0.0703 h−1 (0.0329, 0.108)
µE 0.0703 h−1 (0.0329, 0.108)
µIds 0.0703 h−1 (0.0329, 0.108)
µP 0.0703 h−1 (0.0329, 0.108)
µL 0.35 h−1 experimentally observed
Ribo(0) 995 molecules (−1030, 3020)
HF,high(0) 88 molecules (−30, 206)
HF,low(0) 10 molecules (−4, 23)
pscale 2.80× 103 (−668, 6.28× 103)
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Table 3.2: Estimated kinetic parameters and initial values using Genetic Algorithm.
Parameter name Parameter values Status
k0 0.0036743 h−1 estimated
k1 1 h−1molec−1 ﬁxed
k2 100 h−1 experimentally observed
kc 2.6045 h−1 estimated
kPin 2.6408e− 6 h−1molec−2 estimated
kPout 0.35673 h−1 estimated
k4m 1.7 h−1 experimentally observed
k4p 1.7 h−1 experimentally observed
k5 10 h−1molec−1 ﬁxed
k3 10−4 h−1molec−1 ﬁxed
µunpP 0.70314 h−1 estimated
µcytP 0.36485 h−1 estimated
µTc 0.2318 h−1 estimated
µcytE 0.06 h−1 experimentally observed
µIp 0.054975 h−1 estimated
µds 0.054975 h−1 estimated
µE 0.054975 h−1 estimated
µIds 0.054975 h−1 estimated
µP 0.054975 h−1 estimated
µL 0.35 h−1 experimentally observed
Ribo(0) 500 molecules estimated
HF,high(0) 107 molecules estimated
HF,low(0) 10 molecules estimated
pscale 1.6× 103 estimated
Table 3.3: The values of genetic algorithm operators used in parameter estimation. These
values have been obtained using the formula (3.34). The parameters that have been
obtained using these values are given in Table 3.2.
GA operators Choosen value
Population size 300
Elite children 30
Crossover fraction 189
Mutation size 81
Generation 1000
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3.3 HCV replication dynamics
In order to see whether the model explains the replication process, we ﬁtted the
model to several kinetic datasets and steady-state observations using the multiple
shooting and genetic algorithms which we discussed in Section 3.2. The kinetic
measurements have been obtained by measuring the HCV replication in two cell
lines, which are the high permissive Huh-7 Lunet cells and the less permissive Huh-
7 cells.
The kinetic measurements used in the model calibration are:
• Total number of plus-strand RNAs (molecules)
• Total number of minus-strand RNAs (molecules)
• Polyprotein measurements (luciferase activity)
Experimental settings for the polyprotein measurements diﬀer from that of the
plus and minus-strand RNA. Therefore, we introduced a scale factor, pscale which
normalizes the luciferase activity to the molecule numbers. We estimated this pa-
rameter during the optimization.
Additionally, we used the following steady-state observations:
• The ratio of total plus-strand RNA to total minus-strand RNA is about 10 : 1
[47, 154, 120].
• The plus-strand to minus-strand RNA ratio in the RVs is about 6 : 1 [120].
• The ratio of plus-strand RNA outside the RVs to that of inside the RVs is
about 1 : 1 [120].
We ﬁtted our model to the experimental data from high and low permissive cells
simultaneously. The results demonstrated that the model explains both the kinetic
and steady state data excellently (Figure 3.4). We revealed that the model can
reproduce the kinetic data from high and low permissive cells with the same set
of parameters, except the initial value for the host factor, HF (0). All parameters
obtained from the model ﬁtting are given in Table 3.1. All ﬁgures are shown in this
thesis are obtained using the parameter values from Table 3.1.
Further, we will discuss about the calibration process and observed dynamics
more in details:
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3.3.1 Plus-strand RNA kinetics
Since experimentally accessible information about the plus-strand RNA is in total
numbers, a model output to describe this will be,
RtotP = R
unp
P +R
cyt
P + Tc +RIp +Rds +RIds +RP (3.35)
which is just the sum of all variables containing the plus-strand RNA. The variables
RunpP , R
cyt
P , Tc, RIp, Rds, RIds and RP are the solutions from the system of equations
(2.15).
The model ﬁtting is depicted in (Figure 3.4 A, B). From the plot, we can see
that the model (RtotP ) excellently captures the underlying dynamics. If we look into
the plus-strand RNA dynamics more in details, then we can see the main properties
in the dynamics of the data which are the lowest peak, the saturation time and the
magnitude level of replication. An initial decline in the dynamics reﬂects the phase
where the degradation is dominant over the production. Initially, the decay is mostly
due to the degradation of transfected plus-strands, RunpP , which we will discuss later
in Subsection 4.2.4. The lowest point of replication occurs around t = 8 in the high
and t = 12 hours in the low permissive cells. After t = 8 hours the production of
new-strands outcompete the degradation, and then the rise in plus-strands starts in
the case of high permissive cells. In the low permissive cells, the rise observed later
after t = 12 hours. The replication attains a steady state around t = 24 hours in
the high permissive cells, and around t = 40 hours in the low permissive cells.
3.3.2 Minus-strand RNA kinetics
As mentioned in Subsection 3.3.1, the minus-strand RNA is also given in total
numbers. From the model, we can compute the total minus-strand RNA as follows:
RtotM = Rds +RIds (3.36)
Rds and RIds are the solutions of the system of equations (2.15).
From the ﬁtting, we see that the model (RtotM ) ﬁts to the data with an excellent
accuracy (Figure 3.4 A and B). The kinetics of minus-strand RNA starts from 0
molecules, because initially there is no minus-strand available. The minus-strand
RNA is synthesized during the replication by using the plus-strand RNA as a tem-
plate. As depicted in Figure 3.4, the production of minus-strands increases exponen-
tially at the initial phase and slows down after t = 24 hours in the high and t = 40
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hours in the low permissive cells. From the plot, it is clear that the minus and plus-
strand RNA share some similarities. An initial increase in the minus-strand RNA is
highly correlated with the increase in the plus-strand RNA after t = 8 hours in the
high and t = 12 hours in the low permissive cells. Furthermore, both the plus and
minus-strand RNA saturate approximately at the same time. These similarities in
the dynamics indicate a high correlation in the production between plus and minus-
strand RNA. As steady-state data indicated, at saturation, there are about 10 fold
more plus-strand than the minus-strands available [120]. This can be seen also by
comparing the simulated plus and minus-strand RNA levels at steady state (Figure
3.4). Figure 3.4 also depicts that this ratio holds despite the diﬀerent magnitude
levels of plus and minus-strand RNA in the high and low permissive cells. From
kinetic data, we can see that initially, the rate of rise of minus-strands is diﬀerent
in both cases. In the high permissive cell case, the rise is faster, while that one in
the low permissive case is slower. As it has been seen in the plus-strand case, the
saturation time is also aﬀected. The model correctly reproduces the initial phase,
the magnitude level as well as the saturation time (Figure 3.4 A, B). A saturation
or steady state attaintment time is similar to the plus-strand RNA case.
3.3.3 Polyprotein kinetics
In this case, the output of the model, L is ﬁtted to the kinetic data. We can see that
the model ﬁts to the data with the excellent accuracy (Figure 3.4 A and B). From
the plot, we can observe that the initial rise in the polyprotein dynamics is due to
the translation of transfected positive-strands, which is followed by the decline with
period of till t = 8 hours in the high permissive cells and t = 12 hours in the low
permissive cell case (Figure 3.4 A, B). The decline is caused because the degradation
of positive-strands is overwhelming the production. In this case, the synthesis of
viral proteins is dominated by the degradation. The equilibrium points at t = 8 and
t = 12 hours demonstrate the balance between production and degradation. This
state is followed by an exponential-like increase which lasts till replication dynamics
attain a steady-state. The model is able to capture both kinetics from high and
low permissive cells with the excellent accuracy. Interesting thing is that from the
same plot, we can observe that the lowest peak of polyprotein coincides with the
lowest peak of plus-strand RNA, which indicates a strong correlation between them.
At t = 8 hours, both the plus-strand RNA and the polyprotein dynamics attain
the lowest peak in the high permissive cells. The same can be observed from the
low permissive cells, which occurs at t = 12 hours. Another observation is that the
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saturation time in the plus-strand RNA, minus-strand RNA and polyprotein occurs
approximately at the same time both in the high and low permissive cells.
3.3.4 Steady state observations
The steady state data have been integrated into the optimization in terms of con-
straints.
First, a ratio RtotP /RtotM which obtained from (3.35) and (3.36) satisﬁes 10 : 1 ratio
by giving an excellent ﬁt in two cell lines (Figure 3.4 C).
Total plus-strand RNA in the replication vesicles, we computed by summing up
all components which contain the plus-strands,
RRVP = RIp +Rds +RIds +RP (3.37)
Resulting ratio of RRVP /RtotM is also in excellent agreement with the experimental
data giving 6 : 1 ratio. (Figure 3.4 C middle bar).
Lastly, we compared the plus-strand RNA levels both in the cytoplasm and RV.
Since we have already deﬁned the total plus-strands in the replication vesicles, we
will deﬁne the total numbers in the cytoplasm. This can be deﬁned as,
RCY TP = R
unp
P +R
cyt
P + Tc (3.38)
The resulting ratio RCY TP /RRVP from the simulation can excellently reproduce an
observed value of 1 : 1 ratio (Figure 3.4 C third bar).
Eventually, we conclude that all steady state ratios reproduced from the model
are in close agreement with the data.
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Figure 3.4: Model calibration against experimental data. The data has been normalized
by the total number of transfected cells. The quantities represent the mean molecule
numbers in a single cell. The circles and the error bars represent the mean and the two
standard deviations of the experimental data (mean ± 2∗SD). (A) The model ﬁtting to
the kinetic data from the high permissive Huh7 Lunet cells. (B) The model ﬁtting to
the kinetic data from the low permissive Huh7 cells. (C) The model ﬁtting to the data
reﬂecting the ratios at steady state. RtotP /RtotM ratio represents the ratio of total plus to
minus-strand RNA per cell. RRVP /RtotM ratio represents the ratio of plus to minus-strand
RNA in the RV. RCY TP /RRVP ratio shows the ratio of plus-strand RNA in the cytoplasm
to plus-strand RNA in the RV.
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Chapter 4
Model Validation and Predictions
4.1 Model validation
Model validation is a test of how well model predictions match the set of independent
observations. In other deﬁnition, the model validation is the process of evaluating
model performance against the primary design goal [9]. Model validation aims at
increasing our conﬁdence in the constructed model and this step is required before
proceeding with the model prediction and analysis [29]. We are interested to check
whether our model suﬃcient to explain the experimental data. In other words, we
asked whether the model can also explain an independent data which is not used in
the model calibration. In this section, we performed our model validation with the
experimental data from two independent processes with the best parameter values
obtained from the model calibration (Table 3.1).
4.1.1 Replication deﬁcient virus dynamics
In order to validate our model, we used the kinetic data obtained from a replica-
tion deﬁcient virus (Figure 4.1 A). This data is obtained from the JHF1-based virus
which lacks an GDD motif of NS5B polymerase [78],[19] that is not able to replicate.
GDD motif is responsible for the active site of NS5B polymerase. When this active
site is removed, the virus is not able to replicate and its replication dynamics follows
a decay. Particularly, an inactive viral polymerase is not able to catalyse the reac-
tion responsible for a synthesis of new viral RNAs. Such an observation has been
measured in the high and low permissive cells. Importantly, this data indicates that
there is no diﬀerence in the permissiveness in Huh-7 cells [78]. This information is
used further, when we will discuss the permissiveness later more in details.
We examined this process by using our model. Using the model calibration, we
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estimated the kinetic rates, which best explain the experimental data. We assume
that these parameters represent the true dynamics of viral replication and further
examine the dynamics of replication deﬁcient virus by using these parameters. Since
the viral polymerase, in this case, is inactive, we set the kinetic rate, kPin = 0. By
doing this, we neglect the processes inside the RV and see that the replication
dynamics is totally determined by the processes in the cytoplasm (Figure 4.1). In
this case, the processes are governed by RunpP , R
cyt
P , Tc, P and Ecyt.
Because the polymerase is inactive, there is no synthesis of minus-strand RNA
undergoes. As we see from the Figure 4.1 A, because of no production of new RNA,
the plus-strand RNA level decreases exponentially. In contrast, initially there is
a fast increase in the polyprotein numbers, which follows by an exponential-like
decrease. Since the production stops at the replication stage, initially transfected
plus-strand RNA participate in the polyprotein translation, which can be seen from
the initial increase in the polyprotein levels. Once the numbers of plus-strands elim-
inate due to degradation, then the degradation becomes dominant and the decline
in the polyprotein levels is observed. Comparing the model dynamics with the ex-
perimental data demonstrated that the model can excellently explain the replication
dynamics (Figure 4.1). Additionally, this supports how well the model parameters
have been estimated and how correctly the model exhibits the true dynamics.
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Figure 4.1: Model validation using a replication deﬁcient virus. The circles and the error
bars represent the mean and the two standard deviations of the experimental data (mean
± 2∗SD). (A) Plus-strand RNA dynamics. (B) Polyprotein dynamics. The solid lines
indicates the model predictions with the parameters that have been obtained from the
model calibration using only the replication competent virus. The model captures the
experimentally observed dynamics in both the plus-strand RNA and the polyprotein by
setting the formation rate of the replication vesicles, kPin to zero. Note that both the
experimental data in (A) and (B) show no signiﬁcant diﬀerence between the high and low
permissive cells, indicating that diﬀerences between the two cell lines occur post protein
translation.
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4.1.2 Initiation hampered HCV RNA dynamics
In this section, we discuss about the validation of our model with inhibited HCV
dynamics.
The 5′ nontranslated region (NTR) and the X tail in the 3′ NTR are the least
parts of the HCV genome and play important role in the initiation of RNA synthesis.
In [19], by using the subgenomic replicons of the HCV isolates Con1 (genotype 1) and
JFH1 (genotype 2), the authors characterized the genotype speciﬁcities of the repli-
cation signals contained in the nontranslated regions (NTRs). They demonstrated
that the replacement of the JFH1 5′ NTR and X tail with the corresponding Con1
sequence resulted in a signiﬁcant decrease in a replication eﬃciency. Speciﬁcally,
the exchange of the X tail reduced the minus-strand synthesis, while a substitu-
tion of the 5′ NTR impaired the synthesis of progeny plus strands. Moreover, the
authors analyzed recombinant NS5B polymerases of both isolates and found some
genotype speciﬁc template preference for the 3′ end of plus-strand RNA in vitro. In
order to address a genotype speciﬁcity, they constructed a series of intergenotypic
replicon chimeras and observed that the NS5B recognizes the genotype speciﬁc sig-
nals in nontranslated regions. The NTRs of plus-strand RNA viruses contain the
signals important for the initiation of RNA synthesis. The 3′ X region of the HCV
genome has been shown to contain signals for the initiation of minus-strand synthe-
sis. Nascent plus-strand synthesis is thought to be regulated by the 3′ end of the
minus-strand RNA. The reduction of replication eﬃciency by heterologous NTRs is
thought to be due to a speciﬁc impairment of the initiation of minus-strand synthesis
in the case of the 3′ X tail and of plus-strand synthesis in the case of the 5′ NTR.
To verify this hypothesis, the authors transfected Luc JFH replicons (polyprotein)
with an authentic or a Con1-derived 5′ NTRs and/or 3′ X tails into Huh7 cells and
analyzed the plus- and minus-strand synthesis at diﬀerent time points after trans-
fection. They observed that the replication eﬃciency was highest for a replicon
harboring authentic NTRs (5′ X JFH), whereas the replication eﬃciency in other
replicons harboring heterologous NTRs was impaired (Figure 4.2 A).
We were curious to examine whether our model can reproduce this observation.
To perform this task, we used the parameter values obtained from the model cali-
bration. In a case of 3′ X tail exchange, the parameters kPin and k3 are responsible
for the initiation of the plus-strand synthesis. Here, an expectation will be whether
a change in this parameters can reproduce the inhibited dynamics which was ob-
served experimentally. Therefore, to verify this hypothesis, by setting kPin, k3 and
a scale factor for polyprotein free, we estimated these parameters by ﬁtting the
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model to the experimental data (Table 4.1). Here, the scale factor is used to convert
luciferase activities to the molecule numbers. Because the luciferase activities may
change from one experiment to another, we assumed that this scale factor is diﬀerent
from that which has been used in the model calibration. As a result, we see that
the model nicely captures the kinetic data reﬂecting the dynamics of polyprotein
marker (luciferase) in a case of 3′ X tail exchange (Figure 4.2 B (magenta)). From
the ﬁtting, we found out that the estimated parameters are signiﬁcantly smaller
than the parameters in control case (see Table 4.1). Simply,
k3
′X
Pin < k
wild
P in and k3
′X
3 < k
wild
3 . (4.1)
In the case of 5′ NTR exchange, we followed the similar procedure. In this
case, one would expect that the change in the minus-strand intermediate complex
formation rate k5 is responsible for the reported observation. We performed the
ﬁtting of the model to the kinetic data, where only k5 and the scale factor have been
estimated. Results demonstrated that the model can reproduce the data (Figure 4.2
B (cyan)). Model suggests that the replication eﬃciencies which are presented in
terms of polyprotein marker can be explained by tuning this parameter alone, given
the best ﬁt values from the Table 3.1. In a case of 5′ NTR exchange, the model
predicts that the following condition is required (see Table 4.1),
k5
′NTR
5 < k
wild
5 (4.2)
where, the parameters k5′NTR5 and kwild5 are refered to the 5′ NTR exchanged and
wild type cases, respectively. In this case, fulﬁlling this condition is suﬃcient to
explain the inhibited replication dynamics.
Further, fulﬁlling the conditions (4.1) and (4.2), explains the experimentally mea-
sured steady state observations (Figure 4.2 B). When 3’ X tail has been exchanged,
about 2 fold increase in the ratio of plus-strand to minus-strand was observed. Ful-
ﬁlling (4.1) excellently reproduces kinetic as well as steady state observations. In
the case, when 5’ NTR has been exchanged, a profound decrease about 2 fold in
the ratio of plus-strand to minus-strand was observed. As we mentioned already,
fulfulling (4.2) excellently reproduces kinetic measurements and correctly predicts
the changes in the ratio.
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Table 4.1: The parameter values in the case of inhibited HCV replication. The wild type
parameters are from Table 3.1 that have been obtained in Parameter Estimation section.
Parameter Wild type value Estimated value
kPin 2.07e-6 2.62e-7
k3 1e-4 1e-8
k5 10 0.61
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Figure 4.2: Model validation by the synthesis inhibited virus dynamics. (A) The model
ﬁtting to the polyprotein data from JFH replicons. The data shows that the replication
is inhibited when NTRs regions are exchanged. The circles and the error bars represent
the mean and the two standard deviations of the experimental data (mean ± 2∗SD). (B)
The results demonstrate that the model is able to reproduce the observed changes in the
ratio of plus-strand RNA to minus-strand RNA (data is obtained from [19]).
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4.2 Model predictions
In this section, we will discuss about the predictions derived from the model analysis.
First, we will start by overviewing the hypotheses that are used in our analysis.
First important issue, we are going to address is the permissivity of Huh-7 cells
for HCV replication, which we will discuss in Subsection 4.2.1. The interesting
observation is that the genetically identical Huh-7 cells reﬂect a diﬀerent replication
course for viral replication. Many studies reported diﬀerent cellular factors which
may have role in HCV replication (reviewed in [32], [148]). However, whether they
limit the viral replication or not it is not known. Further, how the interactions
of cellular factors with the virus determine a course of viral replication is poorly
understood.
In Subsection 4.2.2, we will examine the hypothesis about a property of repli-
cation vesicles (RV). It was reported that the HCV RNA and the non-structural
proteins (NS) that are associated with the RV are resistant against nuclease and
protease treatment [120]. This leads to the conclusion that the RVs could have
a protective property. In the light of this observation, we are going to address a
question if how this protective property of RV associated with the HCV replication?
In Subsection 4.2.3, we are going to discuss the steady state predictions derived
from the model. We are going to discuss these predictions in comparison to the
experimental observations from [120].
In Subsection 4.2.4, we will discuss about an inﬂuence of transfected HCV RNA
on the initial HCV replication dynamics.
4.2.1 Permissiveness of HCV RNA replication in diﬀerent
cells
The time course kinetic data measured in clonal cells demonstrated that HCV repli-
cation exhibits diﬀerent dynamics (Figure 4.3). By clonal cells, we mean the high
permissive Huh7 Lunet and the low permissive Huh7 cells. This clearly shows the
cell permissiveness for HCV replication. Here, one of the central challenges is to
understand how the cells respond to virus invasion and what processes lead to the
observed diﬀerence in virus replication. Binder et al. [20] suggested that the diﬀer-
ential expression in the cellular factors might cause the observed diﬀerence in virus
replication. Recent developments in HCV research resulted in a huge number of pos-
sible candidates which have been shown to interact with this pathogen (reviewed in
[32], [148], [99]). These candidates were reported to interact from the cell receptors
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till the cellular proteins which needed for virus to form particles. Much is known
in an interaction level, however, less information is available at the functional level.
How does the interaction of virus and host deﬁne the replication course? Where and
when do possibly virus and host interact? What is possible underlying mechanisms
for virus and host interactions? Addressing these questions may help us to elucidate
a mystery of HCV replication and its interaction with the host. Use of mathemati-
cal modeling can help us to address these issues. Therefore, we use our established
model to examine this problem.
From the Figure 4.3, we can see that the course of replication dynamics in both
cells is diﬀerent. Simply, what we see is that the replication in the high permissive
cells is more eﬃcient than that in the low permissive cells. In all cases, we observe
that in the high permissive cells the saturation time is shorter and the magnitude
of replication is higher than that in the low permissive cells. This shows that the
virus within the ﬁrst cell replicates faster and is produced more in numbers. In
constrast, the low permissive cells are less preferable for virus which can be seen
from the delayed saturation time and the reduced steady state level. The number
of possible hypotheses can be drawn to explain this observation.
The ﬁrst hypothesis which can be derived is about a cell to cell variability.
Even the clonal cells may vary in a content of cellular proteins which can play
a key role in the virus replication. Since the HCV strain used in these studies
is the same virus, JFH1, the diﬀerence in replications may only stem from the
cellular host factors which are important in replication. When we mean a host
factor, then it can be any host factor which can participate in the virus replication.
Therefore, when constructing a mathematical model we assumed a role of two host
factors, the ribosomes and the cellular factor which interact with the virus at the
translation and formation stages of replication vesicles, respectively. Any of these
factors may limit the virus replication and cause a diﬀerence in replication. To check
whether this is the case, we ﬁtted our model to the data by assuming the diﬀerent
initial conditions for the ribosomes and the host factor at the formation stage of
replication vesicles. For the high permissive cells, we assume Rhighibo (0) and H
high
F (0),
and for the low permissive cells, Rlowibo (0) and H lowF (0). Results demonstrated that the
diﬀerence replication is best expained by the diﬀerent conditions for the host factor
which participates in the replication vesicles formation (Figure 4.3). The simulations
showed that the diﬀerence in a ribosome content cannot explain the diverse course
of replication (Figure 4.4 A). Use of replication deﬁcient data suggested that this
diﬀerence in replication cannot stem from the translation process, and as we see our
model simulations support this observation (Figure 4.4 A).
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Additionally, we examined the other possibilities which may explain the diﬀer-
ence to ensure if the explanation with the host factor is unique.
One possible hypothesis in this case is the diﬀerent degradation due to a variation
in a cellular environment. Therefore, we assumed diﬀerent degradation rates in two
cells. We checked this also for diﬀerent degradation rates in the cytoplasm and the
replication vesicles. As a result, we showed that neither of these factors can explain
the observed diﬀerence in the replication (Figure 4.4 B and C).
Another hypothesis which could be addressed is whether the diﬀerence in the
transfection setting can explain the permissivity in clonal cells. It is usually the case
in transfecting the virus into the cell, where the numbers of viral strains, RunpP (0)
cannot be controlled and the diﬀerence in numbers may cause the diﬀerence in
replication. However, we found out that the diﬀerent values of RunpP (0) cause the
diﬀerence in the saturation time whereas they did not aﬀect the magnitude levels
(Figure 4.4 D).
It appears that the cellular host factor which participates in the formation of
replication vesicles is the only factor which can explain the observed diﬀerence in
HCV replication. Importantly, the host factor diﬀerence excellently explains the
diﬀerence in all three variables (Figure 4.3). The model predicts that about 9-10
fold diﬀence in the host factor amount explains the cell permissivity for replication
best (Table 3.1).
Further, we examined how this cellular host factor aﬀects the virus concentration.
Therefore, we analyzed if how the replication course changes with respect to the
host factor amount. Results revealed that there is a linear correlation between the
plus, minus-strand RNA and the host factor (Figure 4.5). It demonstrates that
the relation between them can be quantiﬁed with a simple relation, in the form
of f(x) = ax + b. It shows an easy controlability of the virus when we know
this host factor. This also shows that this host factor speciﬁcally limits the level
of viral RNA, whereas the viral protein levels are less aﬀected (Figure 4.5). The
polyprotein and the host factor levels have a nonlinear-like relation, which shows that
the polyprotein levels saturate at the less amount of host factor compared to viral
RNA. From Quinkert et al. [120], we know that about 50% of plus-strand RNA and
95% of viral proteins reside in the cytoplasm. Since the host factor which explains
the diﬀerence in replication participates in the replication vesicles formation, about
half of plus-strand RNA and only < 5% of viral protein are directly dependent on
the host factor. The diﬀerence in dependencies cause the linear relation for the
plus-strand RNA and the nonlinear relation for the viral proteins.
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Figure 4.3: The diﬀerence in the replication dynamics in Huh7 clonal cells can be ex-
plained by the diﬀerential expression level of the cellular host factor. The circles and the
triangles denote the experimental data from the high and low permissive cells, respec-
tively. (A) Total plus-strand RNA (B) Total minus-strand RNA (C) Polyprotein. The
results have been obtained by ﬁtting the model to the experimental data simultaneously
only with the diﬀerent host factor values. The parameter and diﬀerent host factor values
are given in Table 3.1.
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Figure 4.4: Eﬀect of diﬀerent factors on the plus-strand RNA, minus-strand RNA and
polyprotein. Results have been obtained by ﬁtting the model to the data with the diﬀerent
values of the ribosomes, the degradation rates in the cytoplasm and the replication vesicles,
and the transfected HCV RNA. (A) Eﬀect of the diﬀerent ribosome numbers. It is clearly
seen that the ribosomes aﬀects the polyprotein, whereas the plus and minus-strand RNA
are not aﬀected. (B) Eﬀect of the diﬀerent degradation rates in the cytoplasm. The
diﬀerence in the cytoplasmic degradation aﬀects the replication only initially, while the
later dynamics are less aﬀected. (C) Eﬀect of the diﬀerent degradation rates in the
replication vesicles (RV). The diﬀerence caused by the degradation rates in the RVs is
profound, but the later dynamics are not at steady state anymore. (D) Eﬀect of the
diﬀerent transfected HCV RNA numbers on the replication dynamics. Only the saturation
time is severy aﬀected, while the magnitude level is not inﬂuenced.
72 Chapter 4 Model Validation and Predictions
0
1
2
3 x 10
5
10 20 30 40 50 60 70 80
0
2000
4000
6000
host factor molecules
Po
lyp
ro
te
in
 m
ol
ec
ul
es
pl
us
-st
ra
nd
 RN
A 
m
ol
ec
ul
es
Figure 4.5: The correlation of the virus and the host factor which explains the replication
permissiveness. This correlation is calculated at steady state. The blue curve indicates
the polyprotein and the red curve indicates the plus-strand RNA with respect to the host
factor amount. In the range between 10 and 80 host factor molecules, the plus-strand
RNA steady state levels respond linearly to concentration changes of the host factor. The
polyprotein levels show a bi-phasic steady state behavior, with an exponential response
up to increasing host factor amounts to about 70 molecules, by showing a saturation
thereafter.
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4.2.2 Degradation inside the replication vesicles
The role of replication vesicles in viral RNA synthesis is not well understood. It is
currently hypothesized that it may include: the physical support and organization of
the RNA replication complex [79]; the compartmentalization and local concentration
of viral products [136]; tethering of the viral RNA during unwinding; provision of
lipid constituents important for replication; and the protection of the viral RNA
from double-strand RNA-mediated host defences or RNA interference.
The results published in [120] have demonstrated that the HCV plus- and minus-
strand RNAs are highly resistant to the nuclease treatment. Additionally, the same
studies revealed that < 5% of the NS5B polymerase molecules are the protease re-
sistant. These ﬁndings indirectly indicate the protective role of replication vesicles.
We were interested to see how this protective behavior of the replication vesicles
is linked to the HCV replication. Simply, we ask whether this linkage can be elu-
cidated using our model. Since the replication vesicles remain to be a black box,
meaning that they are still not accessible for the experiments, useful information
or a prediction can be drawn from the modeling. Therefore, in this case, we used
replication model which is calibrated and validated with the experimental data to
analyze this problem.
For simplicity, we ﬁxed the same parameter values for the degradation of the
viral components in replication vesicles as we did in the model calibration.
µVMS = µIp = µds = µIds = µE = µP (4.3)
After we introduce a quantity s, which in turn describes the ratio of the degradation
rates of viral components in the cytoplasm and replication vesicle or simply,
s = µcyt
µVMS
(4.4)
Here, µcyt accounts for the degradation rates µcytP and µTc . From the model calibra-
tion, we have seen that these kinetic rates diﬀer not so much.
After we analyzed the model behavior w.r.t. the change in the ratio s. For this
purpose, we ﬁxed the estimated value of µcyt and changed µVMS and observed the
model output. The best ﬁt has been obtained by returning s > 1 or µcyt > µVMS.
As the result, we observed that the replication course is successful for the large
values of s (Figure 4.6). Once the ratio was set to a smaller value, the replication
started to show a decline. When the ratio s was set to 1, so the degradation rates are
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equal, µcyt = µVMS, the model predicts a complete clearance of the minus-strands by
t = 20 hours, whereas the plus-strands level get cleared about t = 25 hours (Figure
4.6 A and B). This demonstrates that the minus-strands are more susceptible to
the change in the ratio s and protected by the vesicles from high degradation. The
polyprotein marker level was decreased considerably by showing a drastic decline
which predicts a complete clearance about t = 50 hours (Figure 4.6 C).
The non-structural protein, NS5B level is less susceptible against s than the
polyprotein levels by getting cleared after t = 80 hours (Figure 4.6 D). From ex-
perimental observations, we know that the degradation rate of polyprotein, µL is
higher than the degradation rate of NS5B, µcytE . Therefore, the clearance time of
NS5B protein is longer than that one of polyprotein marker. Interestingly, in the
case when the degradation rates are equivalent, the production of viral components
still proceeds but at a slower rate and when the balance between the production
and the decay has reached a critical threshold, the decay becomes dominant and the
replication started to decline.
With this simple analysis, we showed that how the protective property of repli-
cation vesicles can be explained by the diﬀerent degradation rates in the cytoplasm
and the replication vesicles which is consistent with the observed protective prop-
erty of replication vesicles. These observations demonstrated that for a successful
replication, the degradation in the replication vesicles should be much smaller than
that in the cytoplasm, thereby supporting the theory about the protective role of
replication vesicles. As we see from the plot, all three variables are sensitive to the
small changes in the ratio s. From the parameter estimation, we revealed that the
conﬁdence interval for the degradation rate inside the replication vesicles is very nar-
row, therefore, the small changes in this rate cause severe changes in the replication
dynamics.
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Figure 4.6: The replication dynamics w.r.t. the diﬀerent values of s = µcyt/µVMS (rep-
resentation is in logarithmic scale). This ﬁgure highlights how the diﬀerence in the degra-
dation rates in the cytoplasm and the replication vesicles aﬀect the replication dynamics.
The optimal and successful replication is obtained with s = 10, which means that the
degradation in the cytoplasm is about 10 fold higher than the degradation in the replica-
tion vesicles.
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4.2.3 Steady state predictions
Experimental observations revealed that at steady state the level of viral proteins
accumulates up to 800000−2×106 molecules per cell [120]. Available data indicates
that there are 2 to 3 orders of magnitude abundant NS5B proteins than the viral
RNAs.
We performed a simulation with the parameter values which best explain the
experimental data. Particularly, we have calculated the predicted level of NS5B
proteins, the plus and minus-strand RNA from the model and have taken the re-
spective ratios at t = 72 hours after transfection. The total amount of NS5B proteins
can be calculated by solving and summing the equations for Ecyt, E, RIp and RIds
which give the total amount of NS5B proteins,
Etotal = Ecyt + E +RIp +RIds (4.5)
Further, the derived ratios from the simulation have been compared with the ex-
perimentally observed ratios. As a result, we have seen that the model can reproduce
the experimentally observed results (Figure 4.7). Figure 4.7 depicts the results from
the high permissive cells (HPC). In particular, our model predicts about 1.5 × 106
molecules for the HPC, which is consistent with the experimental observations. For
the LPC (low permissive cells), model predicts about 3-4 fold less proteins than the
HPC. The reason why the model predicts less protein numbers is due to host factor
amount. In addition to the cellular ribosomes, the host factor also signiﬁcantly af-
fects the protein levels. As reported, the polyprotein levels are positively correlated
with the host factor amount (Figure 4.5).
Overall, these results demonstrate that the model is correctly structured so that
it can reproduce a real data which was not used in the model calibration. In [48], it
was reported that the amount of ribosome complexes is the main parameter which
signiﬁcantly aﬀects the NS5B level. In our model, it also preserves its function and
its estimated value is consistent with the reported value from [48].
Furthermore, it was reported that at steady state about < 0.1% of NS5B proteins
are enzymatically active. This shows that only a minor fraction of polymerase is
active that can be used as a replication machinery. In order to calculate the active
fraction of polymerase, we summed up the polymerase inside the replication vesicles,
Eactive = RIp + E +RIds (4.6)
When calculated this number from the model with the calibrated parameters, we
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found out that they consist about < 0.1% which is consistent with the experimen-
tally reported value (Figure 4.7 B). The model predicts that there are more active
polymerase in HPC than in LPC. Together, the model predictions performed with
the calibrated parameters are in a close agreement with the experimental data,
thereby showing a predictive power of the established model.
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Figure 4.7: The steady state predictions. (A) The ratio of NS5B proteins to plus and
minus-strand RNA at steady state. The model predictions are in close agreement with
the experimental observations. (B) The percentage of active NS5B polymerase in the
high and low permissive cells. The experimental results showed that the active fraction of
NS5B polymerase consists of less than 0.1% of total NS5B. The active fraction of NS5B
polymerase is the number of polymerase within the replication vesicles (RV or VMS).
4.2.4 Transfected plus-strand RNA degradation
After the HCV RNA has been introduced into the cell, it interacts with the host
ribosomes to form a viral polyprotein. After transfection, there is approximately
an exponential decline in the HCV RNA numbers till t = 8 hours in the HPC and
t = 12 hours in the LPC.
We revealed that an inclusion of the additional reaction (2.1) in Subsection 2.1.1,
which accounts for the processing of transfected plus-strand RNA is required to
explain the kinetic data, because without this step, the model failed to ﬁt. Further,
we analyzed the importance of this step in explaining the experimental data. The
model results suggested that the decay which has been observed initially is mainly
determined by the exponential function of the form
RunpP = R
unp
P (0)e−(k0+µ
unp
P )t. (4.7)
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Figure 4.8 depicts the simulated dynamics of transfected plus-strand RNA ob-
tained from (4.7). In particular, the model predicts that till the half life time, which
is about 1 hour, about 99 % all plus-strand RNA are determined by RunpP . About
t = 3 hours, still 95 % are determined by the transfected plus-strand RNA. As we
know from the data, the production of minus-strand and the new plus-strand RNA
starts earlier, however, the degradation is still severly dominant over the produc-
tion. The situation changes close to the equilibrium point around t = 8 hours, where
the contribution of transfected plus-strands decreases up to 10 % for HPC, whereas
for LPC, this number shows about 40 %. In the light of these predictions, we can
explain this process with few words.
In the experimental measurements, a large number of HCV RNA copies are
transfected into the cell. Out of these transfected plus-strand RNA, only a small
fraction can successfully replicate. Diﬀerent factors can aﬀect this observation. It
may be that the transfected plus-strands need to adapt to the host cell environ-
ment and this adaptation ﬁlters them to those which can replicate successfully and
those which just degrade. In other words, the viral plus-strand RNA, RunpP may
need some time to adapt to the cell environment before it is translated by the ri-
bosomes, Ribo, and at the meantime, degrade with the rate which is higher than
the rate of the processed RNA, RcytP . Since the transfected plus-strand RNA has no
feedback, it declines until it gets completely cleared from the cell. Since the decline
in the transfected RNA follows an exponential decline, we can easily calculate the
degradation rate and the corresponding half life. As we reported, the half life of
transfected RNA is roughly about t = 1 hour, which coincides with the half life of
total plus-strand RNA. By ﬁtting the model to the experimental data, we estimated
that the corresponding degradation rate is about µunpP = 0.758 h−1. In summary,
we conclude that the initial decline in the total plus-strand RNA until t = 4 hours
is mainly determined by the decay of the transfected plus-strand RNA.
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Figure 4.8: The comparison of the transfected and total plus-strand RNA. It is clearly
seen that initially, the decline of the total plus-strand RNA, RtotP is mainly deﬁned by the
decline of the transfected plus-strand RNA, f(t) = RunpP .
4.3 Sequential binding of ribosomes to HCV RNA
In Section 2.4, we discussed about the model of sequential attachment of ribosomes
to the HCV RNA. In this section, we will discuss about the results in comparison
to the simpliﬁed model where 10 molecules of ribosomes simultaneously attach to
the HCV RNA molecule.
The model gives the similar results to the simple case, if the following condition
is fulﬁlled:
k1 < k
∗
1 (4.8)
This condition implies that the rate of the ﬁrst ribosome to attach the HCV RNA
molecule should be lower than that of the subsequent ribosomes. The model sim-
ulations predict very low rate for the ﬁrst ribosome to attach, whereas the rate for
the subsequent attachment was maximized (Figure 4.9). Figure 4.9 depicts the dy-
namics of the polyprotein marker (luciferase) and the plus and minus strand RNA
dynamics. In order to predict the experimentally observed level of polyprotein, the
model predicts the involvement of more ribosome complexes than that which was
observed in the simple case. The simulations demonstrated that about 5 fold more
ribosome complexes are required to obtain the experimentally observed level. When
the kinetic rate k1 is slow and the ribosome complexes, Ribo(0) are comparable to
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the value from the simple case, we observe that the magnitude of polyprotein marker
decreased by several folds (Figure 4.9, lowest dashed curve (right)).
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Figure 4.9: Polyprotein (black), plus strand RNA (blue) and minus strand RNA dynamics
(red). The dynamics have been obtained for the diﬀerent values of k∗1/k1 (left) and the
ribosome complexes, Ribo(0) (right). The sequential model requires the initial binding rate,
k1 to be much more slower than the rate of the subsequent ribosomes, k∗1. Furthermore,
the model predicts more ribosome complexes compared to the simple model to obtain the
correct level of polyprotein dynamics.
Chapter 5
Sensitivity Analysis
The behavior of physical and chemical systems is aﬀected by many parameters that
characterize the system. The analysis of how a system responds to changes in the
parameters is called parametric sensitivity [156]. In most cases, when some parame-
ters are varied slightly, while keeping the remaining parameteres ﬁxed, the response
of a system also changes slightly. However, other set of parameter combinations can
cause the system to respond enormously, even of one or more parameters are varied
only slightly. In this case, it is said that the system behaves in a parametrically
sensitive manner [156].
Sensitivity Analysis is a method for quantifying uncertainty and its objective is
to identify critical inputs, such as parameters and initial conditions of a model and
quantifying how the input uncertainty impacts models outcome [84]. In this chap-
ter, we discuss the use of sensitivity analysis to evaluate an inﬂuence of parameter
variations on the model predictions by local and global sensitivity methods.
5.1 Local Sensitivity Analysis
A local sensitivity analysis investigates the impact on the model output based on
changes in the parameters only very close to the nominal values [84]. When the
input factors such as parameters or initial conditions are known with a little uncer-
tainty, one can examine the partial derivative of the output function with respect
to the input factors. In the following, we will give a brief overview about the local
sensitivity analysis and for more details refer to [156], [129].
Here, we consider a system described by an ordinary diﬀerential equation,
dy
dt
= f(y, φ, t) (5.1)
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with the initial condition y(0) = y0. Where y is the dependent variable, t is the time,
and φ represents the vector containing them system input parameters. The function
f ∈ C1 is a continuously diﬀerentiable function. That is, all partial derivatives of
f with respect to xj, ∂fi/∂xj, with i, j = 1, ..., n, exist and are continuous. This
guarantees that the above equation has a unique solution, y = y(t, φ), which is
continuous in t and φ.
Let φj +∆φj denote the change from φj in the jth parameter in the parameter
vector φ. Then the corresponding solution becomes
y = y(t, φj +∆φj) (5.2)
This solution is continuous in φj and can be expanded into a Taylor series as follows:
y(t, φj +∆φj) = y(t, φj) +
∂y(t, φj)
∂φj
∆φj +
∂2y(t, φj + θ∆φj)
∂φ2j
∆φ2j
2 (5.3)
where 0 < θ < 1. If ∆φj is suﬃciently small, i.e., ∆φj << φj, the Taylor series can
be truncated after the second term on the right hand side, leading to
∆y = y(t, φj +∆φj)− y(t, φj) = ∂y(t, φj)
∂φj
∆φj (5.4)
where ∆y represents the variation of y due to the change of the input parameter
φj, given by ∆φj. If we divide both sides of the equation (5.4) and consider an
inﬁnitesimal variation (∆φj → 0)
s(y;φj) =
∂y(t, φj)
∂φj
= lim
∆φj→0
y(t, φj +∆φj)− y(t, φj)
∆φj
(5.5)
This deﬁnes a local sensitivity of the variable, y, with respect to parameter, φj [156].
Higher order local sensitivities can be deﬁned using similar procedure.
In order to compare the computed sensitivities between the diﬀerent input pa-
rameters, a normalized sensitivity is commonly used. The normalized sensitivity of
y with respect to φj is deﬁned as follows:
S(y, φj) =
φj
y
∂ ln y
∂ lnφj
= φj
y
s(y;φj) (5.6)
Here, the magnitudes of the input parameter φj and the variable y are normalized. If
the local sensitivity s(y;φj) is known, the computation of S(y;φj) is straightforward.
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When the system is described by dependent variables of size n,
dyi
dt
= f(yi, φ, t), yi(0) = yi (5.7)
where i = 1, .., n, the sensitivity measure can be generated by the column sensitivity
vector:
s(yi, φ) =
∂yi
∂φj
=
[
∂y1
∂φj
,
∂y2
∂φj
, ...,
∂yn
∂φj
]T
= [s(y1;φj), s(y2;φj), ..., s(yn;φj)]T (5.8)
By combining all the row and column sensitivity vectors, we get an n×m sensitivity
matrix, which comprises sensitivity indices as elements.
s(yi, φ) =
∂yi
∂φj
=

∂y1
∂φ1
∂y1
∂φ2
· · · ∂y1
∂φm
∂y2
∂φ1
∂y2
∂φ2
· · · ∂y2
∂φm
... ... . . . ...
∂yn
∂φ1
∂yn
∂φ2
· · · ∂yn
∂φm

(5.9)
5.1.1 Results
We performed a local sensitivity analysis for 16 kinetic rates and 3 initial values.
This analysis has been performed in Matlab using Simbiology Toolbox. Figure 5.1
shows the normalized sensitivity values for the parameters. We arranged the model
parameters into ﬁve diﬀerent groups, with respect to the steps in the replication
cycle that they participate in:
• Cytoplasmic RNA processing: RunpP (0), k0, µunpP , µcytP
• Protein translation and cleavage: k1, µTc , Ribo(0), k2, kc, µcytE
• Formation of the replication vesicles: kPin, HF (0)
• Genome replication: k4m, k4p, k5, µVMS, k3
• Other: kPout, µL
From Figure 5.1, we see that at the cytoplasmic RNA processing, the plus-
strand RNA is very sensitive against the degradation of the transfected plus-strand
RNA, µunpP . From the model calibration, we have seen that this parameter plays
an important role and the sensitivity analysis supports this observation. The initial
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value of plus-strand RNA, RunpP and the processing rate, k0 mainly aﬀect the minus-
strand RNA and polyprotein levels.
At the translation and the cleavage, the degradation rate of translation com-
plexes, µTc has a signiﬁcant eﬀect on the polyprotein level but having less eﬀect on
the plus- and minus-strand RNA. In addition to this, the ribosome numbers, Ribo
and the translation rate, k2 have a signiﬁcant eﬀect on the polyprotein level, but also
having a less inﬂuence on the plus- and minus-strand RNA. Overall, the translation
rate k2 is the most sensitive parameter for the polyprotein levels.
At the replication vesicle formation, the cellular host numbers, HF inﬂuence the
levels of plus and minus-strand RNA signiﬁcantly by being ranked as a third most
sensitive parameter for both variables.
At the genome replication, the synthesis rate of complementary minus-strand
RNA, k4m is found to be very sensitive for the minus-strand RNA by being ranked
as a second after the degradation rate inside the replication vesicles, µVMS. The
polyprotein levels are very sensitive against the synthesis rate of plus-strand RNA,
k4p. The degradation rate inside the replication vesicles, µVMS is one of the most
sensitivite parameters which aﬀects the level of all three variables. It is ranked as a
second for the plus-strand RNA and the most sensitive for the minus-strand RNA.
It has also the inﬂuential eﬀect on the polyprotein level.
The export rate of new plus-strand RNA from the replication vesicles into the
cytoplasm, kPout is important for the polyprotein levels. Finally, the polyprotein
level is very sensitive against its degradation rate, µL.
Furthermore, the parameters µcytP , k1, kc, µ
cyt
E , k5 and k3 are found to be insen-
sitive for all three variables. The parameters RunpP (0), k0, µTc , Ribo, k2, kPin, kPout
and µL are partially sensitive either for one or two variables. The parameters µunpP ,
HF (0), k4m, k4p and µVMS are found to be sensitive for all three variables.
The local sensitivity analysis perturbes the parameters only at the vicinity of the
nominal values, therefore, these parameters may be insensitive only in the neighbor-
hood of the nominal values. To get more insights, we will perform a global sensitivity
analysis and discuss it in Section 5.2.
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Figure 5.1: Local sensitivity analysis on the model parameters. Shown are the parametric
sensitivities for the plus, minus-strand RNA and the polyprotein. The degradation rate
of the transfected plus-strand RNA, µunpP is the most sensitive parameter for the plus-
strand RNA, while µVMS is the most sensitive parameter for the minus-strand RNA. The
translation rate k2 is the most sensitive parameter for the polyprotein.
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5.2 Global Sensitivity Analysis
The local sensitivity methods derive measures of importance by estimating the eﬀects
of inﬁnitesimal variations of each factor having on the model output, in the region
of a ﬁxed nominal point. The local methods are widely used on steady-state models
and on studies dealing with the stability of a nominal point. The local methods can
only account for small variations from the nominal values and fail to capture the
large variations in a parameter set.
Global sensitivity methods are advantageous when performing a full search of the
parameter space, hence providing information independent of nominal points. Fur-
thermore, the global methods can account the total uncertainty in the model output,
while all parameters are varied at the same time. In addition, the global sensitivity
analysis methods evaluate the eﬀect of a parameter while all other parameters are
varied simultaneously, accounting for interactions between parameters without de-
pending on the stipulation of the nominal point. The most widely used methods in
global sensitivity analysis are Fourier Amplitude Sensitivity Testing (FAST) method
[31], Morris [100], Sobol [139] and Derivative based Global Sensitivity methods [68].
In this section, we are going to overview the Extented Fourier Amplitude Sensitivity
Testing (eFAST) and its application to our model.
5.2.1 Extended Fourier Amplitude Test (eFAST)
Extended Fourier Amplitude Test was developed by Saltelli et al. [132],[130],[131].
Extended Fourier Amplitude Test is based on the original Fourier Amplitude Test
developed by Collins and Avissar [28], Schaibly and Shuler [135] and Cukier et al.
[30]. eFAST allows the computation of the total contribution of each input factor
to the output’s variance. Here, we will give a short overview of the classical FAST
and the eFAST from [84] and [130].
Let us consider the model given by y = f(x). The output y is the function of
n input factors x = (x1, x2, ..., xn) through the model f . Let us assume that the
domain of input factors is the unit hypercube given by
Kn = (x| 0 ≤ xi ≤ 1; i = 1, ..., n) (5.10)
Let us assume that x is a random vector with the probability distribution function
(pdf) P (x) = P (x1, x2, ..., xn). A summary statistic is given by the rth moment of
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y:
〈y(r)〉 =
∫
Kn
f r(x1, x2, ..., xn)P (x1, x2, ..., xn)dx (5.11)
Using a multidimensional Fourier transformation of f , one can perform an ANOVA-
like decomposition1 of the variance of y as a function of the input x in order of
increasing dimensionality. In this case, it is done by computing the main eﬀects and
the interactions of any order. The curve which explores the space Kn is given by a
set of parametric equations,
xi(s) = Gi(sinωis), ∀i = 1, 2, ..., n (5.12)
where s is a scalar variable deﬁned in the range −∞ < s < +∞. Gi are the trans-
formation functions. {ωi} is a set of diﬀerent angular frequencies. As s varies, all
the factors change simultaneously along the curve that systematically explores Kn
with a diﬀerent frequency ωi. Each xi periodically oscillates at the corresponding
frequency ωi depending on Gi. The high amplitude oscillations of y at the fre-
quency ωi are obtained, if the ith factor has a strong inﬂuence on the output. If the
frequencies ωi are linearly independent,
n∑
i=1
riωi 6= 0, −∞ < ri < +∞ (5.13)
then (5.11) can be computed by an one-dimensional integral
y(r) = lim
T→∞
1
2T
∫ T
−T
f r(x1(s), ..., xn(s))ds (5.14)
The variance of the model is
D = 〈y(2)〉 − 〈y(1)〉2 ≡ y(2) − (y(1))2 (5.15)
and can be computed by evaluating the one-dimensional integral (5.14). By assum-
ing f(s) within the ﬁnite interval (−pi;pi), and setting T = 2pi, one gets
yr = 12pi
∫ pi
−pi
f r(s)ds (5.16)
and
Dˆ = y(2) − (y(1))2 = 12pi
∫ pi
−pi
f 2(s)ds−
[ 1
2pi
∫ pi
−pi
f(s)ds
]2
(5.17)
1ANOVA (Analysis of Variances) for details see Appendix A.
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The function f(s) can be expanded to a Fourier series
y = f(s) =
+∞∑
j=−∞
{Ajcosjs+Bjsinjs}, (5.18)
where the Fourier coeﬃcients Aj and Bj are deﬁned as
Aj =
1
2pi
∫ pi
−pi
f(s)cosjsds
Bj =
1
2pi
∫ pi
−pi
f(s)sinjsds
(5.19)
and j is an integer frequency.
A spectrum of the Fourier series expansion is deﬁned as
Λj = A2j +B2j , j ∈ Z (5.20)
By evaluating the spectrum for the frequency ωi and its higher harmonics pωi, one
can estimate the portion of the output variance, Di:
Dˆi =
∑
p∈Z0
Λpωi = 2
+∞∑
p=1
Λpωi , (5.21)
where, Z0 is the set of all relative integers except 0.
The total variance is estimated as
Dˆ =
∑
j∈Z0
Λj = 2
+∞∑
j=1
Λj, (5.22)
The ratio
SFAST = Dˆi
Dˆ
(5.23)
is the ﬁrst order sensitivity index which is a fraction of total variance that estimates
the main eﬀect of xi on y.
The classical FAST method estimates the ﬁrst-order eﬀects, while the higher-
order eﬀects are neglected. In order to compute these higher-order eﬀects, one
needs to consider the frequencies which do not belong to the set
p1ω1, p2ω2, ..., pnωn, pi = 1, 2, ...,∞, i = 1, ..., n
These frequencies will account for a residual variance D −∑
i
Di which include the
higher order interactions among the factors that are not considered by the ﬁrst order
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indices. In this case, a frequency ωi is assigned for the ith factor and a diﬀerent
frequency ωi′ is assigned to all the remaining factors. By evaluating the spectrum at
the frequency ωi′ and the higher harmonics piωi, one can estimate a partial variance
D−i which includes all the eﬀects of any order except i.
The total-order variance is computed as
DTi = D −D−i (5.24)
This means that DTi is calculated as the remaining variance after the contribution
of the complementary, D−i is subtracted.
The total-order sensitivity indices are computed by
STi =
DTi
D
= D −D−i
D
= 1− D−i
D
= 1− S−i (5.25)
The ﬁrst-order indices are computed from (5.23). To get more eﬃcient param-
eter sampling, eFAST implements a random resampling of search curves, because
diﬀerent search curves produce diﬀerent combinations of parameters thereby leading
to the diﬀerent sensitivity measures. Additionally, due to the symmetry properties
of trigonometric functions, the same samples are repeated.
By using the advantage of repeated measurements, Marino et al. [84] proposed
a novel method based on dummy parameters to determine the signiﬁcance of ﬁrst
and total order indexes. This dummy parameter does not appear in the model
equations and does not aﬀect the model. The authors used a two-sample t test1
on the data resulted from the resampling to determine if the sensitivity indexes of
a parameter of interest are signiﬁcantly diﬀerent from the indexes returned for the
dummy parameter.
5.2.2 Results
As we discussed in Section 5.1, the local sensitivity gives the information only at
the vicinity of nominal values, and this deﬁciency can be solved by using the global
sensitivity analysis. We performed the global sensitivity analysis using eFAST. De-
tailed information about its implementation can be found in [84]. It allows us to
determine the sensitivity of parameter values in more details within the deﬁned in-
terval range. From the introduction of eFAST, we know that it gives the information
about the ﬁrst and total-order sensitivities. Figure 5.2 and 5.3 depict that the ﬁrst
1It is assumed that two samples are from the normal distributions with unknown and unequal
variances.
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order sensitivities comprise only a small of part of whole sensitivities, while a major
contribution comes from the total order sensitivities.
The ranges for the parameters were chosen as
(best ﬁt values/10, best ﬁt values*10) (5.26)
and the sensitivities were calculated within these ranges. Table 5.1 indicates the
best ﬁt values and the parameter ranges deﬁned using (5.26). We found out that it
is feasible to divide the time course into the highly dynamic initial phase and the
slow dynamic steady-state phase, since there is no signiﬁcant diﬀerence is found out
between the individial time points. Therefore, we computed the sensitivities at 4
hours for the initial phase, and at 72 hours as a reference for the steady state.
Performing the analysis revealed that initially at 4 hours (Figure 5.2) at the
cytoplasmic RNA processing, the processing rate of transfected RNA, k0, and the
degradation, µunpP are one of the parameters which aﬀect the viral replication sig-
niﬁcantly. They aﬀect all the plus, minus-strand RNA and the polyprotein lev-
els. The model demonstrated that the initial degradation of plus-strand RNA after
transfection, is determined mainly by the degradation rate, µunpP . From the model
development, we know that these steps are essential in explaining the kinetic data.
The sensitivity analysis supports this observation by indicating them as one of the
most inﬂuential parameters at the initial stage of replication. However, the eﬀect of
these parameters is not inﬂuential at the later stages of the replication, at 72 hours
(Figure 5.3). This directly indicates the dynamical nature of the replication, that
the inﬂuence of some processes varies during the time.
The degradation of the processed plus-strand RNA, µcytP , is found to be a non-
sensitive at the initial stages of replication, however, appears to be important at
steady-state for the plus-strand RNA.
The most inﬂuential parameter at the translation stage, is the translation rate of
polyprotein, k2. Since the polyprotein levels are directly dependent on this kinetic
rate, it is one of the most important parameters which has a high sensitivity. This
parameter is one of the few parameters which aﬀects the level of all three variables
at the initial and later stages of replication.
At the replication vesicles formation, the formation rate kPin is sensitive only at
the initial stages and aﬀects the level of all three variables. But at steady state, it
is not sensitive anymore. The parameters in the replication vesicles are found to be
the most inﬂuential even at the initial stage of replication. This directly highlights
the importance of the processes inside the replication vesicles.
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Initially, the synthesis rate of new plus-strand RNA, k4p, aﬀects the level of plus-,
minus-strand RNA and polyprotein, while k4m and µVMS aﬀect mainly the level of
plus and minus-strand RNA. At steady state, the degradation rate, µVMS is the
most sensitive parameter which aﬀects the viral replication and is found to be the
most inﬂuential parameter in general. k4p still shows an impact for the plus-strand
RNA and a less sensitivity for the minus-strand and the polyprotein at later stages
of replication. The parameter k3 is insentivite initially and mainly inﬂuences the
level of the plus-strand RNA at steady state.
The parameter kPout is also one of the parameters which signiﬁcantly aﬀects the
viral replication initially. The polyprotein, L is very sensitive against its degrada-
tion rate, µL at the initial and later stages of replication. Overall, this analysis
highlighted that the processes inside the replication vesicles play an important role
in the viral replication.
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Figure 5.2: The parameter sensitivity at t = 4 hours. Shown are the ﬁrst and total order
sensitivities for the plus, minus-strand RNA and the polyprotein. Initially, the processing
rate k0, the degradation rate µcytP , the synthesis rates k4m, k4p and the degradation rate
µVMS are the most inﬂuential parameters for the plus and minus-strand RNA. The pro-
cessing rate k0, the degradation rate µcytP , the translation rate k2, the synthesis rate k4p,
the export rate kPout and the polyprotein degradation rate µL are the most inﬂuential
parameters for the polyprotein. The dummy parameter is independent of model and is
included by eFAST during the simulation. The sensitivities that are diﬀerent than that of
the dummy parameter are considered to be inﬂuential.
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Figure 5.3: The parameter sensitivity at t = 72 hours. Shown are the ﬁrst and total
order sensitivities for the plus, minus-strand RNA and the polyprotein. At steady state,
the degradation rate inside the replication vesicles, µVMS is the most inﬂuential parameter
for the plus, minus-strand RNA and the polyprotein. In addition, the degradation rate
of processed free plus-strand RNA, µcytP , the translation rate k2 and the synthesis rate
k4p are also most inﬂuential for the plus-strand RNA. The translation rate k2 is found be
important for the minus-strand RNA. The degradation rate of polyprotein µL aﬀects the
polyprotein level at most. The translation rate k2 is also has a signiﬁcant eﬀect on the
polyprotein.
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5.2.3 Local sensitivity versus global sensitivity
In this section, we will discuss about the diﬀerence and the common points of the
local and global sensitivities for the replication model.
At the cytoplasmic RNA processing, the parameters µunpP and k0 are found to
be signiﬁcant both in the local and global analysis (Figure 5.1 and Figure 5.2). Of
course, from Figure 5.2 it is clear that they have a signiﬁcant eﬀect at the initial stage
of replication. This highlights the importance of these rates in the HCV replication.
The parameter, µcytP is insensitive according to the local sensitivity analysis, however,
found to have an eﬀect on the plus-strand RNA at the later stages of replication
(Figure 5.3).
The ribosome numbers, Ribo is insensitive according to the global sensitivity,
whereas, it has an inﬂuential eﬀect on the polyprotein level in the local analysis.
The translation rate, k2 in the local analysis is a sensitive parameter only for the
polyprotein. However, according to the global analysis, it is one of the most sensitive
parameter at the initial and later stages of replication.
At the replication formation, the formation rate of vesicles, kPin is sensitive
rather than the host factor numbers, HF (0) when performing the global analysis.
The synthesis rates, k4m and k4p are sensitive both in the local and global sensi-
tivity analysis. In the global analysis, they are sensitive only in the initial phase of
replication. Interestingly, in both analyses, k4p found to aﬀect mostly the polypro-
tein level (Figure 5.1 and Figure 5.2). The degradation rate inside the replication
vesicle, µVMS is also found to be important in both analyses. The global analy-
sis revealed this parameter as the most important at steady state, while the local
sensitivity analysis showed it to be the most important for the minus-strand RNA
level.
The parameter kPout is important for the polyprotein level in the local analysis.
According to the global analysis at 4 hours, it is shown to have a signiﬁcant eﬀect.
At steady state, it has an inﬂuential eﬀect on the plus-strand RNA. The degrada-
tion rate of polyprotein, µL is sensitive for the polyprotein level according to both
analyses.
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Table 5.1: The parameter ranges for the global sensitivity analysis. The parameter
ranges have been deﬁned as indicated in (5.26). For more information see the text.
Parameters Best ﬁt values Parameter ranges for global GSA
k0 0.00587 h−1 (0.0005787, 0.0587)
k1 1 h−1molec−1 (0.1, 10)
k2 100 h−1 (10, 1000)
kc 1 h−1 (0.1, 10)
kPin 2.07e− 6 h−1molec−2 (2.07e− 7, 2.07e− 5)
kPout 0.333 h−1 (0.0333, 3.33)
k4m 1.7 h−1 (0.17, 17)
k4p 1.7 h−1 (0.17, 17)
k5 10 h−1molec−1 (1, 100)
k3 1e− 4 h−1molec−1 (1e− 5, 1e− 3)
µunpP 0.758 h−1 (0.0758, 7.58)
µcytP 0.487 h−1 (0.0487, 4.87)
µTc 0.243 h−1 (0.0243, 2.43)
µcytE 0.06 h−1 (0.006, 0.6)
µVMS 0.0703 h−1 (0.00703, 0.703)
µL 0.35 h−1 (0.035, 3.5)
Ribo(0) 995 molecules (99.5, 9950)
HF (0) 88 molecules (8.8, 880)
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Chapter 6
Identiﬁability Analysis
Modeling biological processes often results with a large number of parameters. An
important issue is therefore to examine whether these parameters can be uniquely
determined from an input, initial conditions and observed outputs. Moreover, be-
fore estimating these parameters from the experimental data, a serious problem to
overcome is how to verify whether the model parameters are identiﬁable based on
the measurements of output variables. In the following, we will give a brief overview
of identiﬁability analysis and for more details refer to [91].
Lets assume that a general dynamic system is expressed as follows:
x˙(t) = f(t, x(t), u(t), θ),
y(t) = h(x(t), u(t), θ),
(6.1)
where x(t) ∈ Rm is a vector of state variables, y(t) ∈ Rd is a measurement vector,
u(t) ∈ Rp an input vector, and θ ∈ Rq is a parameter vector. For the inverse
problem, θ is unknown and has to be estimated from the experimental data.
Deﬁnition 6.0.1. The dynamic system given by (6.1) is identiﬁable if θ can be
uniquely determined from the given system input u(t) and the measurable systems
output y(t). Otherwise, it is non-identiﬁable.
Deﬁnition 6.0.2. A system structure is globally identiﬁable if for any admissible
input u(t) and any two parameter vectors θ1 and θ2 in the parameter space Θ,
y(u, θ1) = y(u, θ2) holds if and only if θ1 = θ2.
Note that, u(t) is called an admissible input if it satisﬁes all system constraints
at any time of interest and a solution of the dynamic system exists.
Deﬁnition 6.0.3. A system structure is locally identiﬁable if for any θ within an
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open neighborhood of some point θ∗ in the parameter space Θ, y(u, θ1) = y(u, θ2)
holds if and only if θ1 = θ2.
The parameters for which no unique solution exists are termed as non-identiﬁable.
These non-identiﬁabilities can arise from diﬀerent sources. There are two main
sources exist that are the non-identiﬁabilities due to a model structure and an insuf-
ﬁcient amount of data. First, the model structure itself may cause the parameters to
be functionally related which leads to the non-identiﬁability. The branch of identiﬁ-
ability analysis which deals with this kind of problems is called a prior or structural
identiﬁability. Second, the model parameters are estimated by ﬁtting the model to
the experimental data and the limited amount of data may cause non-identiﬁabilities
in the model parameters. The branch of identiﬁability analysis dealing with this
problem is called a practical identiﬁability. In the following, we will overview the
identiﬁability methods and for more information refer to [52], [143], [44], [91].
6.1 Prior Identiﬁability
A prior identiﬁability is concerned with the ability to uniquely identify the model
parameters from a noise-free experimental data, given a particular input-output
experiment [143]. We follow a deﬁnition given in [91].
Deﬁnition 6.1.1. For an admissible input u(t) in the time range of interest [t0, t1]
and a given initial state x0 = x(t0), which is independent of θ and not an equilibrium
point, if there exists an open set Θ0 within the parameter space Θ such that, for
any two diﬀerent parameter vectors θ1, θ2 ∈ Θ0, the solutions x(t, θ, u) exist on
[t0, t0+], (t0 <  ≤ t1−t0) for both θ1 and θ2, and y(t, θ1, x0, u(t)) 6= y(t, θ2, x0, u(t))
on [t0, t0 + ], the system structure is locally strongly identiﬁable.
This deﬁnition can be applied in deﬁning the prior or structural identiﬁability
and Xia and Moog [161] introduced the following deﬁnition.
Deﬁnition 6.1.2. Let CNu [t0, t1] is the function space expanded by all input func-
tions that are N times diﬀerentiable and let M denote on open set of initial system
states. The system stucture is said to be structurally identiﬁable if there exists open
and dense subsets M0 ⊂ M , Θ0 ⊂ Θ, and U0 ⊂ CNu [t0, t1] such that the system is
locally strongly identiﬁable at θ given u for any x0 ∈M0, θ ∈ Θ0, and u ∈ U0.
Prior identiﬁability analysis can be performed without any experimental obser-
vation. This analysis heavily relies on two basic assumptions: model structures are
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absolute accurate and measurements are error free [91]. But, in practice these two
assumptions are not valid. For example, in biomedical research, both the model un-
certainty and the measurement error are usually large. Therefore, the estimates of
model parameters might still be unreliable, when even prior identiﬁability suggests
that the model parameters can be uniquely identiﬁed.
There are various methods available to detect the structural non-identiﬁabilities
such as a power series expansion [116], a volterra and generating power series ap-
proach [70], a similarity transform approach [155] or diﬀerential algebraic methods
[74], and a mean optimal transformation method [52].
6.2 Practical Identiﬁability
A practical identiﬁability deals with the accuracy of parameter values that can be
estimated from noisy measurements [143]. As already mentioned in previous section,
in practice, the assumptions on which prior identiﬁability analysis relies are not valid.
Therefore, it is necessary to evaluate whether structurally identiﬁable parameters
can be reliably estimated from a noisy data.
In this case, we assume that the output model contains measurements errors,
y(t) = h(x(t), u(t), θ) + ε(t) (6.2)
where ε(t) is a measurement error and ε ∈ N(0, σ2).
Rodriguez-Fernandez et al. [126], [127] developed a method for practical iden-
tiﬁability analysis of ODE models by analyzing the correlations between the model
parameters. We will shortly review the idea of this approach [91].
Let us assume the parameter estimate θˆ = [θˆ1, θˆ2, ..., θˆq] that has been obtained
after ﬁtting the model to experimental data. The correlation matrix of the param-
eter estimates is calculated based on the Fisher Information matrix (FIM)1 which
quantiﬁes a measure of informativeness of noisy measurement data for estimating
the model parameters:
R =

r11(θˆ1, θˆ1) r11(θˆ1, θˆ2) · · · r1q(θˆ1, θˆq)
r21(θˆ2, θˆ1) r22(θˆ2, θˆ2) · · · r2q(θˆ2, θˆq)
... ... . . . ...
rq1(θˆq, θˆ1) rq2(θˆq, θˆ2) · · · rqq(θˆq, θˆq)

(6.3)
1For more details refer to Appendix A.
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where rij is the correlation coeﬃcient between parameter estimates θˆi and θˆj (i, j =
1, 2, ..., q). This correlation coeﬃcient is deﬁned as −1 ≤ rij ≤ 1. If rij is close to 1,
then it means that there is a strong correlation between the parameters θˆi and θˆj.
A strong correlation means that the parameters strongly depend on each other and
a change in a model parameter θˆi can be compensated by an appropriate change in
a model parameter θˆj. Thus, the highly correlated parameters are non-identiﬁable.
If the measurements errors are assumed to be uncorrelated and ε ∈ N(0, σ2),
then (6.1) is given as
FIM =
N∑
i=1
(
∂yˆi
∂θˆ
)T
V −1
(
∂yˆi
∂θˆ
)
(6.4)
where i is the ith time point of experimental observation, N is the total number
of observations, yˆi is the model approximation of observation, θˆi is the parameter
estimate of the model and V is a matrix of weights on variances which is positive
deﬁnite. According to the Cramer Rao theorem [123],
C = FIM−1 (6.5)
where C denotes a covariance matrix.
The elements of the correlation matrix then can be deﬁned as
rij =
Cij√
CiiCjj
, i 6= j,
rij = 1, i = j.
(6.6)
The inverse of FIM provides a lower bound for the variances of the parame-
ter estimates based on the Cramer-Rao inequality1 [73]. The lower bounds of the
parameter variances are computed by
σ2pi ≥ [FIM−1]ii, (6.7)
From this statement, a 95% conﬁdence interval for each parameter is deﬁned as
[pi − 1.96σpi , pi + 1.96σpi ] (6.8)
A parameter is said to be a practically identiﬁable when its value is non-zero within
the 95% conﬁdence interval. We applied the practical identiﬁability analysis to
our model parameters by ﬁtting the model to the experimental data. For detailed
1For details see Appendix A.
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information, we refer to Section 6.4.
6.3 Local Identiﬁability Analysis
In this Section, we will discuss about a local identiﬁability analysis which gives
information at the vicinity of nominal values. This analysis is also known as a
sensitivity-based identiﬁability analysis. The idea of sensitivity analysis can also be
used to examine the identiﬁability of model parameters.
Sensitivity-based identiﬁability analysis resembles the structural identiﬁability
analysis approach because it does not require the experimental data and assumes
that the measurements are error free. It diﬀers from the structural analysis by the
fact that it does not use a model structure which is essential for the structural
analysis. This sensitivity based method is diﬀerent from the practical identiﬁability
analysis in the sense that it does not take the observation error into account and
similar in the sense that both require the nominal or actual estimates. This method
is considered to be between the structural and practical identiﬁability analyses. We
will discuss this approach in this section and the interested reader is referred to [91],
[57].
A sensitivity based approach requires a predetermined nominal value, therefore,
parameter identiﬁability is evaluated with respect to a particular point in the pa-
rameter space. The following deﬁnitions are introduced to deﬁne the concept of
at-a-point identiﬁability [74], [119].
Deﬁnition 6.3.1. Let θ∗ denote a ﬁxed point in the parameter space Θ. A system
is globally at-a-point identiﬁable if, for any admissible input u(t) and any parameter
vector θ ∈ Θ, y(u, θ) = y(u, θ∗) implies θ = θ∗.
Deﬁnition 6.3.2. Let θ∗ denote a ﬁxed point in the parameter space Θ. A system
is locally at-a-point identiﬁable if, for any admissible input u(t) and any parameter
vector θ within an open neighborhood of θ∗, y(u, θ) = y(u, θ∗) implies θ = θ∗.
Let us assume the number of time points t1 ≤ t2 ≤ ... ≤ tN at which the
state variables are measured. Then the sensitivity coeﬃcient at each time point
tk, k = 1, 2, ..., N for a given nominal parameter vector θ∗ is given as
sij(tk) =
∂yi(tk, θ∗)
∂θj
, i = 1, ..., d j = 1, ..., q (6.9)
where yi is the ith component of y and θj is the jth component component of θ.
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Then the sensitivity matrix for all time points is deﬁned as
SdN×q =

s11(t1) · · · s1q(t1)
· · · . . . · · ·
sd1(t1) · · · sdq(t1)
... ... ...
s11(tN) · · · s1q(tN)
· · · . . . · · ·
sd1(tN) · · · sdq(tN)

(6.10)
The parameter is identiﬁable if the system output is highly sensitive to a small
perturbation of the parameter. The correlation between any two parameters can be
evaluated by analyzing the dependence of the sensitivity matrix columns. Jacquez
and Greif developed a correlation method to study identiﬁability for linear models
which is also applicable for nonlinear models [58], [57].
Lets consider a Taylor expansion of the ﬁrst order for the system output in the
neighborhood of the nominal parameter vector θ∗,
yk(θ) = y(x(tk), u(tk), θ)
≈ y(x(tk), u(tk), θ∗) + ∂y(x(tk), u(tk), θ)
∂θ
∣∣∣∣∣∣
θ=θ∗
· (θ − θ∗),
(6.11)
where k = 1, 2, ..., N denotes the index of the measurements time points. Consider
rk denote the measurements at tk without errors and ∆ = θ − θ∗. We can then
obtain the residual sum of squares between the exact measurements and the linear
approximation,
RSS(∆θ) =
N∑
k=1
rk − yk(θ∗)− ∂y(x(tk), u(tk), θ)
∂θ
∣∣∣∣∣∣
θ=θ∗
·∆θ
2
=
N∑
k=1
∂y(x(tk), u(tk), θ)
∂θ
∣∣∣∣∣∣
θ=θ∗
·∆θ
2
(6.12)
Note that rk − yk(θ∗) = 0. Then we can formulate (6.12) in terms of sensitivity
matrix,
RSS(∆θ) = (S∆θ)T ·S∆θ, (6.13)
where S is the sensitivity matrix deﬁned in (6.10).
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The minimum of RSS(∆θ) is obtained when STS·∆θ = 0. θ = θ∗ is the unique
solution of STS·∆θ = 0, if STS is of full rank. This indicates that the model
parameters θ are locally identiﬁable at θ∗. If STS is singular, then there at least one
nontrivial solution θˆ 6= θ∗ exists such that the model parameters are not identiﬁable
at θ∗.
It is important to identify those parameters that are not identiﬁable if STS is not
of full rank. This can be done by calculating the correlations between parameters
using the sensitivity matrix (6.10). Each column of (6.10) indicates the sensitivity of
the system responses at all time points with respect to one speciﬁc parameter. Thus,
the correlation between two parameters can be calculated as the sample correlation
of two columns in the sensitivity matrix (6.10)
corr(S∗i , S∗j ) =
cov(S∗i , S∗j )
σ(S∗i )σ(S∗j )
(6.14)
where S∗i and S∗j denote ith and jth columns of the sensitivity matrix, respectively.
cov(S∗i , S∗j ) denotes the sample covariance between S∗i and S∗j . σ(S∗i ) and σ(S∗j ) are
the sample standard deviations of S∗i and S∗j , respectively. As mentioned before, if
the correlation between any two parameters is close to 1, then these two parameters
are non-identiﬁable.
We are going to apply this idea of local identiﬁability to our model parameters
and the details will be discussed in Section 6.4.
6.4 Results
We identiﬁed the non-identiﬁable parameters when performing a model ﬁtting to
the experimental data. We iteratively ﬁtted the model to the data and deﬁned the
parameters which are non-identiﬁable. We performed the practical identiﬁability
analysis by ﬁtting the model to the data (for parameter estimation refer to Chapter
3). During the ﬁtting, it has been observed that the parameters k1, kc, k5 and k3
have large conﬁdence intervals, which means they cannot be properly estimated from
the data. When performing the practical identiﬁability analysis, Hengl et al. [52]
suggested to ﬁx the parameter within plausible ranges to that value which belongs
to the best ﬁt. In order to render all parameters identiﬁable, we performed a ﬁxation
of these parameters.
The parameter k1 is insensitive within the reported range [1, 100] in [48], which
is accepted to be a plausible range. Therefore, we set k1 = 1 which is the lowest
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range for k1. We found out that this parameter is sensitive below the lowest range.
As it was reported in Dahari et al. [48], we ﬁnd out that to ensure the experi-
mentally observed 10:1 ratio, the condition k3 << k5 should be fulﬁlled. The model
simulations demonstrated that when these parameters are equivalent, then this ratio
is not valid anymore. Therefore, we set k5/k3 = 105 which satisﬁes the ratio of the
plus-to minus-strand RNA. Furthermore, we observed during the parameter estima-
tion for our model that the optimization was trying to push the parameters k5 and
kc to the values beyond the upper bounds of the biologically plausible range, which
are [0, 10] and [0, 1], respectively. In order to avoid this, we ﬁxed these parameters
to their upper bounds, k5 = 10 h−1 and kc = 1 h−1.
During the optimization, we observed that the condition, µTc < µ
cyt
P was vio-
lated. Simply, the optimization returned almost equal values for both parameters.
This condition implies that the free plus-strand RNA, RcytP degrades faster than the
plus-strand RNA within the translation complexes, Tc. Further using this fact, we
assumed that RcytP degrades two times faster than Tc, and set µcytp /µTc = 2. This
allows us to get rid of one free parameter.
Finally, we performed the optimization for the remaining 11 free parameters and
obtained a well-conditioned problem with identiﬁable parameters (Table 6.1).
We then performed a local identiﬁability analysis at the best ﬁt values in order
to determine non-identiﬁable parameters using SensSB [125], a software toolbox for
the development and sensitivity analysis of systems biology models. This analysis
is able to determine the identiﬁability in a case of unlimited and error free data and
can distinguish between the non-identiﬁability due to the structure of the model or
the lack of experimental data. The result of this analysis is depicted in Figure 6.1
which represents the parameter correlation matrix.
The correlation matrix quantiﬁes the relationship between the parameters, where
the elements of the correlation matrix are the correlation coeﬃcients between the i-
th and j-th parameter. As in Section 6.1, a high correlation between two parameters
means that the change in the model output caused by the change in the parameter
can be compensated by the appropriate change in the other parameter. This then
prevents the parameters from being uniquely identiﬁable despite the output is very
sensitive to changes in the individual parameters.
The results demonstrated that most parameters at the neighborhood of best ﬁt
values are identiﬁable (Figure 6.1). The correlation values of these parameters are
signiﬁcantly diﬀerent from the high and low correlation values. Therefore, this anal-
ysis supports the goodness-of-ﬁt and the optimality of the estimated parameters.
This analysis revealed that only the parameters µcytE and µL are highly correlated.
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Table 6.1: Practical identiﬁability analysis on the model parameters.
Parameter name Parameter values Status
k0 0.00587 h−1 identiﬁable
k1 1 h−1molec−1 ﬁxed
k2 100 h−1 experimentally observed
kc 1 h−1 ﬁxed
kPin 2.07 × 10−6 h−1molec−2 identiﬁable
kPout 0.333 h−1 identiﬁable
k4m 1.7 h−1 experimentally observed
k4p 1.7 h−1 experimentally observed
k5 10 h−1molec−1 ﬁxed
k3 10−4 h−1molec−1 ﬁxed
µunpP 0.758 h−1 identiﬁable
µcytP 0.487 h−1 identiﬁable
µTc 0.243 h−1 identiﬁable
µcytE 0.06 h−1 experimentally observed
µVMS 0.0703 h−1 identiﬁable
µL 0.35 h−1 experimentally observed
Ribo(0) 995 molecules identiﬁable
HF,high(0) 88 molecules identiﬁable
HF,low(0) 10 molecules identiﬁable
pscale 2.80× 103 identiﬁable
A high correlation means that the change in the output caused by the change in
µcytE is compensated by the change in µL. Interestingly, these parameters have been
experimentally observed which indicates that even the experimentally observed pa-
rameters can be rendered as non-identiﬁable.
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Figure 6.1: The correlation matrix which represents the correlation between the individual
parameters. The positive values indicate a positive correlation, whereas the negative
values indicate a negative correlation. The diagonal elements have a perfect correlation
of 1 which indicates that the parameter perfectly correlates with itself. This correlation
matrix indicates that all parameters except µcytE and µL are locally identiﬁable at the
vicinity of best ﬁt values. The parameters µcytE and µL are highly correlated and the
correlation value is close to 1.
Chapter 7
Discussion
In this chapter, we will discuss essential aspects of this work. In particular, we will
give a short summary and a discussion of the results of each chapter. The main
statements and results are summarized in Section 7.1. In Section 7.2, our model
developed in this thesis will be compared and discussed with the other existing
models. In Section 7.3, we will discuss a future perspective and ultimate goals of
this work.
7.1 Summary
In this thesis, we developed a mathematical model based on the ordinary diﬀential
equations with the focus to investigate the mechanisms which elucidate the Hepatitis
C Virus replication.
In Chapter 1, we discussed the biological insights about the HCV and its life-
cycle. We gave a broad overview about the recent status of HCV research from the
clinical and basic science perspective. HCV research is inspired from the clinical
studies, and became a hot topic for the basic science. The current statistics claims
that only about 50-60 % of all treated patients show a positive response to the drug
treatment. The limited eﬃciency of current available drug treatment led to a need
to understand HCV lifecycle in more details, and a better understanding of HCV
lifecycle will lead to the development of new drugs with a high eﬃciency. From this
chapter, we see that the HCV lifecycle consists of three essential parts, which are
the entry, the replication and the particle formation or the assemly.
HCV entry into the host cell is the ﬁrst step in the virus life-cycle which starts
with the attachment of the virus particle to the host cell. This is done by the spe-
ciﬁc interactions between several receptors on the cell surface and a viral attachment
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protein on the surface of the particle. Identiﬁcation of the factors which are limiting
the HCV entry at this stage may prevent a succesful virus replication. The appli-
cation of the electroporation1 allows a transfection of virus strains into the cell by
ignoring the virus entry and focus directly on the replication and the assembly. The
development of subgenomic HCV made possible to isolate the virus replication by
ignoring the HCV assembly. In subgenomic HCV, the regions in the genomes which
encode for structural proteins are deleted, which are essential for the formation of
virus particles. HCV replication is the process which consists of the translation
where the HCV genome is translated into a viral polyprotein which is cleaved into
several non-structural proteins, and the replication which undergoes in the vesicles
called “replication vesicles”. Overall, HCV replication process is poorly understood
and the development of mathematical models made possible to study the process in
a systematic way.
As we discussed, the ﬁrst attempt to model the HCV replication was done by
Dahari et al. [48] and this model was calibrated with the data from Quinkert et
al. [120]. The model can nicely reproduce the steady state data and explain the
mechanism underlying the observed ratio between the plus and minus-strand RNA.
However, we showed that the model is unable to ﬁt to the kinetic data, thereby
showing a complexity of the replication process. This model only considers the ef-
fect of cellular ribosomes which is reported to be a limiting factor for the replication.
The kinetic data indicates that the replication process is highly dynamic and a large
number of virus host interactions imply the high complexity of the process.
In Chapter 2, we discussed the development of the new mathematical model for
HCV replication. First, the model was represented in terms of kinetic reactions and
then using mass action kinetics was converted into the ordinary diﬀerential equa-
tions. We assumed that whole replication process undergoes in the cytoplasm and
the replication vesicles. Initially, after transfection, we assumed that the transfected
plus-strand RNA is processed before being translated. This assumption allows us
to ﬁlter those plus-strands which are able to participate in the translation and the
replication. Those which are not able to replicate are considered to be defective and
they degrade before being translated. As we already mentioned in Subsection 2.1.1,
the viral RNA lacking a coat protein might degrade faster before adapting to the
cell environment.
1The use of high-voltage electric shocks to introduce DNA into cells can be used with most
cell types, yields a high frequency of both stable transformation and transient gene expression. It
is usually used in molecular biology to introduce some substance into a cell [117]
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After the processing, the plus-strand RNA is translated by the host ribosomes
into the viral polyprotein. This polyprotein is then cleaved into several non-structural
proteins. One of these proteins NS4B induces the formation of replication vesicles,
and this process we considered implicitly in our model. Another protein, NS5B
participates in the formation of replication complexes within the replication vesicles
together with the translated plus-strands and the cellular host factor. As mentioned,
a number of cellular factors have been found to be associated with the replication
complex. Therefore, we assumed the interaction of the host factor with the virus at
the formation of replication complex. As the replication complex here we mean an
intermediate plus-strand replicative complex. This complex leads to the synthesis
of complementary minus-strand RNA which exists in the form of double-stranded
RNA. In this case, a polymerase within the replication complex plays a machinery
role by copying the minus-strand RNA from the plus-strand RNA. The minus-strand
RNA which exists within the double-strand RNA then interacts with the polymerase
to form an intermediate minus-strand replicative complex. Within this complex, the
minus-strand RNA serves as a template for the synthesis of new plus-strand RNA.
The newly produced plus-strands then interact with the polymerase in the produc-
tion of the minus-strand RNA or leaves the vesicle to participate in the translation.
This export serves as a feedback for the translation which allows the new plus-strand
RNA to be translated and further participate in the genome replication.
As we mentioned earlier, many cellular host factors have been found to interact
with the virus, however, in the model, we considered only the eﬀect of two host
factors, the ribosomes and the cellular factor that participates in the formation of
replication vesicles. Due to a limited amount of experimental data, we kept the
model simple than actually required.
Further important thing is the number of replication vesicles which are formed
during replication. Quinkert et al.[120] reported the existence of several hundred
replication vesicles formed during a viral ampliﬁcation. As reported in [48], we as-
sumed the formation of a single replication vesicle, which approximates many vesicles
if they are formed at the same time. However, Wölk et al. [160] reported the ex-
istence of replication vesicles with diﬀerent sizes. This indicates that these vesicles
may be formed gradually as the number of viral RNA increases. This observation
also supports that these replication vesicles may grow in size as the virus repli-
cates. In order to include these details, a more complex model will be required, and
our model is limited to incorporate these assumptions. In this case, instead ODEs
more complex PDE models can be exploited to incorporate above mentioned eﬀects.
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In Chapter 3, the results obtained from the model calibration with the new
model are discussed. The model calibration problem is formulated as an inverse
problem where apart solving diﬀential equations we have to estimate the parameter
values so that the model predictions match the experimental data. In the optimiza-
tion problem, we formulated an objective function which represents the diﬀerence
between the model and the experimental data. The optimization problem was re-
duced to the ﬁnite dimension by using the Multiple Shooting algorithm and the
resulting nonlinear constrained least squares function was solved by using the Gen-
eralized Gauss-Newton method. The list of the estimated parameter values are given
in Table 3.1.
Additionally, we used the evolutionary optimization, the Genetic Algorithm
which was performed independently (Table 3.2). Genetic Algorithms are search
algorithms based on the mechanics of natural selection and natural genetics [46].
Due to its random nature, the genetic algorithm improves the chances of ﬁnding a
global solution. It enables to solve unconstrained, bound-constrained, and general
optimization problems, and it does not require the functions to be diﬀerentiable or
continuous [86]. The results showed that the parameter results obtained by this
algorithm lie close to that one which were obtained by the Multiple Shooting Al-
gorithm. Overall, the optimization problem is counted as a diﬃcult problem when
the number of estimated parameters are high. The gradient-descent method like the
Gauss-Newton method suﬀers from stucking into a local minima by giving only par-
tial information about the optimality of the solution. The evolution based method
like the Genetic Algorithm is advantageous by allowing to search a broader space
and a chance to ﬁnd a global minima in this case is higher. Taking together, the com-
bination of both approaches gives the more conﬁdent results about the optimality
of the solution.
The optimization results show that the model can excellently ﬁt to the experi-
mental data. Interestingly, the model ﬁts to the two kinetic datasets from the high
(Huh7 Lunet cells) and low permissive cells (Huh7 cells) simultaneously. In con-
trast to the existing model, the model can excellently explain the kinetic data even
from the both cells. The model also excellently ﬁts to the steady state data from
Quinkert et al. [120]. The only parameter which is responsible for the diﬀerence in
the replication dynamics in both cells is the amount of the cellular host factor which
participates in the formation of replication complex within the replication vesicles.
Chapter 4 focuses on the validation of model dynamics and predictions as well
as conclusions drawn from the model. As already discussed, initially, we used the
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replication deﬁcient JFH virus measurements to validate our model. We demon-
strated that by setting the formation rate of the replication vesicles, kPin to zero,
the model excellently reproduces the plus-strand RNA and the polyprotein dynamics
by using the parameters which have been obtained from the ﬁtting. This validation
supports the plausibility of the model parameters.
Another model validation was performed using the mutated HCV genome kinet-
ics, where the non-translated regions of the viral genome have been exchanged which
leads to the decrease in the replication eﬃciency. This eﬃciency was measured in
terms of polyprotein kinetics, and at the same time, the steady state changes in the
ratio of plus to minus-strand RNA were observed. We show that the model nicely
reproduces these kinetic and saturation data, by tuning only those parameters which
mimick the changes in the non-translated regions. From the steady state data which
represents the ratio of the plus-strand RNA to the minus-strand RNA, we can see
the severe changes in the ratio when these regions are mutated (Figure 4.2). From
this plot, we easily observe that the mutation in the region which is responsible for
the minus-strand synthesis causes a dramatic decrease in the synthesis of minus-
strand RNA. The model, however, can explain the observation only qualitatively by
predicting only a slight change in the ratio. This shows that the model lacks some
detailed mechanisms which may help to explain the changes properly.
Quantitative predictions require a calibration and a validation of the model and
after completing these steps, we performed predictions using the model. One of
our central predictions is the prediction of the source which is responsible for the
replication permissiveness in the high permissive Huh7 Lunet and the low permissive
Huh7 cells. We demonstrated that the replication permissiveness can be explained
by the diﬀerential expression of the cellular host factor which participates in the
formation of replication vesicles. We showed the uniqueness of this observation by
searching the other possible factors that can explain this observation. It is known
that most conformational changes in the cell after the virus infection happens by
the formation of replication vesicles. A limited amount of cellular host factor at this
stage may limit the formation of these vesicles which are essential for the genome
replication. Additionally, we showed that the replication attains a steady state
due to the limited amount of the host factor. A large number of cellular factors
have been found to be associated with the HCV replication, however, the speciﬁc
role of them is unknown. This prediction can help to ﬁlter these factors according
to their properties and lead to the identiﬁcation of the cellular host factors which
may limit the HCV replication. However, in reality, there are several other host
factors may exist that can limit the replication. This model may not be appropriate
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one to apply if there the other limited factors exist. Our model approximates the
interactions of many host factors which interact with the virus at the formation of
replication vesicles.
Furthermore, by using a simple analysis, we showed that for the successful repli-
cation the degradation inside the replication vesicles should be smaller than the
degradation in the cytoplasm. This prediction supports the observation that the
replication vesicles protect the viral genome and the protein from the host protease
and nuclease. However, in experimental conditions, it is diﬃcult to measure the
degradation rate inside the replication vesicles which makes things impossible to
verify this prediction.
Further, we showed that the model excellently predicts some observations at
steady state such as the protein level which are about a million molecules and the
active polymerase levels which are < 0.1% of total polymerase and they are in
close agreement with the experimental observations. However, in the low permissive
cells, the model predicts about 2-3 fold less proteins than the observed one. The
experimental data is derived from the high permissive cells, as it was reported in
[120]. The situation might be diﬀerent in the case of the low permissive cells,
therefore, the additional measurements are needed to verify this prediction.
We also revealed an importance of the assumption about the processing of trans-
fected viral genome by showing that the initial decrease in the plus-strand RNA
mainly determined by the decay in the transfected viral genome. It is diﬃcult to
detect if the viral RNA degrades at diﬀerent rates in the cytoplasm. It might be
that the virus degrades at the same rate and thereby uses diﬀerent mechanisms to
sustain a successful replication. However, the assumption of the diﬀerent degrada-
tion rates for the viral RNA helps to explain the experimental data.
Chapter 5 focuses on the parameter sensitivity analysis where we investigated
the important parameters which aﬀect the HCV replication. As already discussed,
we performed two types of sensitivity analysis to get a more detailed knowledge
about the parameters. The local sensitivity analysis aimed at investigating the sen-
sitivity at the vicinity of nominal values (best ﬁt values). The results demonstrated
the various eﬀects of parameters for the plus, minus-strand RNA and the polypro-
tein levels. The most inﬂuential and common parameters for all three variables,
plus-, minus-strand RNA and polyprotein are µunpP , HF (0), k4m, k4p and µVMS. It
is obviously seen from these results that the kinetic rates associated with the repli-
cation vesicles are the most important. This indicates the importance of existence
of the replication vesicles.
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In order to get more detailed information, we performed a global sensitivity anal-
ysis with eFAST (Extended Fourier Amplitude Test). This analysis was performed
on the initial and saturation stages of the replication. The parameters k0 and µunpP
are the most inﬂuential parameters at the initial stage of replication. However, these
parameters are not sensitive at steady state. The most sensitive parameter is the
degradation rate inside the replication vesicles, µVMS. The parameters within the
replication vesicles are also found to be sensitive initially. Overall, the sensitivity
analysis revealed a strong correlation between the three variables and the common
inﬂuential parameters. It appeared that in most cases, the inﬂuential parameter
for one variable is also sensitive for another variable. It also demonstrates a high
dependence of the replication processes on each other. In general, this analysis is
very useful to detect a vulnerable step in the replication process and to identify a
possible target for a drug treatment.
Chapter 6 discusses about the identiﬁability of the model parameters. Identiﬁ-
ablity is a prerequisite before making proper predictions, because non-identiﬁabilities
in the model can enormously aﬀect an outcome of the prediction. This is inevitable
process due to the lack of enough experimental measurements to fully calibrate the
model and this problem can be solved by acquiring a large amount of data. We
performed a ﬁtting and a ﬁxing approach to decrease the number of the free param-
eters. If no ﬁxing is done then the conﬁdence intervals of the parameters are wide
which indicates the non-identiﬁabilities in the model parameters.
Further, using a local identiﬁability analysis, we showed an optimality of the es-
timated parameters (Figure 6.1). We demonstrated that only the degradation rates
µL and µcytE are highly correlated. These parameters are experimentally observed,
but still rendered structurally non-identiﬁable at the vicinity of the best ﬁt values.
Structural non-identiﬁability manifests itself in functionally related parameters and
is independent of the accuracy of available experimental data. This analysis is use-
ful to support the parameter estimation problem and to explore the robustness of
the system at the vicinity of nominal values by computing the local sensitivities.
However, this kind of analysis gives information only in a neighborhood of the best
ﬁt values and for a complete analysis a global identiﬁability is needed.
7.2 Comparison with other models
We have already discussed the ﬁrst replication model in details in Section 1.4. Here,
we are going to discuss the other related models from [92] and [89].
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Mishchenko et al. in [92] reported a model for a suppression of subgenomic
HCV RNA replication in the cell culture in the presence of HCV NS3 protease and
NS5B inhibitors. In this model, the authors considered a role of human vesicle-
associated membrane protein (VAP-A) which is critical for the assembly of the
active replicase complex on the membrane. This protein was assumed to play a
limiting role in the replication. However, whether this protein limits the replication
or not is not known. Since there can be a dozen of such factors which may limit
the replication, the experimental validation is needed. Additionally, they did not
consider the formation of replication vesicles which is found to be crucial for the
virus to amplify eﬃciently. The protective property of replication vesicles is found
to be essential, as we showed using our analysis in Subsection 4.2.2.
Recently, McLean et al. [89] published another model for intracellular lifecycle
of plus-strand RNA virus which was applied for HCV case. This model is based on
the model reported in [48]. In addition to the viral replication, they considered the
assemly of viral particles. They studied the alternative strategies for the allocation
and reallocation of the viral genomes in HCV lifecycle. Moreover, the authors in-
vestigated an inherent trade-oﬀ in the replication of plus-strand RNA viruses within
cells that results from the translation, the replication and the packaging. They re-
ported using the model that a free allocation of the viral genomes among translation,
replication and packaging gives the most productive strategy for the virus. As in
[92], they did not consider the formation of replication vesicles. In contrast to our
model, they did not take into account the eﬀect of the cellular factor on the viral
replication. With our analysis, we demonstrated that the model cannot explain the
viral kinetics quantitatively without incorporating a cellular host factor.
Both models described above suﬀer from a lack of kinetic data, thereby leading
to the problems in the parameter estimation. The use of kinetic data allowed us to
properly establish a mathematical model, which quantitatively ﬁts to the data and
explains the cause of the diﬀerent HCV replication in the Huh7 clones.
7.3 Perspectives for future work
7.3.1 Infection model
In transfection, a large number of the viral genome are introduced into the cell
and it is usually done in vitro studies. It allows us to model this process by using a
deterministic approach. However, in a real situation, it has been observed that only a
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small amount of virus can lead to the successfull replication in the cell. In this case,
a deterministic approach is not valid anymore and instead a stochastic modeling
should be applied. Nevertheless, testing a deterministic modeling and applying a
stochastic approach is widely used in a practice. This approach has an advantage
to estimate the parameters ﬁrst by using the deterministic model and to perform
further simulations using the stochastic approach. Since the multiplicity of infection
(MOI) is too low in the natural infection, the processing of transfected plus-strand
RNA which accounts for defective and non-defective virus can be neglected. In our
case, the HCV entry into the cell was neglected and therefore, this step was necessary
to explain the data. In a natural case, the virus infects the cell by attaching to the
cell surface receptors, fuses and enters the cell. It means that only the virus which
successfully enters the cell can participate in the replication. Under such conditions,
the stochastic model may yield qualitatively diﬀerent behavior, since it allows for
inherent ﬂuctuations in the levels of viral constituents [141].
The use of the stochastic analysis provides certain advantages over the deter-
ministic analysis. The random ﬂuctuations might aﬀect reaction dynamics, when
modeling the process as a discrete rather than continuous entities [87]. The model
parameters have already been estimated through the deterministic modeling and
only the stochastic simulations are required by using these parameters. In this case,
multiple stochastic simulations are required to obtain reasonable results and an av-
erage of these results can be compared with the deterministic analysis to reveal the
important diﬀerences between these two analyses. Eventually, it will be interesting
to see how the infection setting diﬀers from the known deterministic setting. Of
course, for the model validation some extra measurements for the infection setting
are required.
7.3.2 Future application of the model
Despite the recent advances in understanding of HCV biology, many questions re-
main without answers. The development of mathematical models for HCV replica-
tion will certainly enhance our understanding. Therefore, our model may serve as a
nice tool to study the complex nature of HCV lifecycle.
Some studies reported a number of cellular factors which are associated with the
HCV replication (see [32]). Certainly, not a single, but the complex interactions of
these host factors with the virus might shape the outcome of the viral replication.
However, our understanding of how these interactions resulted in the successful
replication is still in its infancy. In this respect, our model can be extended to
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include the known host factors which will help us to analyze the eﬀect and the
role of the host factors on the replication process. This is important because some
studies suggested to apply the drugs not against the virus itself but on the cellular
host factors which found to be associated with the virus.
Our model is based on the experimental settings where the immune pathway was
silenced to obtain a successful replication. The model can be extended to study a
complex interaction between the virus and the host immune system. The immune
pathway which detects HCV genome is an RIG-pathway which leads to a production
of type I interferons (IFNs) in the infected cells [163]. It was reported that the HCV
escapes this pathway by using unknown mechanisms. In this case, our model can
be used in developing a comprehensive model to study the host immune and virus
interactions.
Currently available experimental studies with the subgenomic HCV allowed us
to model only the replication cycle of HCV. Using the infection setting it is possible
to extend the studies to the whole HCV lifecycle. Usage of mathematical model in
this case will be of great help.
Today, a number of mathematical models are available to study the eﬀect of
drug treatment against the HCV infection [12], [102], [33]. These models consider
the virus infection only in a population of cells, whereas the models for a single cell
level are limited. The future goal is to integrate the replication model in the single
cell level with the population based models and to get a more comprehensive model
to improve the eﬃciency of the drug treatment.
Appendix A
Law of Mass Action
Assume a reversible chemical reaction with N reactants Si, i = 1, ..., N and M
products Pj, j = 1, ...,M , given by
N∑
i
αiSi 

M∑
j
βjPj (1)
where αi and βj denote the number of the reactants and products molecules involved
in a single reaction step. From [4], the kinetic rates of the forward and reverse
reactions are given as follows
[forward rate] = k1
N∏
i
Sαii
[reverse rate] = k−1
M∏
j
P
βj
j
(2)
This formula shows that the rate of the reaction is directly proportional to the
product of the reactant concentration. It means that the rate of reactions depend
on the probability of simultaneous collision of the corresponding number of the
reactant molecules.
From (2), for the stationary non-equilibrium state, we can derive
[forward rate] = [reverse rate]
which gives
k1
k−1
=
N∏
i
Sαii
M∏
j
P
βj
j
(3)
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This ratio is called the law of mass action. This means when a reversible reaction
has attained an equilibrium, the ratio of molar concentrations of the reactants to
those of the products remains constant.
ANOVA Decomposition
We will deﬁne a deﬁnition of ANOVA decomposition from [139]. Lets deﬁne the
output variable as y = f(x), x = (x1, ..., xn), deﬁned in the unit hypercube 0 ≤
x1 ≤ 1, ..., 0 ≤ xn ≤ 1. The representation of f(x) in the form
f(x) = f0 +
∑
i
fi(xi) +
∑
i<j
fij(xi, xj) + ...+ f12...n(x1, ..., xn). (4)
is called ANOVA - decomposition if
f0 =
∫
f(x)ds (5)
and
1∫
0
fi1,...,isdxip = 0 for 1 ≤ p ≤ s. (6)
The conditions (5) and (6) uniquely deﬁne all the terms in (4). To deﬁne one-
dimensional terms, one needs to integrate (4) over all variables except xi.
∫
f(x)
∏
p6=i
dxp = f0 + fi(xi). (7)
This operation can be extended to deﬁne all higher order terms. If one assumes f(x)
to be square integrable then by squaring and integrating (4), the following can be
obtained ∫
f2(x)dx− f20 =
n∑
s=1
n∑
i1<...<is
∫
f2i1,...,isdxx1,...,xs (8)
If x is a random point uniformly distributed in the hypercube, then f(x) and
fi1,...,is(x1, ..., xs) will be random variables. From the equation (8), one deﬁnes the
constants,
D =
∫
f2(x)dx− f 20 (9)
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and
Di1,...,is =
∫
f 2i1,...,isdxx1,...,xs (10)
where D is called a total variance, and Di1,...,is are called variances.
Fisher Information Matrix
The Fisher Information Matrix plays a central role in the estimation, identiﬁcation
and information theory and provides a summary of the information in the data
relative to the quantities of interest [140]. In the following, we will deﬁne a Fisher
information matrix from Navarro et al. [101]. Let X = (X1, ..., Xn) be a random
sample and let f(X|θ) denote a probability density function for some model of the
data with the parameter vector θ = (θ1, ..., θk). The Fisher information matrix of
sample size n then is given by the k × k matrix whose elements are given by the
covariance between the ﬁrst partial derivatives of the log-likelihood,
In(θ)ij = Cov
[
∂ ln f(X|θ)
∂θi
,
∂ ln f(X|θ)
∂θj
]
(11)
Another deﬁnition of Fisher information matrix is given based on the expected values
of the second partial derivatives,
In(θ)ij = −E
[
∂2 ln f(X|θ)
∂θi∂θj
]
(12)
If no expectation is taken, one obtains a data-dependent quantity called an observed
Fisher information. Here, we can give a small example: for a normal distribution
with the parameters µ and σ2, the Fisher information matrix is given by
In(θ) =
 nσ2 0
0 n2σ4
 (13)
Cramer-Rao lower bound
The Cramer-Rao lower bound provides a lower bound on the variance of any unbi-
ased parameter estimation method and is an important tool in the assessment of a
parameter estimation method [56]. The Cramer-Rao lower bound is computed as
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the inverse of Fisher Information Matrix. Now we review Cramer-Rao lower bound
from [101]. Let T (X) denote any statistic and let ψ(θ) be the expectation of T (X)
given by ψ(θ) = E[T (X)]. Then for all θ, the following is obtained,
V ar(T (X)) ≥ (
dψ(θ)
dθ
)2
In(θ)
(14)
which is called Cramer-Rao inequality, whereas the right hand side of this inequality
is called Cramer-Rao lower bound. If T (X) is an unbiased estimator for θ, then (14)
is given by,
V ar(T (X)) ≥ 1
In(θ)
(15)
When one increases In(θ), the variance becomes smaller which gives more precise
information about the location of unknown parameter. This inequality can be gen-
eralized to the multi-parameter case, θ = (θ1, ..., θk),
V ar(Tmult(X)) ≥ γ(θ)T In(θ)−1γ(θ) (16)
where Tmult(X) is a statistic for multi-parameter case and γ(θ) is a k× 1 vector
with elements γ(θi) = ∂g(θ)/∂θi.
Appendix B
In the following, we will give a short overview about the biological background.
This overview summarizes most of biological terminologies that have been appeared
throughout the thesis.
• HCV genotypes: There are 6 major genotypes and they diﬀer in their nu-
cleotide sequence by 30 − 35%, and within an HCV genotype, 11 common
subtypes (1a-c, 2a-c, 3a, 3b, 4a, 5a, and 6a) can be deﬁned that diﬀer in their
nucleotide sequence by 20− 25% [32].
• NS5B [32] : NS5B RNA-dependent RNA polymerase belongs to a class of
membrane proteins. It is a key enzyme responsible for both plus and minus-
strand RNA synthesis. HCV replication proceeds by the synthesis of a com-
plementary minus-strand RNA using the plus-strand RNA as a template and
the subsequent synthesis of genomic plus-strand RNA from this minus-strand
RNA.
• NS4B [32]: NS4B is a relatively poorly characterized protein. One of its
functions is to induce the formation of the replication vesicles which serves as
a scaﬀold for the HCV replication complex.
• NS5A [32]: NS5A is a phosphoprotein that can be found in basally phospho-
rylated and hyperphosphorylated forms. Phosphorylation of NS5A is a con-
served feature among hepaciviruses and pestiviruses and is found in ﬂavirus
NS5B proteins, arguing that it has an important role in the HCV lifecycle.
Some studies suggested that the phosphorylated state of NS5A modulates the
eﬃciency of HCV RNA replication.
• NS2-3 protease: The NS2-3 protease is known also as an autoprotease and it
is not important for RNA replication in vitro but is essential for the complete
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replication cycle in vitro and in vivo [32]. NS2-3 protease cleaves the site
between NS2 and NS3 and NS2 is a short lived protein that looses its protease
activity after self-cleavage from NS3 [108].
• NS3-NS4A protease [108]: NS3 is a multifunctional viral protein contain-
ing a serine protease and NS4A is a cofactor of NS3 protease activity. This
protease is essential for the HCV lifecycle and catalyzes HCV polyprotein
cleavage at NS3/NS4A, NS4A/NS4B, NS4B/NS5A and NS5A/NS5B junc-
tions. It is one of the most popular viral targets for anti-HCV therapeutics. It
has been shown that this protease blockades the intracellular double-stranded
RNA sensor protein (RIG-I) pathway.
• p7[32] : P7 is a small polypeptide that is often incompletely cleaved from E2.
It is not required for RNA replication in vitro but is essential for productive
infection in in vivo.
• E1 and E2 Envelope Glycoproteins: The two envelope glycoproteins, E1
and E2 are the essential components of the HCV virion envelope and necessary
for viral entry and fusion [108].
• Core protein: The ﬁrst structural protein encoded by the HCV is the core
protein which forms the viral nucleocapsid [32].
• Low density lipoprotein receptor [108]: Low density lipoprotein receptor
is an endocytic receptor that transports lipoproteins into the cells through
receptor-mediated endocytosis. Virus-like particles complexed with LDLs have
been reported to enter the cells via LDL receptor.
• SR-BI [108]: A scavenger receptor B type I is a glycoprotein with a large
extracellular loop anchored to the plasma membrane. It is considered as a
fatty acylated protein located in the lipid raft domain and is highly expressed
in the hepatocytes. It has been proposed as the another candidate receptor
for HCV.
• IRES [75]: “An internal ribosome entry site is a nucleotide sequence that
allows for a translation initiation in the middle of a messenger RNA (mRNA)
sequence as a part of the greater process of protein synthesis. Usually, in
eukaryotes, the translation can be initiated only at the 5’ end of the mRNA
molecule, since 5’ cap recognition is required for the assembly of the initiation
complex. IRES are often used by viruses as a means to ensure that the viral
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translation is active during periods of time when the host translation is inhib-
ited. These mechanisms of host translation inhibition are varied, and can be
initiated by both the virus and the host, depending on the type of virus in
question.”
• CD81: The cell surface protein which is encoded by CD81 gene and this pro-
tein mediates the signal transduction events that play a role in the regulation
of cell development, activation, growth and motility [118]. It has been shown
that HCV binds to this protein through its envelope glycoprotein E2 [108].
• Endocytosis: Endocytosis is a mechanism for cells to remove ligands, nutri-
ents, and plasma membrane (PM) proteins, and lipids from the cell surface,
bringing them into the cell interior [105]. HCV enters the cell through endo-
cytosis [108].
• Viral nucleocapsid [76]: A capsid plus the enclosed nucleic acid is called
a nucleocapsid. Capsid is a protein coat which encloses the nucleic acid of
a virion and composed of multiple copies of one protein or a few diﬀerent
proteins, each of which is encoded by a single viral gene.
• 5’ cap [76]: 5’ cap is a guanine nucleotide which has been added 5’ end of
mRNA shortly after the start of transcription. The cap protects an mRNA
from an enzymatic degradation and assists in its export to the cytoplasm. The
cap is also bound by a protein factor required to begin the translation in the
cytoplasm .
• Ribosomes [76]: An enormously complex molecular machine composed of
both the RNA and the protein that carry out the translation. During the
translation, the ribosomes assemble and link together the amino acids in the
precise order dictated by the mRNA sequence according to the nearly universal
genetic code.
• RNA polymerase: A large enzyme that catalyzes the linkage of nucleotides
into a single-stranded ribonucleic acid (RNA) [76].
• Mutation: Changes or mistakes which occusionally occur spontaneously dur-
ing DNA or RNA replication causing changes in the sequence of nucleotides
[76].
• Gene expression: The overall process of selectively reading and using genetic
information [76].
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• Fatty acids: Fatty acids are an important source of many cells and are stored
in the form of triacylglycerols within an adipose tissue [76].
• DNA [76]: Deoxyribonucleic acid contains all the information required to
build the cells and the tissues of an organism. The information stored in DNA
is arranged in the hereditary units, known as genes, that control the identiﬁable
traits of an organism. In the process of transcription, the information stored
in DNA is copied into a ribonucleic acid (RNA).
• mRNA [76]: Messenger RNA carries the genetic information and the instruc-
tions from DNA that specify the correct order of amino acids during a protein
synthesis. In HCV, its genome acts as an mRNA.
• Viruses [76]: Viruses are the parasites of the cellular genetic system. They
cannot reproduce by themselves and must commandeer a host cell’s machinery
to synthesize viral proteins and some cases to replicate the viral genome. The
entire infectious virus particle is called a virion which consists of the nucleic
acid and an outer shell of protein.
• Cell line: A culture of cells with an indeﬁnite lifespan which is considered
immortal [76].
• Protease [76]: Protease is an enzyme that cleaves the polypeptide bonds in a
protein. Through this mechanism, the proteases degrade a variety of proteins
and peptides.
• Nuclease [76]: Nuclease is an enzyme that cleaves the bonds between the
nucleotide subunits of nucleic acids. They degrade RNA and DNA into their
mononucleotide building blocks.
• Co-precipitation (Immunoprecipitation): Immunoprecipitation (IP) is a
method that uses the antigen-antibody reaction principle to identify a protein
that reacts speciﬁcally with an antibody from mixture of proteins so that its
quantity or physical characteristics can be examined [3].
• Immunostaining [49]: Immunostaining is a technique widely used for a co-
localization of multiple peptide antigens. Immunostaining can be used for a
variety of applications based on investigating the presence or the absence of
a protein, its tissue distribution, its sub-cellular localization, or changes in a
protein expression or degradation.
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• ER membranes[76] : The endoplasmic reticulum is an organelle of cells that
synthesizes lipids and detoxiﬁes certain hydrophobic compounds. It also func-
tions in the synthesis, processing and sorting of secreted proteins, lysosomal
proteins and certain membranes.
• Golgi apparatus [76]: Golgi processes and sorts the secreted proteins, the
lysosomal proteins and the membrane proteins synthesized on the rough ER
before they reach to the ﬁnal destination.
• Subgemonic replicons: Subgenomic replicon is a subset of full length repli-
con that is capable of autonomous replication in the Huh7 cells.
• miRNAs Micro RNA is a short RNA with 21 and 22 nucleotides long that
hybridizes to the 3’ non-translated regions of speciﬁc target mRNAs. It re-
presses the translation of these mRNAs by yet unknown mechanism [76].
• RNA interference [76]: RNA interference (RNAi) is a post-transcriptional
process triggered by the introduction of double-stranded RNA (dsRNA) which
leads to a gene silencing in a sequence-speciﬁc manner. The studies with the
extracts of Drosophilia embryos showed that a long double-stranded RNA that
mediates interference is initially processed into a double-stranded intermediate
referred to as short interfering RNA (siRNA).
• Cyclosporin A (CsA) Cyclosporin A (CsA) is a cyclic peptide of fungal
origin and a potent immunosuppressant. It is used to prevent a rejection
of kidney and liver transplants. It appears to act on the immune system
by inhibiting the initial steps of T-lymphocyte activation [51]. It has been
observed that CsA inhibits the HCV replication in vitro [32].
• Cyclophilin B [60]: Cyclophilin B is a secreted protein which binds to
the immunosuppressive drug cyclosporin A. Cyclophilin B possesses a cellular
peptidyl-prolyl ciss-trans isomerase activity and interacts with the C-terminal
region of NS5B to directly stimulate its RNA binding activity, and thereby
contributes to the eﬃcient replication of HCV RNA.
• PI4KIII [124]: PI4KIII is an enzyme that catalyzes the synthesis of phos-
phatidylinositol 4-phosphate which is prevalent in the membrane of the Golgi
apparatus. It was reported that an enzymatic activity is critical for HCV
replication.
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• p68: p68 also known as DEAD box protein, is a putative RNA helicase. They
are implicated in a number of cellular processes involving an alteration of RNA
secondary structure, such as a translation initiation, a nuclear and mitochon-
drial splicing, and a ribosome and spliceosome assembly [118]. It has been
reported that p68-NS5B interaction may serve to mediate HCV replication
[45].
• Nucleolin: Nucleolin is a eukaryotic nucleolar phosphoprotein involved in the
synthesis and maturation of ribosomes [118].
• hnRNP A1 [118]: The heterogeneous nuclear ribonucleoprotein A1 (hn-
RNPs) are the RNA binding proteins and they form a complex with the het-
erogeneous nuclear RNA (hnRNA). These proteins are associated with pre-
mRNAs in the nucleus and appear to inﬂuence a pre-mRNA processing and
other aspects of the mRNA metabolism and transport.
• Septin 6: Septin 6 is a member of the septin family of GTPases and the
members of this family are required for cytokinesis [118].
• Cis-acting elements: Cis-acting elements are regions of a non-coding DNA
or RNA that bind to the transcription factors that act to repress or activate
the gene expression [55].
• PTB: Polypyrimidine tract binding (PTB) protein is an ubiquitous cellular
factor binding to RNA or single-stranded DNA, and is highly conserved during
evolution [26]. It was reported that PTB may also be involved in the viral
replication and has been observed to modulate an HCV IRES activity binding
to the several sites within the viral genome [64].
• hVAP-A [118]: Human vesicle associated membrane protein A (hVAP-A) is
present in the plasma membrane and the intracellular vesicles. It may also
be associated with the cytoskeleton. This protein may function in a vesicle
traﬃcking, a membrane fusion, a protein complex assembly and a cell motility.
• Lipid rafts: Lipid rafts are the specialized membrane microdomains that
serve as organizing centers for an assembly of signaling molecules, an inﬂuence
membrane ﬂuidity and a traﬃcking of membrane proteins, and regulate dif-
ferent cellular processes such as a neurotransmission and a receptor traﬃcking
[66].
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• Recombinant protein [76]: A protein that is encoded from a recombinant
DNA or RNA which is simply any DNA or RNA molecule composed of the
sequences derived from diﬀerent sources. The diﬀerence between the recombi-
nant DNA and the DNA is only in the sequence of the nucleotides within that
identical overall structure.
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Appendix C
Publications
The work in this thesis has been partially published in the following conferences and
journals:
1. Sulaimanov N, Knapp B., Mazur J., Kaderali L.Modeling HCV Virus-Host In-
teractions. Poster presentation at the Symposium on Viral Kinetic Modeling,
Frankfurt, September 19-20, 2008.
2. Sulaimanov N., Binder M., Lohmann V., Bartenschlager R., Kaderali L. Mod-
eling the Dynamics of Hepatitis C Virus Intracellular Replication. Poster pre-
sentation at the German Symposium on Systems Biology, Heidelberg, May
12-15, 2009.
3. Sulaimanov N., Binder M., Lohmann V., Bartenschlager R., Kaderali L. Sys-
tems Biology of Hepatitis C Virus Replication. Poster presentation at the
Conference on Systems Biology of Mammalian Cells, Freiburg, June 3-5, 2010.
4. Sulaimanov N., Binder M., Lohmann V., Bartenschlager R., Kaderali L. Mod-
eling the Intracellular Dynamics of HCV. Poster presentation at the Interna-
tional Conference on Systems Biology of Human Disease, Boston, June 16-18,
2010.
5. Sulaimanov N., Binder M., Lohmann V., Bartenschlager R., Kaderali L. Sys-
tems Biology of Hepatitis C Virus Replication. Poster presentation at the 1st
Cellular Networks Conference, Heidelberg, September 23-26, 2010.
6. Sulaimanov N., Binder M., Lohmann V., Bartenschlager R., Kaderali L. Sys-
tems Biology of Hepatitis C Virus Replication. Poster presentation at the 11th
International Conference on Systems Biology, Edinburgh, October 11-14, 2010.
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7. Sulaimanov N., Binder M., Lenz S., Schlöder J., Lohmann V., Bartenschlager
R., Kaderali L. Modeling Virus-Host Interactions. Poster presentation at the
International Conference on Systems Biology of Human Disease, Boston, June
22-24, 2011.
8. Clausnitzer D., Sulaimanov N., Binder M., Lohmann V., Bartenschlager R.,
Kaderali L (2011). Systembiologie der Hepatitis C-Virus-Wirts-Interaktionen.
Laborwelt 6:13-15.
9. Sulaimanov N., Binder M., Lenz S., Schlöder J., Lohmann V., Bartenschlager
R., Kaderali L. Replication Vesicles are Load- and Choke Points in the Hepati-
tis C Virus Lifecycle. In preparation for the submission to Molecular Systems
Biology.
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